A (2010-2018)

STUDIES ON CONDITIONS and RELATED ARTICLES 

2010-2014 & 2015-2018

*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000-2009 List
>Information in Another Section

ACHALASIA (Esophageal sphincter doesn’t relax, preventing food from entering the intestines)
ACHILLES TENDINOSIS
ACIDEMIA (See ORGANIC ACIDEMIA)
ACNE +
ACUPUNCTURE/ELECTROACUPUNCTURE +
ADD/ADHD*+
ADDICTION/CRAVING/PROBLEMATIC USE*+
ADDISON’S DISEASE
ADENOMA-BENIGN
ADOLESCENTS/YOUNG ADULTS +
ADRENOLEUKODYSTROPHY (Inherited condition that affects the white matter of the nervous system and adrenal cortex)
AGE-RELATED DIFFERENCES
AGING + (See Also OLDER ADULT CANNABIS USERS, MENOPAUSE)
AIDS (See HIV)
ALCOHOLISM/ALCOHOL*+
ALLERGIES AND CANNABINOIDS*+
ALLERGIES TO CANNABIS/CANNABINOIDS*+
ALS/AMYOTROPHIC LATERAL SCLEROSIS +
ALZHEIMER’S DISEASE/DEMENTIA*+
AMNESIA*+
AMOTIVATIONAL SYNDROME*+
ANESTHESIA
ANGELMAN’S SYNDROME (See Also News Section)
ANGIOEDEMA (Similar to Hives, but Swelling is Under the Skin, May be Due to Allergies)
ANGIOGENESIS + (Formation of New Blood Vessels)
ANOREXIA/ANOREXIA NERVOSA + (See Also APPETITE)
ANTI-BACTERIAL PROPERTIES*+ (See Also MRSA)
ANTI-FUNGAL PROPERTIES +
ANTI-INFLAMMATORY> (See INFLAMMATION)
ANTI-MICROBIAL PROPERTIES*+
ANTIOXIDANT PROPERTIES +
ANTI-PARASITIC PROPERTIES
ANXIETY/AGITATION*+ (Anxiety Reducing)
APPETITE*+ (See Also OBESITY, TASTE)
ARTHRITIS +
ARACHIDONYL-2′-CHLOROETHYLAMIDE (See ACEA in the SYNTHETICS Section)
2-ARACHIDONOYLGLYCEROL (See 2-AG in the ENDOCANNABINOID SYSTEM Section)
ASIA SYNDROME/AUTOIMMUNE/INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS
ASTHMA*+ (See Also LUNG FUNCTION)
ATAXIA*+ (Lack of Muscle Coordination During Movements Like Walking, Sometimes Hereditary, See Also SPINOCEREBELLAR ATAXIA and PHARC)
ATHEROSCLEROSIS*+
AUTISM + (See Also FRAGILE X SYNDROME)
AUTOIMMUNE DISORDERS (See Also MULTIPLE SCLEROSIS, ENCEPHALOMYELITIS, LUPUS, ARTHRITIS, IBS, PSORIASIS, DIABETES, GRAVE’S DISEASE, CELIAC DISEASE, etc.)
top


ACHALASIA
Achalasia, status post myotomy (case report–undated)
http://cannabisclinicians.org/view-all-case-reports/entry/597/?pagenum=2
Self-medication of achalasia with cannabis, complicated by a cannabis use disorder (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i20/6381.htm
Review: The Role of Cannabinoids on Esophageal Function—What We Know Thus Far
(full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665514/


ACHILLES TENDINOSIS
Increased Expression of Cannabinoid CB(1) Receptors in Achilles Tendinosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169627/?tool=pubmed


ACNE+
Endocannabinoid signaling and epidermal differentiation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21628127
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full–2014) http://www.jci.org/articles/view/64628
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26142529
Dermatological Aspects of Synthetic Cannabinoid Addiction (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028361
Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27094344
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (full–2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext


ACUPUNCTURE/ELECTROACUPUNCTURE+
Involvement of ERK 1/2 activation in electroacupuncture pretreatment via cannabinoid CB1 receptor in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20654595
Electroacupuncture increases CB2 receptor expression on keratinocytes and infiltrating inflammatory cells in inflamed skin tissues of rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20627823
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Activation of epsilon protein kinase C-mediated anti-apoptosis is involved in rapid tolerance induced by electroacupuncture pretreatment through cannabinoid receptor type 1 (full–2011) http://stroke.ahajournals.org/content/42/2/389.long
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22337285
top

Effects of repeated electroacupuncture on gene expression of cannabinoid receptor-1 and dopamine 1 receptor in nucleus accumbens-caudate nucleus region in inflammatory-pain rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21585053
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22301508
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337285
Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677619/
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730365/
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23880371
Acupuncture therapy for stroke patients (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24215922
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23943518
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice (full–2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension? (full–2015) http://www.cmjournal.org/content/10/1/36
Acupuncture Mechanisms: Anesthesia, Analgesia and Protection on Organ Functions (link to PDF–2015) http://citeseerx.ist.psu.edu/viewdoc/summary? doi=10.1.1.732.8262&rank=2&q=cannabinoid&osm=&ossid
Cannabis-therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323449
Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114016300913
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834685
The endocannabinoid system, a novel and key participant in acupuncture’s multiple beneficial effects (abst–2017) http://www.sciencedirect.com/science/article/pii/S0149763417301318
Electroacupuncture Inhibits NLRP3 Inflammasome Activation through CB2 Receptors in Inflammatory Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28782714
top


ADD/ADHD*+
Oral Delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20520294
Panic Attack after Spice Abuse in a Patient with ADHD (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1243252
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids
(full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210336/
Loss of striatal cannabinoid CB1 receptor function in attention-deficit/hyperactivity disorder mice with point-mutation of the dopamine transporter (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22034972
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22495620
Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation (abst–2012) http://www.sciencedirect.com/science/article/pii/S0197018612000952
Impact of ADHD and cannabis use on executive functioning in young adults (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23992650

Subtypes of Attention Deficit-Hyperactivity Disorder (ADHD) and Cannabis Use (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24093525
Use of micronutrients attenuates cannabis and nicotine abuse as evidenced from a
reversal design: a case study (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/23909004
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25175495
Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24332802
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25650954
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25832823
Use of paracetamol during pregnancy and child neurological development (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25851072
Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25989844
From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder (abst–2015) http://informahealthcare.com/doi/abs/10.3109/16066359.2014.954556
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26489976
top

Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey (full–2016) http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0746-4
Attention deficit hyperactivity disorder and drug addiction rehabilitation patients (full–2016) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004- 282X2016001201003&lng=en&nrm=iso&tlng=en
“I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156614

Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215781/
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders (full–2016) http://journals.sagepub.com/doi/full/10.1177/1087054716640109
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26903256
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529509
Targeting the Endocannabinoid System in Psychiatric Illness (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27811555
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (full–2017) http://www.sciencedirect.com/science/article/pii/S221315821630170X
Substance Use in Undergraduate Students With Histories of Attention-Deficit / Hyperactivity Disorder (ADHD): The Role of Impulsivity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28406351
Concurrent use of cannabis and alcohol: neuropsychiatric effects and consequences (abst -2017) https://www.ncbi.nlm.nih.gov/pubmed/28440194 
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28561272 
Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28576350
How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning (abst–2017)   http://journals.sagepub.com/doi/abs/10.1177/1087054716685842?url_ver=Z39.882003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed


ADDICTION/CRAVING/PROBLEMATIC USE+*
Indian hemp and the dope fiends of Old England (article-undated) http://www.idmu.co.uk/indian.htm
Addictive Properties of Popular Drugs (article–undated) http://www.drugwarfacts.org/cms/Addictive_Properties#sthash.6yenIhQ8.dpbs
Medical marijuana users in substance abuse treatment (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848643/?tool=pubmed
More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945903/
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004984/

Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans
Smoking Their Chosen Cannabis (full-2010)
http://www.nature.com/npp/journal/v35/n9/full/npp201058a.html
Marijuana craving during a public speaking challenge: Understanding marijuana use
vulnerability among women and those with social anxiety disorder (full–2010)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981668/
Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and
female rats: influence of ovarian hormones (full-2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931571/
How important are sex differences in cannabinoid action? (full–2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931555/
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor
Sensitivity in the Striatum (full-2010)
http://www.nature.com/npp/journal/v35/n2/full/npp2009141a.html
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study
in first episode schizophrenia (full–2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900481/?tool=pubmed
Aerobic Exercise Training Reduces Cannabis Craving and Use in Non-Treatment Seeking Cannabis-Dependent Adults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050879/?tool=pmcentrez
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154755/
Characterizing smoking topography of cannabis in heavy users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641906/
Social Anxiety and Marijuana-Related Problems: The Role of Social Avoidance (full-2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981690/
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085576/
The Endogenous Cannabinoid 2-Arachidonoylglycerol Is Intravenously SelfAdministered
by Squirrel Monkeys (full–2011)  http://www.jneurosci.org/content/31/19/7043.long#abstract-1
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21542664
Cannabinoid receptor expression and phosphorylation are differentially regulated
between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0304394011006033
Association between a cannabinoid receptor gene (CNR1) polymorphism and
cannabinoid-induced alterations of the auditory event-related P300 potential (abst–2011) http://www.sciencedirect.com/science/article/pii/S030439401100437X?via%3Dihub
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0278584610004227
Alcohol and cannabis abuse/dependence symptoms and life satisfaction in young
adulthood (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21733007
A randomized, double-blind, placebo-controlled, crossover study to evaluate the
subjective abuse potential and cognitive effects of nabiximols oromucosal spray in
subjects with a history of recreational cannabis use (abst–2011)
http://www.ncbi.nlm.nih.gov/pubmed/21671456
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in CannabisDependent Adolescents (full–2012) http://ajp.psychiatryonline.org/article.aspx?articleID=1184217&resultClick=1
The Interplay between Parental Monitoring and the Dopamine D4 Receptor Gene in Adolescent Cannabis Use (full–2012) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0049432&representation=PDF
Involvement of the endocannabinoid system in reward processing in the human brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266503/
Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251168/
Associations of Alcohol, Nicotine, Cannabis, and Drug Use/Dependence with Educational Attainment: Evidence from Cotwin-Control Analyses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412907/
A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733446/
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012)  https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
top
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012)
http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Social Anxiety and Cannabis Use: An Analysis from Ecological Momentary Assessment
(full – 2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268873/
The genetic basis of the endocannabinoid system and drug addiction in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21937688
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study
With [11C]-(+)-PHNO (full – 2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572464/
Endocannabinoids and the processing of value-related signals. (full – 2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270484/?tool=pubmed
A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use,
withdrawal and executive function deficits in cannabis-dependent adults.
(full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358737/
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are
Dependent on the “Mirror Effect” of Schizophrenia. (full – 2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine
Self Administration and Reinstatement of Nicotine Seeking. (full – 2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266883/?tool=pubmed
Alelle specific differences in the activity of a novel cannabinoid receptor 1(CNR1) gene
intronic enhancer in hypothalamus, dorsal root ganglia and hippocampus. (full – 2012)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339935/
The genetic basis of the endocannabinoid system and drug addiction in humans
(abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21937688
Reduction of dependence to cannabinoids by GLT-1 activating property of the betalactam antibiotic (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23253111
Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug users (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22722508
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
Cognitive ability in early adulthood as a predictor of habitual drug use during later military service and civilian life: the Vietnam Experience Study (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22520690 
Cannabis Use Vulnerability Among Socially Anxious Users: Cannabis Craving During a
Social Interaction (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23002698
The impact of comorbid cannabis use disorders on the clinical presentation of social
anxiety disorder (abst–2012) https://www.ncbi.nlm.nih.gov/pubmed/22047609
Marijuana-related problems and social anxiety: the role of marijuana behaviors in social
situations (abst–2012) https://www.ncbi.nlm.nih.gov/pubmed/22004129
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in
animals (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22807156
The underdiagnosis of cannabis use disorders and other Axis-I disorders among military
veterans within VHA (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22808884
Substance use disorders in the U.S. Armed Forces, 2000-2011 (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/23231051
Assessing Tobacco Dependence Among Cannabis Users Smoking Cigarettes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22855882
Implicit Associations and Explicit Expectancies toward Cannabis in Heavy Cannabis  Users and Controls (full–2013) http://www.frontiersin.org/Addictive_Disorders_and_Behavioral_Dyscontrol/10.3389/fpsyt.2013.00059/full
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635
THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590996/
Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223560/
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662489/
Probability and predictors of transition from abuse to dependence on alcohol, cannabis and cocaine: results from the national epidemiologic survey on alcohol and related conditions (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755735/
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835353/
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817049/
top
Cannabis Cue Reactivity and Craving Among Never, Infrequent and Heavy Cannabis Users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957117/
Low frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid (full–2013) http://jn.physiology.org/content/111/5/1046.long
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742578/
Role of CB2 Cannabinoid Receptor in the Rewarding, Reinforcing and Physical Effects of Nicotine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799072/
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity (full–2013) http://ijnp.oxfordjournals.org/content/16/10/2273
A Randomized Double-blind, Placebo Controlled Trial of Venlafaxine-Extended Release
for Co-occurring Cannabis Dependence and Depressive Disorders (full–2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636166/
Plasma Cannabinoid Concentrations During Dronabinol Pharmacotherapy for Cannabis
Dependence (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955404/
The Subjective Psychoactive Effects of Oral Dronabinol Studied in a Randomized,
Controlled Crossover Clinical Trial For Pain (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013220/
Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence (editorial–2013) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2012.12050615
Legalization of marijuana: unraveling quandaries for the addiction professional (article–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00050/full
Cannabis and Cigarettes (abst–2013) http://jama.jamanetwork.com/article.aspx?articleid=1681388&resultClick=3
Therapeutic potential of cannabinoid medicines (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24006213
Endocannabinoid system and drug addiction: new insights from mutant mice approaches (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23490550

Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23510307
Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23523958
Dysregulation of Cannabinoid CB1 Receptor and Associated Signaling Networks in Brains of Cocaine Addicts and Cocaine-Treated Rodents (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23727505
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829370
Palmitoylethanolamide: From endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23896215
top
Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis-dependent individuals (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24186078
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24247477
Erratum to: Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats (correction to chart–2013) http://link.springer.com/article/10.1007%2Fs00213-013-3380-6
Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol (abst–2013)
https://www.ncbi.nlm.nih.gov/pubmed/23855434
Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24281745
The effects of cannabis use expectancies on self-initiated cannabis cessation (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/add.12233/abstract
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Posttraumatic stress disorder and cannabis use characteristics among military veterans
with cannabis dependence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23617872
Sleep Quality Moderates the Relation between Depression Symptoms and Problematic
Cannabis Use among Medical Cannabis Users (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23721537
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other
neuropsychiatric disorders (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/
Prolonged monoacylglycerol lipase blockade causes equivalent CB1-receptor mediated adaptations in FAAH wild type and knockout mice (full–2014) http://jpet.aspetjournals.org/content/early/2014/05/21/jpet.114.212753.long
Pregnenolone can protect the brain from cannabis intoxication (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057431/
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009342/
Systematic review of N-acetylcysteine in the treatment of addictions (full–2014)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014005031244&lng=en&nrm=iso&tlng=en
Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues (full–2014) http://journal.frontiersin.org/Journal/10.3389/fpsyt.2014.00118/full
Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131522/
top
Delta-9 tetrahydrocannabinol (THC) and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation (ICSS) in mice (full–2014) http://jpet.aspetjournals.org/content/early/2014/11/14/jpet.114.218677.long
Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930061/
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963405/
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial (full–2014) http://archpsyc.jamanetwork.com/article.aspx?articleid=1812720
Evaluation of sex differences in cannabinoid dependence (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971653/
Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice (full–2014) http://www.jneurosci.org/content/34/15/5152.long
Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986824/
Enhanced Endocannabinoid-Mediated Modulation of Rostromedial Tegmental Nucleus Drive onto Dopamine Neurons in Sardinian Alcohol-Preferring Rats (full–2014) http://www.jneurosci.org/content/34/38/12716.long
Chronic stimulation of the tone of endogenous anandamide reduces cue – and stress induced relapse in rats (full–2014) http://ijnp.oxfordjournals.org/content/18/1/pyu025.long
Cannabis Withdrawal in Patients With and Without Opioid Dependence (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127106/
The CB1 Receptor as an Important Mediator of Hedonic Reward Processing (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138748/
Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161674/
Investigation of sex-dependent effects of cannabis in daily cannabis smokers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518446/
Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097075/
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25510937
The endocannabinoid system regulates synaptic transmission in nucleus accumbens by increasing DAGL-α expression following short-term morphine withdrawal (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25296881
top
Cannabinoid modulation of drug reward and the implications of marijuana legalization  (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25463025
Expression and localization of cannabinoid receptor 1 in rats’ brain treated with acute and repeated morphine (link to PDF–2014) http://www.ncbi.nlm.nih.gov/pubmed/25231848
Genetic variation in personality traits explains genetic overlap between borderline
personality features and substance use disorders (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229407/
Paranoid Personality Disorder in the United States: The Role of Race, Illicit Drug Use,
and Income (full–2014)  https://www.researchgate.net/publication/265213487_Paranoid_Personality_Disorder_in_the_United_States_The_Role_of_Race_Illicit_Drug_Use_and_Income
The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944632/
Risk-taking in schizophrenia and controls with and without cannabis dependence (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308438/ 
Expression and localization of cannabinoid receptor 1 in rats’ brain treated with acute and repeated morphine (link to PDF–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25231848
Strain differences in the expression of endocannabinoid genes and in cannabinoid
receptor binding in the brain of Lewis and Fischer 344 rats. (abst – 2014)
https://www.ncbi.nlm.nih.gov/pubmed/24607771
Endocannabinoid signaling and food addiction (abst – 2014)
http://www.sciencedirect.com/science/article/pii/S0149763414002061
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24628797 
Changes in cigarette and alcohol use during cannabis abstinence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24613633
Imaging dopamine transmission parameters in cannabis dependence. (abst – 2014)
http://www.sciencedirect.com/science/article/pii/S0278584613002340?via%3Dihub
The FAAH inhibitor PF-04457845 has THC-like rewarding and reinstatement effects in squirrel monkeys and increases dopamine levels in the nucleus accumbens shell in rats (abst–2014) http://www.fasebj.org/content/28/1_Supplement/838.6.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Association study of CNR1, GAD1 and BDNF polymorphisms with male heroin dependence in the Dai population in Yunnan (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25252306
Neuroinflammation as a possible link between cannabinoids and addiction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25455257
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25459131
Etno-territorial prevalence of hashishism in some Siberian areas (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25403303
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24589297 
Abstinence phenomena of chronic cannabis-addicts prospectively monitored during
controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation
with delta-9-tetrahydrocannabinol and -metabolites in serum (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/25127704
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/adb.12080/full
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies. (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318341/
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America (full–2015) http://eurpub.oxfordjournals.org/content/25/suppl_2/73.long
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset (full–2015) http://link.springer.com/article/10.1007/s10519-015-9723-9/fulltext.html
top

Role of the endogenous cannabinoid system in nicotine addiction: novel insights (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373509/
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545660/
Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements (full–2015) http://www.nature.com/articles/srep16176
Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444130/
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568004/
Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900926-2
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons (full–2015) http://www.mdpi.com/1660-4601/13/1/5/htm
Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25746234
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801289
Are genetic variants for tobacco smoking associated with cannabis involvement? (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900113-1/abstract
Twitter Chatter about Marijuana (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306811/
ADOLESCENTS’ USE OF MEDICAL MARIJUANA: A SECONDARY ANALYSIS OF MONITORING THE FUTURE DATA (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514911/
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26269227
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26386827
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26595473
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586926
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26455361
Separate and combined effects of gabapentin and Δ9-THC in humans discriminating Δ9-
THC (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769128/
Parental Separation and Early Substance Involvement: Results from Children of
Alcoholic and Cannabis Dependent Twins (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908916/
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (abst–2015) http://www.nber.org/papers/w21345
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26500166
Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in
rhesus monkeys (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779715/
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of
Smoked Cannabis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908634/
Towards a comprehensive developmental model of cannabis use disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956073/
Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-like
Behavior (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864655/
Molecular Targets of Cannabidiol in Neurological Disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604182/
Vilazodone for cannabis dependence: A randomized, controlled pilot trial (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937726/
The impact of gonadal hormones on cannabinoid dependence (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696547/
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in
schizophrenia (full–2015)  http://neuro.psychiatryonline.org/doi/full/10.1176/appi.neuropsych.12120398
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Marijuana, Reconsidered: Dr Lester Grinspoon On 45 Years Of Cannabis Science (interview–2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/
Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25725933
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on
Mesocorticolimbic Dopamine Function (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/26638769
A review of co-morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co-use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25662704
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25714966
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at
Glutamatergic Synapses in the Rat Basolateral Amygdala. (abst – 2015)
http://www.sciencedirect.com/science/article/pii/S002839081530201X
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25950588
The hippocampal NMDA receptors may be involved in acquisition, but not expression of ACPA-induced place preference (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26072736
The influence of cannabinoids on learning and memory processes of the dorsal striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092091
top
Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179931
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26202613
Sex differences in associations between cannabis craving and neural responses to cannabis cues: Implications for treatment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237321
Evaluation of the abuse potential of AM281, a new synthetic cannabinoid CB1 receptor antagonist (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26450088
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26364922
Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26507196
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
top
Relationship between the 1359 G/A polymorphism of the Central Cannabinoid Receptor 1 (CNR1) gene and susceptibility to cannabis addiction in a Turkish population (abst–2015)  http://www.tandfonline.com/doi/abs/10.1080/00450618.2014.936895?journalCode=tajf20
Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26212076
Mediating processes between stress and problematic marijuana use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661989
Application of drug testing using exhaled breath for compliance monitoring of drug
addicts in treatment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25562730
Marijuana dependence moderates the effect of posttraumatic stress disorder on trauma
cue reactivity in substance dependent patients (abst – 2015)
http://www.sciencedirect.com/science/article/pii/S0376871615018293
Stimulation OF IN VIVO dopamine transmission and intravenous self-administration in
rats and mice by JWH-018, a Spice cannabinoid (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0028390815300861
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug? (full–2016) http://link.springer.com/article/10.1007/s12640-015-9555-7/fulltext.html
Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait (full–2016) http://www.hindawi.com/journals/np/2016/6481862/ 
Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey (full–2016) http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0746-4 
Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium (full–2016) http://www.nature.com/tp/journal/v6/n3/full/tp201636a.html 
Examination of the Addictive and Behavioral Properties of Fatty Acid-Binding Protein Inhibitor SBFI26 (full–2016) http://journal.frontiersin.org/article/10.3389/fpsyt.2016.00054/full
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273%2816%2930157-X
Trends in cannabis use disorders among racial/ethnic population groups in the United States (full–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30147-8/fulltext
Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886733/
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis (full – 2016) http://www.sciencedirect.com/science/article/pii/S2451902215000099
Attempts to Stop or Reduce Daily Cannabis Use: An Intensive Natural History Study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877269/
Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016301689
Interactions between the endocannabinoid and nicotinic cholinergic s ystems: preclinical evidence and therapeutic perspectives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26728894
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial (full–2016) http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1507-x
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028912/
Black–White Disparities in Criminal Justice Referrals to Drug Treatment: Addressing Treatment Need or Expanding the Diagnostic Net? (full – 2016) http://www.mdpi.com/2076-328X/6/4/21/htm
Involvement of Endocannabinoids in Alcohol “Binge” Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962692/
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males (full–2016) http://www.nature.com/tp/journal/v6/n11/full/tp2016225a.html
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00264/full
Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol Self Administration by Wistar Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152943/
Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats (full–2016) http://ijnp.oxfordjournals.org/content/early/2016/12/19/ijnp.pyw102.long
Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147424/
fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012952/
Attention deficit hyperactivity disorder and drug addiction rehabilitation patients (full–2016) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004- 282X2016001201003&lng=en&nrm=iso&tlng=en
Is attention deficit/hyperactivity disorder among men associated with initiation or
escalation of substance use at 15-month follow up? A longitudinal study involving young
Swiss men (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215781/
Combined treatment with morphine and Δ9-tetrahydrocannibinol (THC) in rhesus
monkeys: antinociceptive tolerance and withdrawal (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851324/
Lipids in psychiatric disorders and preventive medicine (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26728894
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26756393
top
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys (abst–2016) http://link.springer.com/article/10.1007/s00213-016-4211-3
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26888056
Combined treatment with morphine and Δ9-tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26937020
Alcohol and cannabis use among college students: Substitutes or complements? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26894560
Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder (abst -2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472%2815%2900313-X/abstract
The association of specific traumatic experiences with cannabis initiation and transition
to problem use: Differences between African-American and European-American women.
(full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833569/
Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27026633
Comorbid Cannabis and Tobacco Use in Adolescents and Adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27175326
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27144526
A Functional 3’UTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Reward Traits (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27074815
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013 (abst–2016) http://www.jaacap.com/article/S0890-8567%2816%2930101-0/abstract
Genetic and Environmental Factors Associated with Cannabis Involvement (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019486/
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward
Regions (full–2016) https://www.ncbi.nlm.nih.gov/pubmed/27707960
Age of Alcohol and Cannabis Use Onset Mediates the Association of Transmissible Risk
in Childhood and Development of Alcohol and Cannabis Disorders: Evidence for
Common Liability (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565072/
Brain circuitry associated with the development of substance use in bipolar disorder and
preliminary evidence for sexual dimorphism in adolescents (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123602/
Sex Differences in Cannabinoid-Regulated Biology: A Focus on Energy Homeostasis
(full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783283/
Drug abuse in slum population (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776588/
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and
a laboratory model of relapse in cannabis users (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302052/
Pharmacological characterization of repeated administration of the first generation
abused synthetic cannabinoid CP47,497 (link to PDF–2016)  http://www.degruyter.com/view/j/jbcpp.2016.27.issue-3/jbcpp-2015-0118/jbcpp-2015-0118.xml
Dissecting the signaling pathways involved in the crosstalk between mGlu5 and CB1
receptors (link to PDF–2016)  http://molpharm.aspetjournals.org/content/early/2016/06/23/mol.116.104372.long
Connecting the dots, genome-wide association studies in substance use (article–2016)  https://www.researchgate.net/publication/298422234_Connecting_the_dots_genome-wide_association_studies_in_substance_use
Opioids Out, Cannabis In (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2576617
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/26797579
Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27624146
Estradiol impacts the endocannabinoid system in female rats to influence behavioral and
structural responses to cocaine (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0028390816302428
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical
evidence and therapeutic perspectives (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26728894
The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place
preference and physical dependence (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/26971034
KAT2B polymorphism identified for drug abuse in African Americans with regulatory
links to drug abuse pathways in human prefrontal cortex. (abst – 2016)
http://www.ncbi.nlm.nih.gov/pubmed/26202629
An Information Theoretical Study of the Epistasis Between the CNR1 1359 G/A
Polymorphism and the Taq1A and Taq1B DRD2 Polymorphisms: Assessing the
Susceptibility to Cannabis Addiction in a Turkish Population (abst–2016)
https://www.ncbi.nlm.nih.gov/pubmed/26833047
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders  (abst–2016) http://journals.sagepub.com/doi/full/10.1177/1087054716640109
The Relationships of Cigarette and Alcohol Use With the Initiation, Reinitiation, and
Persistence of Cannabis Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26751361
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
The Changing Drug Culture: Medical and Recreational Marijuana (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26881768
Cannabis policy and the uptake of treatment for cannabis-related problems (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27004985
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
(abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27023732
Dermatological Aspects of Synthetic Cannabinoid Addiction (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27028361
Functional effects of cannabinoids during dopaminergic specification of human neural
precursors derived from induced pluripotent stem cells (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27027565
Keep off the grass? Cannabis, cognition and addiction (abst–2016)
https://www.ncbi.nlm.nih.gov/pubmed/27052382
COMT Val158Met genotype and cannabis use in people with an At Risk Mental State for
psychosis: Exploring Gene x Environment interactions (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27052366
Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27156221
Dual Cannabis and Alcohol Use Disorders in Young Adults: Problems Magnified (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27070725
Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27261670
Craving Cannabis: A Meta-analysis of Self-Report and Psychophysiological CueReactivity Studies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27239052
Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27235655
Exercise as an adjunctive treatment for cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27314543
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27292878
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26833888
Older-adult marijuana users and ex-users: Comparisons of sociodemographic characteristics and mental and substance use disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27282425
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304304
Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305419
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27454353
Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27424166
Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27436749 Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27471078
Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27394933
Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27515723
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27578612
Does marijuana “blunt” smoking contribute to nicotine exposure?: Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27639129
Marijuana and tobacco co-administration in blunts, spliffs, and mulled cigarettes: A systematic literature review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27654966
CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27737762
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives (abst–2016) http://www.jsad.com/doi/10.15288/jsad.2016.77.889
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305123
A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305226
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306685
Behavioral Determinants of Cannabinoid Self-Administration in Old-World Monkeys (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28059083
Synthetic cannabinoids: A new addiction matrix (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28063756
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27964871
Identifying HIV care enrollees at-risk for cannabis use disorder (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28006972
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28008372
Exercise deprivation increases negative mood in exercise-addicted subjects and modifies
their biochemical markers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26812592
Sexual dysfunction in men diagnosed as substance use disorder (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/26940022
Drug Dependence and Toxicity of Law-Evading Drugs: Their Mechanisms Explored
from Basic Research (abst in English–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27703102 (abst in Japanese) http://medicalfinder.jp/doi/abs/10.11477/mf.1416200568
Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of
nicotine-seeking behavior in mice (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/26490035
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Using Medical Marijuana to Stop Childhood Seizures (news & abstract – 2016) http://neurosciencenews.com/thc-cbd-childhood-seizures-3618/
Mice expressing a “hyper-sensitive” form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption (full–2017) https://www.ncbi.nlm.nih.gov/pubmed/28426670
Adolescent Female Cannabinoid Exposure Diminishes the Reward-Facilitating Effects of Δ9-Tetrahydrocannabinol and d-Amphetamine in the Adult Male Offspring (full–2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00225/full
Two steps forward, one step back: current harm reduction policy and politics in the United States (full–2017) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017-0157-y
Addictive neurons (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479441/
Epigenetic Interactions between Alcohol and Cannabinergic Effects: Focus on Histone Modification and DNA Methylation (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515243/
Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users (full–2017) https://link.springer.com/article/10.1007%2Fs00213-017-4698-2
Cognitive control in young adults with cannabis use disorder: An event-related brain potential study (full–2017) http://journals.sagepub.com/doi/full/10.1177/0269881117719262
Trends of Cannabis Use Disorder in the Inpatient: 2002-2011 (full–2017) http://www.amjmed.com/article/S0002-9343(17)30094-3/fulltext
Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States (full–2017)
http://www.drugandalcoholdependence.com/article/S0376-8716(17)30228-4/fulltext
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,
Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU)
(full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Social cognitive predictors of treatment outcome in cannabis dependence (full–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30981-4/fulltext
Treatment seeking in cannabis dependence: The role of social cognition (full–2017)
http://www.drugandalcoholdependence.com/article/S0376-8716(16)31002-X/fulltext
Prevalence of consumption of addictive substances amongst Moroccan fishermen (full–2017) Https://journals.viamedica.pl/international_maritime_health/article/view/IMH.2017.0004/42124
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
Alterations in Rat Accumbens Endocannabinoid and GABA Content during Fentanyl
Treatment: The Role of Ghrelin (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713452/
Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol
Consumption in Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777574/
Mediating Effects of Global Negative Effect Expectancies on the Association between
Problematic Cannabis Use and Social Anxiety (full–2017)
https://www.frontiersin.org/articles/10.3389/fpsyt.2017.00249/full
Multidimensional Family Therapy Reduces Self-Reported Criminality Among
Adolescents With a Cannabis Use Disorder (download–2017) http://www.mdft.org/mdft/media/files/Publications/van-der-Pol-et-al-%282017%29-MDFT-reduces-self-criminality-among-adolescents-with-a-cannabis-use-disorder.pdf
S100A10 identified in a genome-wide gene × cannabis dependence interaction analysis
of risky sexual behaviours. (link to download–2017) http://jpn.ca/42-4-160189/
Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders (1st page–2017) http://jamanetwork.com/journals/jama/article-abstract/2610319
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients
Suffering from Chronic Pain (abst–2017)  http://www.ncbi.nlm.nih.gov/pubmed/27346885
Brain cannabinoid receptor 2: expression, function and modulation (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/28065934

Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107687
Whole genome sequence study of cannabis dependence in two independent cohorts (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28111843
Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28117058
Cannabidiol reduces ethanol consumption, motivation and relapse in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28194850
Effect of oxytocin pretreatment on cannabis outcomes in a brief motivational intervention (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28152465
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28268256
Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28340421
Post-sensitization treatment with rimonabant blocks the expression of cocaine-induced behavioral sensitization and c-Fos protein in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28366798
Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28399488
Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28431292
The rewarding effects of ethanol are modulated by binge eating of a high-fat diet during adolescence (abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390817301909
Symptoms of obsessive-compulsive disorder predict cannabis misuse (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28453999
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among young adults in Colorado: Implications for health education and research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28449191
Prevalence, correlates, and trends in tobacco use and cessation among current, former, and never adult marijuana users with a history of tobacco use, 2005-2014 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28525833
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors (abst–2017) https://link.springer.com/article/10.1007%2Fs00213-017-4644-3
The endocannabinoid system as a target for addiction treatment: Trials and tribulations (abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390817302563
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28623823
Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28600874
Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28600897
Substantiated childhood maltreatment and young adulthood cannabis use disorders: A pre-birth cohort study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28622571
Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case-control study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28631421
Chloramphenicol decreases CB1 receptor expression in the nucleus accumbens and prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats (abst–2017) http://www.sciencedirect.com/science/article/pii/S0091305717301776
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653666
Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28669034
The Effects of Cannabidiol (CBD) on Δ9-Tetrahydrocannabinol (THC) Self-Administration in Male and Female Long-Evans Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28682102
Perceived injunctive norms and cannabis-related problems: The interactive influence of parental injunctive norms and race (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28678683
Effects of the 2009 Medical Cannabinoid Legalization Policy on Hospital Use for Cannabinoid Dependency and Persistent Vomiting (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28711691
Effects of cannabinoid drugs on aversive or rewarding drug-associated memory extinction and reconsolidation (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28729064
Blockade of alcohol escalation and “relapse” drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice (abst–2017) https://link.springer.com/article/10.1007%2Fs00213-017-4691-9
Epigenetic mechanisms associated with addiction-related behavioural effects of nicotine and/or cocaine: implication of the endocannabinoid system (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28704272
Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28700366
Cannabis use, attitudes, and legal status in the U.S.: A review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28705601
Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms (abst–2017) http://www.sciencedirect.com/science/article/pii/S0278584617303676?via%3Dihub
Associations between butane hash oil use and cannabis-related problems (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30339-3/fulltext
Adolescent alcohol and cannabis use in Iceland 1995-2015 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28752650
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28755613
Past year cannabis use and problematic cannabis use among adults by ethnicity in Ontario (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30346-0/fulltext
Phenotypic and familial associations between childhood maltreatment and cannabis initiation and problems in young adult European-American and African-American women (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30373-3/fulltext
Effects of Cannabidiol on Morphine Conditioned Place Preference in Mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28793355
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28811670

Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related
Behaviors and Working Memory (abst–2017)
http://www.ncbi.nlm.nih.gov/pubmed/27582345
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological
Pain Without Producing Tolerance or Dependence (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28823711
Understanding marijuana’s effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot
investigation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28823723
17β-Estradiol Potentiates the Reinstatement of Cocaine Seeking in Female Rats: Role of
the Prelimbic Prefrontal Cortex and Cannabinoid Type-1 Receptors (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28825421
Context-dependent effects of rimonabant on ethanol-induced conditioned place
preference in female mice (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30405-2/fulltext
The association between alcohol use trajectories from adolescence to adulthood and
cannabis use disorder in adulthood: a 22-year longitudinal study (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28635349
Reward-related limbic memory and stimulation of the cannabinoid system: An upgrade in value attribution? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28880120
Endocannabinoid mechanism in amphetamine-type stimulant use disorders: A short
review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28912087
ABCB1 C3435T polymorphism is associated with tetrahydrocannabinol blood levels in
heavy cannabis users (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28917442
Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot
study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28921814
Developmentally Specific Associations Between CNR1 Genotype and Cannabis Use
Across Emerging Adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28930056
Adolescent cannabinoid exposure effects on natural reward seeking and learning in rats
(abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29022083
CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: a
Novel Target for Marijuana (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29038246
Song practice as a rewarding form of play in songbirds (abst–2017)
http://www.sciencedirect.com/science/article/pii/S0376635717301894?via%3Dihub
Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid
Mobilization in the Prelimbic Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29100630
Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and
alcohol-induced accumbal dopaminergic signaling (abst – 2017)
http://www.sciencedirect.com/science/article/pii/S0028390817305075?via%3Dihub
Incremental validity of estimated cannabis grams as a predictor of problems and
cannabinoid biomarkers: Evidence from a clinical trial. (abst – 2017)
http://www.drugandalcoholdependence.com/article/S0376-8716(17)30529-X/fulltext
Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of five novel synthetic
cannabinoids in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29138877
Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories:
focus on cannabinoids and ketamine (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4793-4
Psychometric Properties of the Turkish Versions of the Cannabis Use Problems
Identification Test (CUPIT) and the Adult Cannabis Problems Questionnaire (CPQ)
(abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28195831
CHRONIC Δ9-THC IN RHESUS MONKEYS: EFFECTS ON COGNITIVE
PERFORMANCE AND DOPAMINE D2/D3 RECEPTOR AVAILABILITY (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29203575
Acceptability and effectiveness of a web-based psychosocial intervention among criminal justice involved adults (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28285466
Is there a potential of misuse for Magnolia officinalis compounds/metabolites?
(abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28517911
A prospective observational study of problematic oral cannabinoid use (abst–2017)
https://link.springer.com/article/10.1007%2Fs00213-017-4811-6
Predicting Persistent, Limited, and Delayed Problematic Cannabis Use in Early
Adulthood: Findings From a Longitudinal Study (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29096779
Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent
Patients (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29105663
Genome-wide association study identifies a novel locus for cannabis dependence (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29112194
Association between increased EEG signal complexity and cannabis dependence (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29132831
The Intergenerational Transmission of Cannabis Use: Associations Between Parental
History of Cannabis Use and Cannabis Use Disorder, Low Positive Parenting, and
Offspring Cannabis Use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29189023
Cannabis use disorder and male sex predict medical cannabis card status in a sample of
high risk adolescents (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30562-8/fulltext
Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29265574
Is recovery from cannabis use problems different from alcohol and other drugs? Results
from a national probability-based sample of the United States adult population (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29287223
Identity as a cannabis user is related to problematic patterns of consumption among
emerging adults (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29289853
Gene variants and educational attainment in cannabis use: mediating role of DNA
methylation (full–2018)  https://www.nature.com/articles/s41398-017-0087-1
Old and new synthetic cannabinoids: lessons from animal models (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29376443
Mobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460317304604?via%3Dihub
Effects of alcohol and cigarette use on the initiation, reinitiation, and persistence of
cannabis use from adolescence to emerging adulthood (abst–2018) https://www.sciencedirect.com/science/article/pii/S0306460317304744?via%3Dihub
Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29338547
Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the

2013 Canadian Tobacco, Alcohol and Drugs Survey (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29356658
Young adults report increased pleasure from smoking cigarettes when drinking alcohol
but not when using marijuana (abst–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779098/


ADDISON’S DISEASE
Addison’s Disease and Possible Cannabis Withdrawal Syndrome Presenting as an Eating Disorder in a Thirty-Year-Old Female (full–2017) https://www.hindawi.com/journals/crie/2017/4096021/ 


ADENOMA-BENIGN
Value of CNRIP1 promoter methylation in colorectal cancer screening and prognosis assessment and its influence on the activity of cancer cells (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701694/


ADOLESCENTS/YOUNG ADULTS+
Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861285/?tool=pubmed
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965487/
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France (full-2010) http://eurpub.oxfordjournals.org/content/20/2/157.long
PTSD contributes to teen and young adult cannabis use disorders (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784238/?tool=pubmed
Adolescent cannabis use increases risk for cocaine-induced paranoia (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821949/pdf/nihms156770.pdf
A Life-course Perspective on the “Gateway Hypothesis” (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20943588
Patterns of Youth Participation in Cannabis Cultivation (abst–2010) http://jod.sagepub.com/content/40/2/263.abstract
Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/19783382/abstract/Cannabis_withdrawal_severity_and_short_term_course_among_cannabis_dependent_adolescent_and_young_adult_inpatients_
Cannabis Use and Obesity and Young Adults (abst-2010) http://informahealthcare.com/doi/abs/10.3109/00952990.2010.500438
Survey of alcohol, tobacco, and cannabis use in the French army (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20390703
The Effects of Cannabis on Heart Rate Variability and Well-Being in Young Men (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1248314
top
The social contagion effect of marijuana use among adolescents (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018468/?tool=pubmed
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258364/
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186916/
The association between early conduct problems and early marijuana use in college students (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163297/
Gender differences in adolescent marijuana use and associated psychosocial characteristics (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359836/
Synthetic cannabinoid use: a case series of adolescents (full–2011) http://www.jahonline.org/article/S1054-139X%2811%2900277-1/fulltext
Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity
in adolescent but not adult male rats (full–2011)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242894/
Drug-Intake Methods and Social Identity: The Use of Marijuana in Blunts Among
Southeast Asian Adolescents and Emerging Adults (full–2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193281
Effect of Developmental Chlorpyrifos Exposure on Endocannabinoid Metabolizing
Enzymes in the Brain of Juvenile Rats (full–2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143466/
Patterns of use, sequence of onsets and correlates of tobacco and cannabis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183489/
College students and use of K2: an emerging drug of abuse in young persons
(full – 2011) http://www.substanceabusepolicy.com/content/6/1/16
Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British
Cohort Study (must register) (full–2011)  http://www.academia.edu/1090026/Intelligence_across_childhood_in_relation_to_illegal_drug_use_in_adulthood_1970_British_Cohort_Study (abst–2011) https://www.ncbi.nlm.nih.gov/pubmed/22086967
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible
role of Cannabis inhalation (link to PDF–2011) http://cannabisclinicians.org/wp-content/uploads/2011/12/Cannabis-Inhalation-and-Brain-Tumor-Regression-2011.pdf
Cannabis use in a central region of Tunisia (abst in English–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22407249 (full in French)  http://www.jle.com/fr/revues/san/edocs/consommation_de_cannabis_dans_une_region_du_centre_tunisien_291967/article.phtml?tab=texte
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2 (abst–2011) http://pediatrics.aappublications.org/content/128/6/e1622.long
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (abst–2011)http://www.ncbi.nlm.nih.gov/pubmed/21890594

Some features of teenage beer alcoholism combined with hashish addiction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21322145
Pediatric cannabinoid hyperemesis: two cases (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21131803
Adding Tobacco to Cannabis–Its Frequency and Likely Implications (abst–2011)
http://www.ncbi.nlm.nih.gov/pubmed/21454910
Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB1 cannabinoid receptors (abst–2011) http://journals.sagepub.com/doi/full/10.1177/0269881110370503

Cannabis use and Cognitive Function: Eight Year Trajectory in a Young Adult Cohort
(abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21749524
Prospective Study of Cannabis Use in Adolescents at Clinical High-Risk for Psychosis: Impact on Conversion to Psychosis and Functional Outcome (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459073/
Acute Intoxication Caused by a Synthetic Cannabinoid in Two Adolescents (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470439/
Does the “gateway” sequence increase prediction of cannabis use disorder development beyond deviant socialization? Implications for prevention practice and policy (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387340/
Intelligence quotient in childhood and the risk of illegal drug use in middle-age: the 1958 National Child Development Survey (full-2012) http://www.annalsofepidemiology.org/article/S1047-2797%2812%2900170-6/fulltext
top
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042259
Adolescent Exposure of JWH-018 “Spice” Produces Subtle Effects on Learning and Memory Performance in Adulthood (full–2012) http://file.scirp.org/Html/2-3900080_19505.htm
Prevalence and co-use of marijuana among young adult cigarette smokers: An  anonymous online national survey (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507655/
The Interplay between Parental Monitoring and the Dopamine D4 Receptor Gene in Adolescent Cannabis Use (full–2012) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0049432&representation=PDF
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in CannabisDependent Adolescents (full–2012) http://ajp.psychiatryonline.org/article.aspx?articleID=1184217&resultClick=1
Medical Marijuana Laws and Teen Marijuana Use (full–2012) http://ftp.iza.org/dp6592.pdf
Acute intoxication caused by a synthetic cannabinoid in two adolescents (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470439/
Sensation-seeking genes and physical activity in youth (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581711/
Do medical marijuana laws increase marijuana use? Replication study and extension (full–2012) http://www.annalsofepidemiology.org/article/S1047-2797%2811%2900372-3/fulltext
Adolescent Exposure of JWH-018 “Spice” Produces Subtle Effects on Learning and
Memory Performance in Adulthood (full–2012) http://file.scirp.org/Html/2-3900080_19505.htm
Parental Monitoring at Age 11 and Subsequent Onset of Cannabis Use Up to Age 17:
Results From a Prospective Study (full–2012)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281976/
Temporal changes in N-acylethanolamine content and metabolism throughout the periadolescent period (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510355/
Cyclic vomiting syndrome and functional vomiting in adults: association with
cannabinoid use in males (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375678/
Cannabis use and depression: a longitudinal study of a national cohort of Swedish
conscripts (full–2012) http://www.biomedcentral.com/1471-244X/12/112
Chronic administration of THC prevents the behavioral effects of intermittent adolescent
MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity
in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189263/
AKI Associated with Synthetic Cannabinoids: A Case Series (full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613952/
Alcohol as a Gateway Drug: A Study of US 12th Graders (download–2012) https://www.frihetspartiet.net/dokumenter/gateway.pdf
The combined effects of parental divorce and parental history of depression on cannabis use in young adults in France (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22682099
Adolescent Synthetic Cannabinoid Exposures Reported to Texas Poison Centers (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23023462
‘It’s just a social thing’: Drug use, friendship and borderwork among marginalized young people (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23352335
The changing demographic of blunt smokers across birth cohorts (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23201173
Sex and grade level differences in marijuana use among youth (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23705514
Water pipe smoking and psychoactive substances (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23421061
top
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated
Stress on (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23200786
Cognitive ability in early adulthood as a predictor of habitual drug use during later military service and civilian life: the Vietnam Experience Study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22520690

Predictors of stigmatization towards use of various illicit drugs among emerging adults
(abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23061324
Assessing Tobacco Dependence Among Cannabis Users Smoking Cigarettes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22855882
Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901602/
Identity Formation, Marijuana and “The Self”: A Study of Cannabis Normalization among University Students (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847659/
Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600466/
Effects of State Medical Marijuana Laws on Adolescent Marijuana Use (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007871/
Legalization of medical marijuana and marijuana use among youths (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638722/
Weeding out the information: an ethnographic approach to exploring how young people sense of the evidence on cannabis (full–2013) http://www.harmreductionjournal.com/content/10/1/34
Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855086/
Impact of ADHD and cannabis use on executive functioning in young adults (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820098/
Computer and therapist based brief interventions among cannabis-using adolescents presenting to primary care: One year outcomes (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770780/
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947129/
Motivations to quit cannabis use in an adult non-treatment sample: Are they related to relapse? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681844/
From “Social Supply” to “Real Dealing”: Drift, Friendship, and Trust in Drug-Dealing Careers (full–2013) http://jod.sagepub.com/content/43/4/392.full.pdf+html
THE IMPORTANCE OF FAMILY RELATIONS FOR CANNABIS USERS: THE CASE OF SERBIAN ADOLESCENTS (full–2013) http://www.sid.ir/en/VEWSSID/J_pdf/86320130302.pdf
Statistics on cannabis users skew perceptions of cannabis use (full–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
Self-Efficacy and Motivation to Quit Marijuana Use among Young Women (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913034/
Higher rates of adolescent substance use in child welfare versus community populations in the United States (link to PDF-2013) http://www.jsad.com/jsad/article/Higher_Rates_of_Adolescent_Substance_Use_in_Child_Welfare_Versus_Community_/4863.html

An investigation into “two hit” effects of BDNF deficiency and young-adult cannabinoid
receptor stimulation on prepulse inhibition regulation and memory in mice (full–2013) http://www.frontiersin.org/Journal/10.3389/fnbeh.2013.00149/full
Induction of Endocannabinoid Levels in Juvenile Rat Brain Following Developmental
Chlorpyrifos Exposure (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954109/
Low Level Chlorpyrifos Exposure Increases Anandamide Accumulation in Juvenile Rat
Brain in the Absence of Brain Cholinesterase Inhibition (full–2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071163/
Ischemic stroke after use of the synthetic marijuana “spice” (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863350/
Psychoactive substances-Some new, some old: A scan of the situation in the U.S. (full–2013) http://www.drugandalcoholdependence.com/article/S0376-8716%2813%2900373-6/fulltext
From “Social Supply” to “Real Dealing”: Drift, Friendship, and Trust in Drug-Dealing Careers (link to PDF–2013) http://search.proquest.com/openview/7fca7d95539590726bcef9c62d624c4c/1?pq-origsite=gscholar&cbl=34918
Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence (editorial–2013) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2012.12050615

National-level drug policy and young people’s illicit drug use: A multilevel analysis of the European Union (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23298650
top
To What Extent Does Adding Tobacco to Cannabis Expose Young Users to Nicotine? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23674840
Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24281745
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene (abst–2013)  http://onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2011.00380.x/abstract
Police custody following driving under the influence of cannabis: A prospective study  (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23890621
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23669059
Hemoptysis in a young man smoking cannabis (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/23619207
Synthetic Cannabis and Acute Ischemic Stroke (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/24119618
The Relationship Between Subjective Experiences During First Use of Tobacco and
Cannabis and the Effect of the Substance Experienced First (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/23929590
Cannabis use among a sample of 16 to 18 year-old students in Switzerland (full–2014) http://www.hdbp.org/psychiatria_danubina/pdf/dnb_vol26_no1/dnb_vol26_no1_56.pdf
Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118750/
Pediatric exposure to drugs of abuse by hair testing: monitoring 15 years of evolution in Spain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143861/
An Examination of Opinions Toward Marijuana Policies Among High School Seniors in the United States (full–2014) http://www.tandfonline.com/doi/full/10.1080/02791072.2014.962716#tabModule
The Impact of State Medical Marijuana Legislation on Adolescent Marijuana Use (full–2014) http://www.jahonline.org/article/S1054-139X%2814%2900107-4/pdf
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250392/
Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904106/
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963405/
Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071130/
Neurocognition in college-aged daily marijuana users (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074777/
Cannabinoid findings in children hair – what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1692/full
Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana (full–2014) http://informahealthcare.com/doi/pdf/10.3109/00952990.2014.943371
Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097075/
Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161625/
Social anxiety and coping motives for cannabis use: The impact of experiential
avoidance (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149405/
Cannabis Use Behaviors and Social Anxiety: The Roles of Perceived Descriptive and
Injunctive Social Norms (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893635/
Interpersonal Guilt and Substance Use in College Students (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782605/
Synthetic Cannabinoids: Use and predictors in a Community Sample of Young Adults
(full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362955/
Programming of neural cells by (endo)cannabinoids: from physiological rules to
emerging therapies (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Drug use, consequences and perceived accessibility in three Nigerian universities (full–2014) http://file.scirp.org/Html/9-1420229_41669.htm
Prevalence of Cannabis Lifetime Use in Iranian High School and College Students: A
Systematic Review, Meta-Analyses, and Meta-Regression (full–2014)
http://journals.sagepub.com/doi/full/10.1177/1557988314546667
Differences in Δ9-Tetrahydrocannabinol Metabolism and In Vivo Pharmacology
Following Acute and Repeated Dosing in Adolescent Rats (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106361/
Pulmonary Effects of Synthetic Marijuana: Chest Radiography and CT Findings (full–2014) http://www.ajronline.org/doi/full/10.2214/AJR.14.13138
Urine Toxicology Screen in Multiple Sleep Latency Test: The Correlation of Positive
Tetrahydrocannabinol, Drug Negative Patients, and Narcolepsy (full–2014)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298782/
Effects of pubertal cannabinoid administration on attentional set-shifting and
dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia
(full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368886/
Developmental Increase in Hippocampal Endocannabinoid Mobilization: Role of
Metabotropic Glutamate Receptor Subtype 5 and Phospholipase C (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233278/
The Impact of State Medical Marijuana Legislation on Adolescent Marijuana Use 
(full–2014) http://www.jahonline.org/article/S1054-139X%2814%2900107-4/pdf
The Impact of a Motivational Statement and Age of Cannabis Use Onset on
Neuropsychological Test Performance (link to download–2014)
https://www.researchgate.net/publication/268577210_The_impact_of_a_motivational_statement_and_age_of_cannabis_use_onset_on_neuropsychological_test_performance
Cannabis Use and its Effects on Health, Education and Labor Market Success (link to PDF-2014) http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2414469
Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on
social behavior in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24933531
The co-use of tobacco and cannabis among adolescents over a 30-year period (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24443776
Cannabis use and suicidal ideations in high-school students (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25123343
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on
impulsivity in adolescents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Socialization Instances Linked to Cannabis Experimentation Among French Teenagers  (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25099311
Frequent electronic media communication with friends is associated with higher
adolescent substance use (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25471077
Medical marijuana and children (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25647865
EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM (abst–2014)  https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751#sthash.pbnOqzNG.dpuf
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM (abst–2014)  https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
Acute kidney injury associated with smoking synthetic cannabinoid (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/25089722
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic
cannabinoid: a case report (abst in English–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25179201 (abst in Japanese) http://medicalfinder.jp/doi/abs/10.11477/mf.1436102331
top
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America (full–2015) http://eurpub.oxfordjournals.org/content/25/suppl_2/73.long
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 L’aquila Earthquake (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397827/
Sex-dependent vulnerability to Cannabis abuse in adolescence (full-2015) http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00056/full
Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset (full–2015) http://link.springer.com/article/10.1007/s10519-015-9723-9/fulltext.html
Impact of Cannabis Use on the Development of Psychotic Disorders (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352721/
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331066/
Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys (full–2015) http://press.thelancet.com/AdolescentMarijuana.pdf
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25632127
The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140142
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640353/
State Estimates of Adolescent Marijuana Use and Perceptions of Risk of Harm From Marijuana Use: 2013 and 2014 (full–2015)  http://www.samhsa.gov/data/sites/default/files/report_2121/ShortReport-2121.html
High School Students’ Use of Electronic Cigarettes to Vaporize Cannabis (full–2015) http://pediatrics.aappublications.org/content/136/4/611.long
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Prevalence and correlates of hashish use in a national sample of high school seniors in the United States (full–2015) http://www.tandfonline.com/doi/full/10.3109/00952990.2015.1011745
top
Medical marijuana’s public health lessons-implications for retail marijuana in Colorado (full–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1500043
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568004/
E-Cigarettes: A Review of New Trends in Cannabis Use (full–2015) http://www.mdpi.com/1660-4601/12/8/9988
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640936/
Developmental regulation of fear learning and anxiety behavior by endocannabinoids (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12253/full
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318349/
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441859/
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
Young adult cannabis users report greater propensity for risk-taking only in nonmonetary domains (abst–2015) http://www.sciencedirect.com/science/article/pii/S0376871614020006
13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25733759
Synthetic cannabinoid use in a nationally representative sample of US high school seniors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25736618
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25735467
Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661990
Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25858786
K2 and Spice use among a cohort of college students in southeast region of the USA (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26030768
Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26115351
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26468198
Prevalence of Marijuana-Related Traffic on Twitter, 2012-2013: A Content Analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26075917
THE EFFECT OF MEDICAL MARIJUANA LAWS ON BODY WEIGHT (full–2015) The Effect of Medical Marijuana Laws on Body Weight
ADOLESCENTS’ USE OF MEDICAL MARIJUANA: A SECONDARY ANALYSIS OF MONITORING THE FUTURE DATA (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514911/
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586926
The Association of Low Parental Monitoring With Early Substance Use in European
American and African American Adolescent Girls (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712655/
Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain
Structure (full–2015)  http://jamanetwork.com/journals/jamapsychiatry/fullarticle/2429550
Self-reported use of novel psychoactive substances in a US nationally representative
survey: Prevalence, correlates, and a call for new survey methods to prevent under-reporting (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633323/
Urinary early kidney injury molecules in children with beta-thalassemia major (full–2015) http://www.tandfonline.com/doi/full/10.3109/0886022X.2015.1007871
Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary
Artery Risk Development in Young Adults (CARDIA) study (full-2015)
http://link.springer.com/article/10.1007/s00125-015-3740-3
Adolescent cannabis and tobacco use and educational outcomes at age 16: birth cohort
study (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405050/
Longitudinal Effects of School Drug Policies on Student Marijuana Use in Washington
State and Victoria, Australia (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386529/
Prevalence of Marijuana and Other Substance Use Before and After Washington State’s
Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana:
Cohort Comparisons in a Sample of Adolescents (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744815/
Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of
threat (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801124/
Parental Separation and Early Substance Involvement: Results from Children of  Alcoholic and Cannabis Dependent Twins (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908916/
Status Report: Marijuana Legalization in Colorado After One Year of Retail Sales and
Two Years of Decriminalization (full–2015) https://www.crcr.org/wp-content/uploads/2016/04/The-Economic-Impact-of-Marijuana-Tax-and-Regulation-in-Colorado_031716.pdf
The Economic Impact of Marijuana Tax and Regulation in Colorado Cardiovascular side effects related with use of synthetic cannabinoids “bonzai” : two case
reports (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462325/
Assessing the efficacy of MOTI-4 for reducing the use of cannabis among youth in the
Netherlands: a randomized controlled trial (full–2015)
http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(15)00296-2/fulltext
Synthetic cannabis-induced mania (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369931/
Longitudinal associations between social anxiety symptoms and cannabis use throughout adolescence: the role of peer involvement (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854944/
Substance Use among Medical Students: A Literature Review 1988- 2013  (full download in English, abst in Spanish–2015)  http://www.actaspsiquiatria.es/repositorio//17/95/ENG/17-95-ENG-109-21-286815.pdf
Are cannabis laws used for political repression in the Arab Spring countries?
(download–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13065/pdf
Early onset of cannabis use: Does personality modify the relation with changes in
perceived parental involvement? (click “academia” for download–2015)
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Early+onset+of+cannabis+use%3A+Does+personality+modify+the+relation+with+changes+in+perceived+parental+involvement%3F+++++++++++++++&btnG
The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update (link to PDF–2015) http://pediatrics.aappublications.org/content/early/2015/01/20/peds.2014-4147.long
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic
brain injury in adolescent male mice. Association with edema and neurological deficit  (link to PDF–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Associations between cigarette smoking and cannabis dependence: A longitudinal study
of young cannabis users in the United Kingdom (link to PDF–2015)
http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900010-1/abstract
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in
arguments about the drug’s harm to children and adults, but the scientific evidence is
seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
More people think cannabis should be legal than tobacco (poll results–2015)
http://www.studentmoneysaver.co.uk/article/more-people-think-cannabis-should-be-legal-than-tobacco/
Canadian Tobacco Alcohol and Drugs (CTADS): 2013 summary (summary–2015)  https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2013-summary.html
Predicting Alcohol, Cigarette, and Marijuana Use From Preferential Music Consumption
(abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26400900
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
The effect of alcohol availability on marijuana use: Evidence from the minimum legal
drinking age (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/22381404
The role of the Cannabinoid Receptor 1 in adolescents’ processing of facial expressions  (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26527537
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0149763415001244
Cigarette smoking may modify the association between cannabis use and adiposity in
males (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26026899
What are young adults smoking in their hookahs? A latent class analysis of substances
smoked (abst-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091668/
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional
trial (abst–2015) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900379-8/abstract
Parental reporting of response to oral cannabis extracts for treatment of refractory
epilepsy (abst–2015) http://www.epilepsybehavior.com/article/S1525-5050(15)00104-3/fulltext
Adult attention-deficit/hyperactivity disorder and its association with substance use and
substance use disorders in young men (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25989844
Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26165442
top
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis (abst–2015) http://informahealthcare.com/doi/abs/10.3109/03009742.2015.1020863
From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder (abst–2015) http://informahealthcare.com/doi/abs/10.3109/16066359.2014.954556
Teenage Cardiac Arrest Following Abuse of Synthetic Cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26256565
Synthetic Cannabinoid Abuse in Adolescents: A Case Series (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26293411
Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901618-X/abstract
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26489976
Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26711540
CANNABIS: ALTERNATIVE REALITIES (CRA) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26650405
Who receives cannabis use offers: A general population study of adolescents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26433564
Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26212076
Investigating cannabis use normalization by distinguishing between experimental and regular use: a multilevel study in 31 countries (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25785792
Marijuana experiences, voting behaviors, and early perspectives regarding marijuana legalization among college students from 2 states (abst–2015) http://www.tandfonline.com/doi/full/10.1080/07448481.2015.1062769?src=recsys
Evaluating the relationship between cannabis use and IQ in youth and young adults at
clinical high risk of psychosis (abst–2015) http://www.psy-journal.com/article/S0165-1781%2815%2930166-9/abstract
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of
Butane Hash Oil (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
Maternal age and trajectories of cannabis use (abst–2015)
http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901662-2/abstract
A longitudinal study of cannabis use initiation among high school students: Effects of
social anxiety, expectancies, peers and alcohol (abst–2015)
https://www.ncbi.nlm.nih.gov/pubmed/25800726
“Spice” Can Really Heat Things Up (abst–2015)
http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4600
Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of
tobacco and marijuana in adults from 2003-2012 (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26036666
Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study (full–2016) http://jop.sagepub.com/content/early/2016/01/06/0269881115622241.full
top
Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait (full–2016) http://www.hindawi.com/journals/np/2016/6481862/
Update: Drug-Related Emergency Department Visits Involving Synthetic Cannabinoids (full–2016) http://www.ncbi.nlm.nih.gov/books/NBK350768/
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/prp2.220/full
Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865651/
“I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156614
Marijuana Use in Youth from Bench to Bedside to Longitudinal Outlook (full–2016) http://cpa.sagepub.com/content/61/6/316.long
Trends in cannabis use disorders among racial/ethnic population groups in the United States (full–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30147-8/fulltext
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience (full–2016) http://www.sciencedirect.com/science/article/pii/S1059131116000054
Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0091305716300089
Chest pain, troponin rise, and ST-elevation in an adolescent boy following the use of the synthetic cannabis product K2 (full–2016) http://www.annalspc.com/article.asp?issn=0974-2069;year=2016;volume=9;issue=1;spage=79;epage=81;aulast=Zaleta
Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303917
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899060/
Associations Between Cannabis Use and Physical Health Problems in Early Midlife (full–2016) http://archpsyc.jamanetwork.com/article.aspx?articleid=2526003
Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011 (full–2016) http://www.ijdp.org/article/S0955-3959(16)00038-4/fulltext
First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone (full–2016) http://www.hindawi.com/journals/crips/2016/7257489/
National Estimates of Marijuana Use and Related Indicators – National Survey on Drug Use and Health, United States, 2002–2014 (full–2016) http://www.cdc.gov/mmwr/volumes/65/ss/ss6511a1.htm?s_cid=ss6511a1_e
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028912/
Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature (full–2016) https://www.hindawi.com/journals/crips/2016/3640549/
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males (full–2016) http://www.nature.com/tp/journal/v6/n11/full/tp2016225a.html
Acute Eosinophilic Pneumonia with Respiratory Failure Induced by Synthetic Cannabinoid Inhalation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156457/
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747759/
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035052/
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/
Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110529/
Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1878929316300639

Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13645/full
Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748964/
The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado (full–2016) https://peerj.com/articles/2782/
Attention deficit hyperactivity disorder and drug addiction rehabilitation patients (full–2016) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2016001201003&lng=en&nrm=iso&tlng=en
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215781/
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26756393
Alcohol and cannabis use among college students: Substitutes or complements? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26894560
Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder (abst–2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472%2815%2900313-X/abstract
The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27012434
Comorbid Cannabis and Tobacco Use in Adolescents and Adults (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27175326

Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27144526

Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013 (abst – 2016) http://www.jaacap.com/article/S0890-8567%2816%2930101-0/abstract
Psychometric properties of the Spanish version of the Cannabis Use Problems Identification Test among Chilean university students: A validation study (click ELSEVIER for link to PDF–2016) https://www.ncbi.nlm.nih.gov/pubmed/27866060
Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation (abst-2016) http://press.endocrine.org/doi/10.1210/jc.2015-4381?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation (click “Molecular Medicine” for PDF– 2016) http://www.ncbi.nlm.nih.gov/pubmed/26772776
Mitigation of Marijuana-Related Legal Harms to Youth in California (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26891110
Age of Sexual Debut and Cannabis Use in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26881806
Bidirectional Associations Between Cannabis Use and Depressive Symptoms From Adolescence Through Early Adulthood Among At-Risk Young Men (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26997187
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27033329
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27172584
Neural mechanisms of sensitivity to peer information in young adult cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27068178
Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27224428
Marijuana-Related Posts on Instagram (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262456
Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27419383
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453335
Independent Versus Co-occurring Substance Use in Relation to Gambling Outcomes in Older Adolescents and Young Adults (full–2016)

http://www.jahonline.org/article/S1054-139X(16)30417-7/fulltext
Age of Alcohol and Cannabis Use Onset Mediates the Association of Transmissible Risk
in Childhood and Development of Alcohol and Cannabis Disorders: Evidence for
Common Liability (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565072/
Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123602/
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based
Cohort Study of 45 000 Swedish Men (full–2016)  http://stroke.ahajournals.org/content/48/2/265.long

AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked
cannabis in young cannabis smokers (full–2016)  http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html

Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep
quality in emerging adults: a pilot study. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289074/
Digital Interventions for Problematic Cannabis Users in Non-Clinical Settings: Findings
from a Systematic Review and Meta-Analysis. (full – 2016)
http://www.karger.com/Article/FullText/445716
An Examination of Social Anxiety in Marijuana and Cigarette Use Motives Among
Adolescents. (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851246/
Use of marijuana for medical purposes. (link to PDF – 2016)
http://www.ncbi.nlm.nih.gov/pubmed/27660881

Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse – the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent – case report (link to download – 2016) http://www.mppt.hu/folyoirat/1/abstract/?vol=18&issue=3&elsooldal=162

Dose of Reality: The Effect of State Marijuana Legalizations (report–2016) http://www.cato.org/publications/policy-analysis/dose-reality-effect-state-marijuana-legalizations#full
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (2016) (letter–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3333-6
Can your heart handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus (1st page–2016)  http://www.internationaljournalofcardiology.com/article/S0167-5273%2816%2930735-5/abstract
Synthetic Cannabinoid Exposure A New Risk for Children? (1st page–2016) http://journals.sagepub.com/doi/full/10.1177/0009922816664065
Minimal Physical Health Risk Associated With Long-term Cannabis Use—But Buyer
Beware (1st page–2016)
http://jama.jamanetwork.com/article.aspx?articleid=2526619
Medicinal Use of Marijuana: What School Nurses Need to Know (abst–2016)
http://nas.sagepub.com/content/31/3/170.long
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence (abst–2016)
https://www.ncbi.nlm.nih.gov/pubmed/26797579
Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink With Illicit Drug Use (abst–2016)
https://www.ncbi.nlm.nih.gov/pubmed/26645418
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of adolescent rats (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0304394016302907
Cannabis and Psychosis: a Critical Overview of the Relationship (abst–2016) href=”http://link.springer.com/article/10.1007/s11920-015-0657-y”>http://link.springer.com/article/10.1007/s11920-015-0657-y
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26898326
Experience with Gambling in Late Childhood and Early Adolescence: Implications for Substance Experimentation Behavior (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26836642
Cannabis – Position Paper of the German Respiratory Society (DGP) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935046
Lack of hippocampal CB1 receptor desensitization by Δ9-tetrahydrocannabinol in aged mice and by low doses of JZL 184 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26984820
Weeding Out the Truth: Adolescents and Cannabis (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26985645

Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26860734
Because difficulty is not the same for everyone: the impact of complexity in working memory is associated with cannabinoid 1 receptor genetic variation in young adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27108777
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27157075
Prevalence and Correlates of Any and Frequent Synthetic Cannabinoid Use in a Representative Sample of High School Students (abst–2016)http://www.ncbi.nlm.nih.gov/pubmed/27191966
Childhood Maltreatment in the Migraine Patient (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27194425
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27149691
Influence of legal status on the uptake of cannabis in young people (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27096170
Racial Differences and the Role of Neighborhood in the Sequencing of Marijuana and Tobacco Initiation Among Urban Youth (abst–2016)http://www.ncbi.nlm.nih.gov/pubmed/27092865
Decision-Making Does not Moderate the Association between Cannabis Use and Body Mass Index among Adolescent Cannabis Users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27079834
Dual Cannabis and Alcohol Use Disorders in Young Adults: Problems Magnified (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27070725
Traffic accidentability and risky driving behavior in young people in New Caledonia. Results of study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27259836
Substitution and Complementarity of Alcohol and Cannabis: A Review of the Literature (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27249324
Self-reported use of novel psychoactive substances among attendees of electronic dance music venues (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27315522
Secondary Effects of an Alcohol Prevention Program Targeting Students and/or Parents (abst–2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30152-0/abstract
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27292878
Marijuana Misadventures in Children: Exploration of a Dose-Response Relationship and Summary of Clinical Effects and Outcomes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27050740
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176

Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia (abst–2016) http://www.schres-journal.com/article/S0920-9964(16)30060-3/abstract
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27349158
Childhood weight status and timing of first substance use in an ethnically diverse sample (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30111-9/abstract
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304304
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27454353
Cross-section and panel estimates of peer effects in early adolescent cannabis use: With a little help from my ‘friends once removed’ (abst–2016) http://www.sciencedirect.com/science/article/pii/S0277953616303021
Alveolar haemorrhage following a cannabis water pipe (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27421143
Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27427415
Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27394933
Understanding resilience: New approaches for preventing and treating PTSD (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27417856
Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27491817
Adolescent cannabis use: What is the evidence for functional brain alteration? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27514709
Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27521979
Consuming energy drinks at the age of 14 predicted legal and illegal substance use at 16 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27513298
Cannabinoids and Psychosis (3) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568729
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27579692
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Disturbances of sleep and circadian rhythms: novel risk factors for obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27584008
Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27607062
Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27611957
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (abst–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3243-7
Abnormal white matter integrity in synthetic cannabinoid users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27617779
Prevalence and Correlates of Vaping Cannabis in a Sample of Young Adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27631612
Risky substance use and peer pressure in Swiss young men: Test of moderation effects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27632359
The Synthetic Cannabinoids Phenomenon (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27655416
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27659736
UPPS-P model impulsivity and marijuana use behaviors in adolescents: A meta-analysis (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30923-1/abstract
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
“Just one bad high:” considering synthetic cannabinoid outcome expectancies in adolescents (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27749024
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27750184
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
The neurobiology of social play and its rewarding value in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416303724
Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27770657
A social network analysis of substance use among immigrant adolescents in six European cities (abst–2016) http://www.sciencedirect.com/science/article/pii/S027795361630538X
Pseudo-Underage Assessment of Compliance With Identification Regulations at Retail Marijuana Outlets in Colorado (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797687
The Normalization of Cannabis Use Among Bangladeshi and Pakistani Youth: A New Frontier for the Normalization Thesis? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27849430
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27793551
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27875353
From niche to stigma-Headshops to prison: Exploring the rise and fall of synthetic cannabinoid use among young adults (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27894904
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27935269
The consequences of chronic cannabis smoking in vulnerable adolescents (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27986504
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27993113
Is the Legalization of Marijuana Associated With Its Use by Adolescents? (abst–2016) http://www.tandfonline.com/doi/full/10.1080/10826084.2016.1223139?src=recsys
Genetic polymorphisms in genes related to risk-taking behaviours predicting body mass index trajectory among Mexican American adolescents (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27228958
Topiramate and motivational enhancement therapy for cannabis use among youth: a
randomized placebo-controlled pilot study (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/26752416
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (full–2017)
http://www.sciencedirect.com/science/article/pii/S221315821630170X
Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice (full–2017) https://www.ncbi.nlm.nih.gov/pubmed/28209996
Childhood academic ability in relation to cigarette, alcohol and cannabis use from adolescence into early adulthood: Longitudinal Study of Young People in England (LSYPE) (full–2017) http://bmjopen.bmj.com/content/7/2/e012989.long
Physicians disagree on legal age for cannabis (full–2017) http://www.cmaj.ca/content/189/4/E174.long
Giant J (Osborn) Wave due to Bonsai Abuse: Comments on Clinical Practice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322511/
Cannabis and Young Users—A Brief Intervention to Reduce Their Consumption (CANABIC): A Cluster Randomized Controlled Trial in Primary Care (full–2017) http://www.annfammed.org/content/15/2/131.long

Adolescent Female Cannabinoid Exposure Diminishes the Reward-Facilitating Effects of Δ9-Tetrahydrocannabinol and d-Amphetamine in the Adult Male Offspring (full–2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00225/full
Using Attitudes, Age and Gender to Estimate an Adolescent’s Substance Use Risk (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417548/
Patterns of cannabis use during adolescence and their association with harmful substance use behaviour: findings from a UK birth cohort (full–2017) http://jech.bmj.com/content/early/2017/05/17/jech-2016-208503.long
Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272923/
Cannabinoids in Pediatrics (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Longitudinal study of hippocampal volumes in heavy cannabis users (full–2017) http://journals.sagepub.com/doi/10.1177/0269881117718380
Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy? (full–2017) http://www.j-epilepsy.org/journal/view.php?year=2017&vol=7&page=16
Cognitive control in young adults with cannabis use disorder: An event-related brain potential study (full–2017) http://journals.sagepub.com/doi/full/10.1177/0269881117719262
Newly incident cannabis use in the United States, 2002-2011: a regional and state level benchmark (full–2017) https://peerj.com/articles/3616/
Consequences of Adolescent Exposure to the Cannabinoid Receptor Agonist WIN55,212-2 on Working Memory in Female Rats (full–2017) http://journal.frontiersin.org/article/10.3389/fnbeh.2017.00137/full
“It Takes Longer, but When It Hits You It Hits You!”: Videos About Marijuana Edibles on YouTube (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28145799

An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28238865
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28289138
Longitudinal Predictors of Synthetic Cannabinoid Use in Adolescents (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28289139
Residential Mobility, Transience, Depression, and Marijuana Use Initiation Among Adolescents and Young Adults (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28607541

Residential Mobility, Transience, Depression, and Marijuana Use Initiation Among
Adolescents and Young Adults (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457171/

Caffeine and Cannabis Effects on Vital Neurotransmitters and Enzymes in the Brain Tissue of Juvenile Experimental Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28588361

Caffeine and Cannabis Effects on Vital Neurotransmitters and Enzymes in the Brain
Tissue of Juvenile Experimental Rats (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448447/

Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28635664

Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine
Withdrawal Symptoms in Adult Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486147/
Association Between Use of Cannabis in Adolescence and Weight Change into Midlife (link to download–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0168897
Cannabis Users’ Recommended Warnings for Packages of Legally Sold Cannabis: An
Australia-Centered Study (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531364/
Synthetic Cannabinoid Use Among High School Seniors (full–2017) http://pediatrics.aappublications.org/content/early/2017/09/07/peds.2017-1330.long
Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent
Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581875/
Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for
the Endogenous Cannabinoid System and Neuroinflammation (full–2017) http://journal.frontiersin.org/article/10.3389/fnbeh.2017.00015/full
Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists (full–2017) http://sci.amegroups.com/article/view/15022/15166
Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to LongTerm Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent
Cannabidiol (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655843/
Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424589/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis

Concentrates (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
Cannabis Use and Hypomania in Young People: A Prospective Analysis (full–2017) https://www.ncbi.nlm.nih.gov/pubmed/29207008
Mediating Effects of Global Negative Effect Expectancies on the Association between Problematic Cannabis Use and Social Anxiety (full–2017) https://www.frontiersin.org/articles/10.3389/fpsyt.2017.00249/full
Recreational marijuana legalization and college student use: Early evidence (full–2017) https://www.sciencedirect.com/science/article/pii/S2352827317300125?via%3Dihub
Gender-specific associations between involvement in team sport culture and canadian adolescents’ substance-use behavior (full–2017) https://www.sciencedirect.com/science/article/pii/S2352827317301398?via%3Dihub
Multidimensional Family Therapy Reduces Self-Reported Criminality Among Adolescents With a Cannabis Use Disorder (download–2017)  http://www.mdft.org/mdft/media/files/Publications/van-der-Pol-et-al-%282017%29-MDFT-reduces-self-criminality-among-adolescents-with-a-cannabis-use-disorder.pdf

Trends in Lifetime Cannabis Use among Czech School-aged Children from 2002 to 2014 (link to download–2017) http://apps.szu.cz/svi/cejph/show_en.php?kat=archiv/2017-sup-09
Rocky Mountain High: Preventing Cannabis-Related Injuries (1st page–2017) http://www.jenonline.org/article/S0099-1767(16)30339-7/abstract
Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders (1st page–2017) http://jamanetwork.com/journals/jama/article-abstract/2610319
Peer Network Counseling as Brief Treatment for Urban Adolescent Heavy Cannabis Users (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27936376
Support for Marijuana Legalization and Predictors of Intentions to Use Marijuana More Often in Response to Legalization Among U.S. Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27976988
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint Association with Sexual Risk Behavior and Outcomes in Young Adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28083726
Self-reported Driving Under the Influence of Alcohol and Cannabis Among Ontario Students: Associations with Graduated Licensing, Risk Taking and Substance Abuse (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28095034
Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28117058
Cannabis use, COMT, BDNF and age at first-episode psychosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28142064
top
Cannabinoids in treatment-resistant epilepsy: A review (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28188044
Synthetic Pot: Not Your Grandfather’s Marijuana (abst–2017) http://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(16)30185-7
Youth use of electronic vapor products and blunts for administering cannabis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28214740
Cannabis and alcohol use, and the developing brain (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28223098
Marijuana and other substance use among male and female underage drinkers who drive after drinking and ride with those who drive after drinking (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28231494
Adolescents with cannabis use disorders: Adaptive treatment for poor responders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28232290
Prevalence of teenage sleeping disorders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28242150
Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28242263
Cannabis use and bone mineral density: NHANES 2007–2010 (abst–2017) http://link.springer.com/article/10.1007%2Fs11657-017-0320-9
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28319590
Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28340421
Does Starting to Smoke Cigars Trigger Onset of Cannabis Blunt Smoking? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28339595
Predictors of Adult E-Cigarette Users Vaporizing Cannabis Using E-Cigarettes and Vape-Pens (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28323498
Cannabis decriminalization and the age of onset of cannabis use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28395168
Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28397128
Substance Use in Undergraduate Students With Histories of Attention-Deficit / Hyperactivity Disorder (ADHD): The Role of Impulsivity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28406351
Street racing among the Ontario adult population: Prevalence and association with collision risk (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0001457517301203
The Relation between Driving Violations and Health Promotion Behaviors among Undergraduate Students: Self-Report of Road Behavior (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28409675
Cognitive Functioning of Adolescent and Young Adult Cannabis Users in the Philadelphia Neurodevelopmental Cohort (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28414475
The Role of Public Health in Combatting Synthetic Cannabinoid Use in Adolescents (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28433118
Lethal high: acute disseminated encephalomyelitis (ADEM) triggered by toxic effect of synthetic cannabinoid black mamba (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28433979
Characteristics of socially withdrawn youth in France: A retrospective study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28446040
Increasing Use of Cannabis among Arrested Drivers in Norway (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28448164
The rewarding effects of ethanol are modulated by binge eating of a high-fat diet during adolescence (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301909
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among young adults in Colorado: Implications for health education and research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28449191
Ethnoracial differences in cannabis use among native-born and foreign-born high school students in Ontario (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28489512
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior (abst–2017) http://www.sciencedirect.com/science/article/pii/S0149763417300659
Prevalence, correlates, and trends in tobacco use and cessation among current, former, and never adult marijuana users with a history of tobacco use, 2005-2014 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28525833
Early cannabis initiation and educational attainment: is the association causal? Data from the French TEMPO study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28520946
Nucleus Accumbens Functional Connectivity at Age 20 is Associated with Trajectory of Adolescent Cannabis Use and Predicts Psychosocial Functioning in Young Adulthood  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28547854
Effects of sleep on substance use in adolescents: a longitudinal perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28547821
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28544955
The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis (abst–2017) http://www.psyneuen-journal.com/article/S0306-4530(17)30113-0/fulltext
Cannabis increased the risk of primary spontaneous pneumothorax in tobacco smokers: a case–control study (abst–2017) https://academic.oup.com/ejcts/article-abstract/doi/10.1093/ejcts/ezx160/3866758/Cannabis-increased-the-risk-of-primary-spontaneous?redirectedFrom=fulltext
Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605305
Family Structure and Adolescent Substance Use: An International Perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605218
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking in Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605163
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28623823
Ready, willing, and able: The role of cannabis use opportunities in understanding adolescent cannabis use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28600881
Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort (abst– 2017) https://www.ncbi.nlm.nih.gov/pubmed/28600897
Changes in undergraduates’ marijuana, heavy alcohol, and cigarette use following legalization of recreational marijuana use in Oregon (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28613454
User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28624604
Substantiated childhood maltreatment and young adulthood cannabis use disorders: A pre-birth cohort study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28622571
Impulsivity as a mechanism linking child abuse and neglect with substance use in adolescence and adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28606210
Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28641496
Structural Neuroimaging Correlates of Alcohol and Cannabis Use in Adolescents and Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28646566
Daily associations between cannabis motives and consumption in emerging adults (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30278-8/fulltext
Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice (abst – 2017) http://www.sciencedirect.com/science/article/pii/S0091305717301211
Longitudinal pathways from unconventional personal attributes in the late 20s to cannabis use prior to sexual intercourse in the late 30s (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28648991
At the intersection of neurology and psychiatry : the impact of the differential diagnosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653514
History of cannabis use is associated with altered gait (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28666180
U.S. cannabis legalization and use of vaping and edible products among youth (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28662974
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28685756
Illicit drug consumption in school populations measured by wastewater analysis (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30304-6/fulltext
Cannabis Use and Cannabis Use Disorders Among Youth in the United States, 2002-2014 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28686820
School, Friends, and Substance Use: Gender Differences on the Influence of Attitudes Toward School and Close Friend Networks on Cannabis Involvement (abst – 2017) https://link.springer.com/article/10.1007%2Fs11121-017-0816-y
Exposure to and Content of Marijuana Product Reviews (abst–2017) https://link.springer.com/article/10.1007%2Fs11121-017-0818-9
Perceived injunctive norms and cannabis-related problems: The interactive influence of parental injunctive norms and race (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28678683
Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine densities in brain regions important to zebra finch vocal learning and production in an antidepressant-sensitive manner (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28743448
Epigenetic mechanisms associated with addiction-related behavioural effects of nicotine and/or cocaine: implication of the endocannabinoid system (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28704272
Characterizing marijuana concentrate users: A web-based survey (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30311-3/fulltext
Cannabis use, attitudes, and legal status in the U.S.: A review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28705601
Regular cannabis and alcohol use is associated with resting-state time course power spectra in incarcerated adolescents (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30324-1/fulltext
Legalization of cannabis: Considerations for intervening with adolescent consumers (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28729196
Associations between Adolescent Cannabis Use and Neuropsychological Decline: A Longitudinal Co-Twin Control Study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28734078
Adolescent peer networks and the moderating role of depressive symptoms on developmental trajectories of cannabis use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28738220
Post-High School Changes in Tobacco and Cannabis Use in the United States (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28742412
Adolescent alcohol and cannabis use in Iceland 1995-2015 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28752650
Phenotypic and familial associations between childhood maltreatment and cannabis initiation and problems in young adult European-American and African-American women (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30373-3/fulltext
SOGS-RA gambling scores and substance use in adolescents (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28783970
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28538134
Substance Use in Young Swiss Men: The Interplay of Perceived Social Support and
Dispositional Characteristics (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28379109
Developmentally Specific Associations Between CNR1 Genotype and Cannabis Use
Across Emerging Adulthood (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28930056
Adolescent cannabinoid exposure effects on natural reward seeking and learning in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29022083
A Cloud on the Horizon – A survey into the use of electronic vaping devices for
recreational drug and new psychoactive substance (NPS) administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29025078
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061872
Acute and long-term effects of Δ9-tetrahydrocannabinol on object recognition and
anxiety-like activity are age- and strain-dependent in mice (abst–2017)
http://www.sciencedirect.com/science/article/pii/S0091305716302672?via%3Dihub
Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29122973
Adolescent ethanol intake alters cannabinoid type-1 receptor localization in astrocytes of the adult mouse hippocampus (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29168269
New Psychoactive Substances in Pediatric Patients (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29173782
Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic
Cannabinoid Use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29194599
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic
deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids imbalance (abst–2017)
http://www.jneurosci.org/content/early/2017/06/20/JNEUROSCI.3516-16.2017
Acceptability and effectiveness of a web-based psychosocial intervention among criminal justice involved adults (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28285466
Regulating Cannabis Social Clubs: A comparative analysis of legal and self-regulatory practices in Spain, Belgium and Uruguay (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28189980
Cannabis use and dating violence among college students: A call for research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28109121
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599212
Bilateral multiple exudative retinal detachments and macular edema in a patient
diagnosed with synthetic cannabinoid (Bonzai) intoxication (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29275529
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29178411
Monoacylglycerol lipase inhibition alters social behavior in male and female rats after post-weaning social isolation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29292159
Predicting Persistent, Limited, and Delayed Problematic Cannabis Use in Early
Adulthood: Findings From a Longitudinal Study (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29096779
Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender,
2004-2013 (abst–2017) https://link.springer.com/article/10.1007%2Fs11121-017-0848-3
Four Mechanistic Models of Peer Influence on Adolescent Cannabis Use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29104847
Religiosity as a Substance Use Protective Factor Among Female College Students (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110202
Prevalence and motives for drugged driving among emerging adults presenting to an emergency department (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317304008?via%3Dihub
Event-Specific Cannabis Use and Cannabis Use Motives (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29161157
The Intergenerational Transmission of Cannabis Use: Associations Between Parental History of Cannabis Use and Cannabis Use Disorder, Low Positive Parenting, and Offspring Cannabis Use (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/29189023
Patterns of simultaneous and concurrent alcohol and marijuana use among adolescents (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29261344
Is Cannabis Use Associated with Various Indices of Motivation Among Adolescents? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29272172
Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis (abst–2017) https://link.springer.com/article/10.1007%2Fs00415-017-8715-5
Identity as a cannabis user is related to problematic patterns of consumption among emerging adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29289853
Effects of CB1 receptor antagonism and stress exposures in adolescence on
socioemotional behaviours, neuroendocrine stress responses, and expression of relevant proteins in the hippocampus and prefrontal cortex in rats (full–2018)
https://www.sciencedirect.com/science/article/pii/S0028390817304963?via%3Dihub
Marijuana use among adults: Initiation, return to use, and continued use versus quitting over a one-year follow-up period (full–2018)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30535-5/fulltext
Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine
neuron activity in a rodent model of schizophrenia susceptibility (link to PDF–2018) https://academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyy003/4796858
The association between adolescent cannabis use and anxiety: A parallel process analysis (abst–2018) https://www.sciencedirect.com/science/article/pii/S0306460317304148?via%3Dihub
Effects of alcohol and cigarette use on the initiation, reinitiation, and persistence of cannabis use from adolescence to emerging adulthood (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0306460317304744?via%3Dihub
E-cigarette use, dual use of e-cigarettes and tobacco cigarettes, and frequency of cannabis use among high school students (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460317304847?via%3Dihub
Does social context matter? An ecological momentary assessment study of marijuana use among college students (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460318300042?via%3Dihub
Legislative Norms to Control Cannabis Use in the Light of Its Prevalence in Czech Republic, Poland, Slovakia, and Hungary (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29346846
Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the 2013 Canadian Tobacco, Alcohol and Drugs Survey (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29356658
Cannabis use among middle and high school students in Ontario: a school-based crosssectional study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29367264
Young adults report increased pleasure from smoking cigarettes when drinking alcohol but not when using marijuana (abst–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779098/
Does Marijuana Use at Ages 16-18 Predict Initiation of Daily Cigarette Smoking in Late Adolescence and Early Adulthood? A Propensity Score Analysis of Add Health Data (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29388049


ADRENOLEUKODYSTROPHY
Synthetic cannabinoids revealing adrenoleukodystrophy (abst–2016) http://www.sciencedirect.com/science/article/pii/S0967586815004567 


AGE-RELATED DIFFERENCES
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900481/?tool=pubmed
Immune thrombocytopenia in children and adults: what’s the same, what’s different? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232253/
Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514639/
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated
Stress on (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23200786
An age–period–cohort analysis of cannabis use prevalence and frequency in Germany, 1990–2009 (abst–2012) http://jech.bmj.com/content/early/2011/10/20/jech-2011-200180
CNR1 variation is associated with the age at onset in Huntington disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23747361
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies (full–2014)  http://journal.frontiersin.org/article/10.3389/fneur.2014.00161/full
Alterations in the Medullary Endocannabinoid System Contribute to Age-related
Impairment of Baroreflex Sensitivity (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424182/
Cannabis use history and characteristics of quit attempts: A comparison study of
treatment-seeking and non-treatment-seeking cannabis users (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250402/
Hormonal status and age differentially affect tolerance to the disruptive effects of delta-9-tetrahydrocannabinol (Δ(9)-THC) on learning in female rats (full–2015)  http://journal.frontiersin.org/article/10.3389/fphar.2015.00133/full
Sexual identity and prevalence of alcohol and other drug use among Australians in the general population (abst–2015) http://www.ijdp.org/article/S0955-3959(15)00347-3/abstract
Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis (abst–2015) http://www.psy-journal.com/article/S0165-1781%2815%2930166-9/abstract
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25914159
Maternal age and trajectories of cannabis use (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901662-2/abstract
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males (full–2016) http://www.nature.com/tp/journal/v6/n11/full/tp2016225a.html

Age of Alcohol and Cannabis Use Onset Mediates the Association of Transmissible Risk in Childhood and Development of Alcohol and Cannabis Disorders: Evidence for Common Liability (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565072/
Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114015003412
Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27379411
Using Attitudes, Age and Gender to Estimate an Adolescent’s Substance Use Risk (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417548/
Daytime-Dependent Changes of Cannabinoid Receptor Type 1 and Type 2 Expression in Rat Liver (full–2017) http://www.mdpi.com/1422-0067/18/9/1844/htm
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,
Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol (full–2017) http://www.neurobiologyofaging.org/article/S0197-4580(17)30321-4/fulltext
Investigation of the COMT Val158Met variant association with age of onset of
psychosis, adjusting for cannabis use (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698868/
Age dependent plasticity in endocannabinoid modulation of pain processing through postnatal development (link to PDF–2017) http://journals.lww.com/pain/Abstract/publishahead/Age_dependent_plasticity_in_endocannabinoid.99170.aspx
Early cannabis initiation and educational attainment: is the association causal? Data from the French TEMPO study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28520946
U.S. cannabis legalization and use of vaping and edible products among youth (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28662974
Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28700366
Cannabis use, attitudes, and legal status in the U.S.: A review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28705601
Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28340421
Cannabis use, COMT, BDNF and age at first-episode psychosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28142064
Impaired contrast sensitivity at low spatial frequency in cannabis users with early onset (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29031837
Acute and long-term effects of Δ9-tetrahydrocannabinol on object recognition and
anxiety-like activity are age- and strain-dependent in mice (abst–2017)
http://www.sciencedirect.com/science/article/pii/S0091305716302672?via%3Dihub
Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor (abst–2017) http://www.thebonejournal.com/article/S8756-3282(17)30474-X/fulltext
Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender,
2004-2013 (abst–2017) https://link.springer.com/article/10.1007%2Fs11121-017-0848-3
Marijuana use among adults: Initiation, return to use, and continued use versus quitting over a one-year follow-up period (full–2018)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30535-5/fulltext
Alcohol, tobacco and cannabis consumption in adolescents from a multicultural
population (Burela, Lugo) (download–2018)  http://www.adicciones.es/index.php/adicciones/article/download/915/906
Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in
Olfactory Neuroepithelium Cells (abst–2018)  https://link.springer.com/article/10.1007%2Fs12035-017-0833-7
Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the 2013 Canadian Tobacco, Alcohol and Drugs Survey (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29356658
Cannabis use among middle and high school students in Ontario: a school-based crosssectional study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29367264
Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids of female C57BL/6 mice (abst–2018)  https://www.sciencedirect.com/science/article/pii/S1388198117302044?via%


AGING+ 
The Management of Chronic Pruritus in the Elderly (full–2010) http://www.skintherapyletter.com/2010/15.8/2.html
N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093655/

Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20936991
The effects of Cannabis sativa L. seed (hempseed) in the ovariectomized rat model of menopause (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21069097
The type 2 cannabinoid receptor protects against age-related bone loss and ovariectomy induced bone loss by stimulating bone formation (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2900619-8/abstract
Does cannabis use increase the risk of death? Systematic review of epidemiological
evidence on adverse effects of cannabis use (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20565525
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131310/?tool=pubmed
Comparison of Cannabinoid CB1 Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [18F]MK-9470 (full–2011) http://www.hindawi.com/journals/ijmi/2011/548123/
Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with
obesity and metabolic syndrome in postmenopausal Polish women? (full – 2011)
http://www.nature.com/ijo/journal/v35/n3/full/ijo2010145a.html
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033
Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480765
Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514639/
top

Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full–2012) http://www.jneuroinflammation.com/content/9/1/10
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake (full–2012) http://www.karger.com/Article/FullText/343563
Pharmacological manipulation of cannabinoid neurotransmission reduces
neuroinflammation associated with normal aging (full–2012)
http://file.scirp.org/Html/1-8201656_23229.htm
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical
neurons exposed to amyloid-β and in the cortex of aged rats (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464574/
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical
neurons exposed to amyloid-beta and in the cortex of aged rats (download–2012)
http://www.jbc.org/content/early/2012/08/13/jbc.M112.350678.long
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/11982628
Combined deficiency of the CB1 and CB2 receptors enhances peak bone mass by inhibiting osteoclast differentiation but increases age-related bone loss by promoting adipocyte differentiation and reducing osteoblast differentiation (abst–2012) http://www.thebonejournal.com/article/S8756-3282%2812%2900153-6/abstract
The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health (full–2013)
http://www.hindawi.com/journals/sci/2013/796715/
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance
(full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575938/
Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23281018
Anandamide deficiency and heightened neuropathic pain in aged mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23597506
Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23954857
GPR55 Deletion in Mice Leads to Age-Related Ventricular Dysfunction and Impaired Adrenoceptor-Mediated Inotropic Responses (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25275556
Differential effects of delayed aging on phenotype and striatal pathology in a murine model of huntington disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236397/
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/?term=24889782
Plasma-Free Fatty Acids, Fatty Acid-Binding Protein 4 and Mortality in Older Adults (from the Cardiovascular Health Study) (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25073566
top

Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24768821
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25456842
Enhanced microglial activity in FAAH-/- animals (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25534441
Stimulation of cannabinoid receptors by using Rubus coreanus extracts to control
osteoporosis in aged male rats (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25136745
Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on
bone mass and bone turnover (abst–2014)  https://link.springer.com/article/10.1007%2Fs00223-013-9793-8
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567222/
THE EFFECT OF MEDICAL MARIJUANA LAWS ON BODY WEIGHT (full–2015)  http://www.os-extra.cannabisclinicians.org/wp-content/uploads/2016/03/MMJ_laws_Body-weight.pdf
Age-related changes in the endocannabinoid system in the mouse hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26278494
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26303348
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
(full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514994/
CB1 receptor blockade counters age-induced insulin resistance and metabolic
dysfunction (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783351/
β-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures in vitro (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228512/
Protective effects of trans-caryophyllene on maintaining osteoblast function (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28026135
Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114015003412
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer’s Disease and Mild Cognitive Impairment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825096
Lack of hippocampal CB1 receptor desensitization by Δ9-tetrahydrocannabinol in aged mice and by low doses of JZL 184 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26984820
Circulating levels of endocannabinoids and oxylipins altered by dietary lipids in older women are likely associated with previously identified gene targets (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302013
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27567873
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity
and Breadth of Antigen-specific Antibody Responses in Young and Aged mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314369/
Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the
Endocannabinoid System in Brain Protection and Repair (full–2017) https://link.springer.com/article/10.1007%2Fs11745-017-4292-8
Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol (full–2017)  http://www.neurobiologyofaging.org/article/S0197-4580(17)30321-4/fulltext
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
MicroRNA-139 modulates Alzheimer’s-associated pathogenesis in SAMP8 mice by targeting cannabinoid receptor type 2 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28218780

Obesity is a concern for bone health with aging (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28385284
A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28481360
Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28750802
Marijuana Use in the Elderly: Implications and Considerations (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28595684


ALCOHOLISM/ALCOHOL*+
The use of Cannnabidiol (CBD) to Reduce Insomnia and the Urge To Use Alcohol in a Geriatric person in on going Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/420/?pagenum=2
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/437/?pagenum=2
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/601/?pagenum=2
Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women (full–2010) http://www.nutritionandmetabolism.com/content/7/1/49
Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis (full–2010) http://ijnp.oxfordjournals.org/content/13/2/191.long
top
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965487/
The Endocannabinoid System Tonically Regulates Inhibitory Transmission and Depresses the Effect of Ethanol in Central Amygdala (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904853/
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878847/
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is
reversed by chronic forced ethanol consumption (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004984/
Cannabinoid receptor type 1 expression modulates alcohol-induced liver fibrosis (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321809/
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is
reversed by chronic forced ethanol consumption (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004984/
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance
Exposure (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed
Survey of alcohol, tobacco, and cannabis use in the French army (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20390703
Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/21116612
11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid ethyl ester (THC-COOEt): unsuccessful search for a marker of combined cannabis and alcohol consumption (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20074877/abstract/11_nor_Delta9_tetrahydrocannabinol_9_carboxylic_acid_ethyl_ester__THC_COOEt_:_unsuccessful_search_for_a_marker_of_combined_cannabis_and_alcohol_consumption_

Role of the endocannabinoid system in alcoholic liver disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21525760
The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20380913/abstract/The_effects_of_cannabis_and_alcohol_on_simulated_arterial_driving:_Influences_of_driving_experience_and_task_demand_
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045517/
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
Effect of an Acute Consumption of a Moderate Amount of Ethanol on Plasma Endocannabinoid Levels in Humans (full–2011) http://alcalc.oxfordjournals.org/content/47/3/226.full
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018238/
top
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating kupffer cell polarization in mice (full–2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.24524/full
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258364/
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186916/
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (full–2011) http://www.lufg.com.au/files/media/Popular_intoxicants_what_lessons_can_be_learned.pdf
Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption (full – 2011)
http://ftp.iza.org/dp6112.pdf
Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations:
alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol) (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033515/?tool=pmcentrez
The role of the cannabinoid system in the pathogenesis and treatment of alcohol
dependence (click full text link for download–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21934185
Some features of teenage beer alcoholism combined with hashish addiction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21322145
Intermittent ethanol consumption depresses endocannabinoid-signaling in the dorsolateral striatum of rat (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0028390811000177
Alcohol, psychoactive drugs and fatal road traffic accidents in Norway: a case-control
study (abst – 2011) http://www.sciencedirect.com/science/article/pii/S0001457510004112?via%3Dihub
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392453/
Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372600/
Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249519/
Borderline personality traits and substance use: genetic factors underlie the association with smoking and ever use of cannabis, but not with high alcohol consumption (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744119/
Involvement of the Endocannabinoid System in Ethanol-Induced Corticostriatal Synaptic Depression (full–2012) https://www.jstage.jst.go.jp/article/jphs/120/1/120_12118FP/_pdf
Effects of ethanol, Δ(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477605/
Positron Emission Tomography Shows Elevated Cannabinoid CB 1 Receptor Binding in Men with Alcohol Dependence (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418442/
top
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012) https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
Endocannabinoid system: A newer molecular target for the treatment of alcohol-related
behaviors (full – 2012)
http://www.wjgnet.com/2220-3192/full/v1/i3/44.htm
The Relationship between Cannabis Use Disorders and Social Anxiety Disorder in the
National Epidemiological Study of Alcohol and Related Conditions (NESARC) (full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350824/
A placebo-controlled study to assess Standardized Field Sobriety Tests performance
during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456923/
Alcohol as a Gateway Drug: A Study of US 12th Graders (download–2012)  https://www.frihetspartiet.net/dokumenter/gateway.pdf
Detecting impairment associated with cannabis with and without alcohol on the
Standardized Field Sobriety Tests (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22763669
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell
carcinoma development and progression: Recent advances and challenges (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22727410
Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice  (abst–2012) http://www.sciencedirect.com/science/article/pii/S019701861200174X
Alcohol and cannabis consumption in the French Army: determination of consumer
profiles to focus on prevention and care (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22128723
The impact of comorbid cannabis use disorders on the clinical presentation of social
anxiety disorder (abst–2012) https://www.ncbi.nlm.nih.gov/pubmed/22047609
Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats (full–2013) http://www.frontiersin.org/Behavioral_Neuroscience/10.3389/fnbeh.2013.00064/full
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders (full–2013) http://www.clinicalepigeneticsjournal.com/content/5/1/14
Perception of tobacco, cannabis, and alcohol use of others is associated with one’s own use (full–2013) http://www.ascpjournal.org/content/8/1/15
Influence of Ethanol on the Pharmacokinetic Properties of Δ9-Tetrahydrocannabinol in Oral Fluid (full–2013) http://jat.oxfordjournals.org/content/37/3/152.full
Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068845
The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance (full–2013) http://www.nutritionandmetabolism.com/content/10/1/71
Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the national epidemiologic survey on alcohol and related conditions (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755735/
Differential expression and functional role of cannabinoid genes in alcohol users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818789/
top
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096899/
Reduced Cannabinoid CB1 Receptor Binding in Alcohol Dependence Measured with
Positron Emission Tomographys (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594469/
A spontaneous deletion of α-Synuclein is associated with an increase in CB1 mRNA
transcript and receptor expression in the hippocampus and amygdala: Effects on alcohol
consumption (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931467/
Harms and benefits associated with psychoactive drugs: findings of an international
survey of active drug users (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107777/
Effect of Diet on Tissue Levels of Palmitoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107972/article
Use of micronutrients attenuates cannabis and nicotine abuse as evidenced from a
reversal design: a case study (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23909004
Prevalence of alcohol and other drugs and the concentrations in blood of drivers killed in road traffic crashes in Sweden (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24265165
Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol. (abst – 2013)
https://www.ncbi.nlm.nih.gov/pubmed/23855434
Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23291357
Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23510307
Lifetime prevalence of alcohol and substance use in egypt: a community survey (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23577901
Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23740372
Endogenous cannabinoids in amygdala and hippocampus in post-mortem brains of Cloninger type 1 and 2 alcoholics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23747173
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid mediated gastroprotective effect in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24145131
Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and
beyond (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24180513
Risk of severe driver injury by driving with psychoactive substances (abst–2013)
http://www.sciencedirect.com/science/article/pii/S0001457513002315
Police custody following driving under the influence of cannabis: A prospective study
(abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23890621
Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnint.2014.00058/full
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol / high fat diet induced pancreatitis (full–2014) http://www.molecularpain.com/content/10/1/66
Enhanced Endocannabinoid-Mediated Modulation of Rostromedial Tegmental Nucleus Drive onto Dopamine Neurons in Sardinian Alcohol-Preferring Rats (full–2014) http://www.jneurosci.org/content/34/38/12716.long
top
Acute alcohol use temporally increases the odds of male perpetrated dating violence: A diary analysis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858531/
Can Cannabis be Considered a Substitute Medication for Alcohol? (full–2014) http://alcalc.oxfordjournals.org/content/early/2014/01/07/alcalc.agt182.full
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy  full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112960/
Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence (full–2014) http://www.jneurosci.org/content/34/8/2822.long
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963405/
Drug use, consequences and perceived accessibility in three Nigerian universities
(full–2014) http://file.scirp.org/Html/9-1420229_41669.htm
The Effect of Medical Marijuana Laws on Marijuana, Alcohol, and Hard Drug Use
(link to PDF–2014) http://www.nber.org/papers/w20085#fromrss
Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24424782
Changes in cigarette and alcohol use during cannabis abstinence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24613633
Recreational drug use and binge drinking: Stimulant but not cannabis intoxication is associated with excessive alcohol consumption (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24975774
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24999220
The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/adb.12160/abstract
Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in los angeles (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25188696
Gene-Specific Disruption of Endocannabinoid Receptor 1 (cnr1a) by Ethanol Probably Leads to the Development of Fetal Alcohol Spectrum Disorder (FASD) Phenotypes in Japanese Rice Fish (Oryzias latipes) Embryogenesis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25251458
top
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24589297
The culpability of drivers killed in New Zealand road crashes and their use of alcohol and other drugs (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0001457514000645
Spicing up the military: Use and effects of synthetic cannabis in substance abusing army
personnel (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24727109
Drug and Alcohol Crash Risk (full–2015) http://kimabim.s3.amazonaws.com/812117-Drug_and_Alcohol_Crash_Risk.pdf
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Drugs of Abuse in HIV infection and neurotoxicity (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.00217/full
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 L’aquila Earthquake (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397827/
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol (full–2015) http://www.clinchem.org/content/61/6/850.long
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25632127
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC) (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.01452/full
Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons (full–2015) http://www.alcoholjournal.org/article/S0741-8329%2815%2930019-7/fulltext
Prenatal exposure to recreational drugs affects global motion perception in preschool children (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652269/
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neuro-degeneration in neonatal mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25857698
top

Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism (full – 2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665616/
THE EFFECT OF MEDICAL MARIJUANA LAWS ON BODY WEIGHT (full–2015)  http://www.os-extra.cannabisclinicians.org/wp-content/uploads/2016/03/MMJ_laws_Body-weight.pdf
Microstructural analysis of rat ethanol and water drinking patterns using a modified
operant self-administration model (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506870/
Prevalence of Marijuana and Other Substance Use Before and After Washington State’s
Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana:
Cohort Comparisons in a Sample of Adolescents (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744815/
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling (full–2015) http://www.mdpi.com/2076-3425/5/4/456/htm
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral
fluid-blood cannabinoid relationships (full–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26257143
Roles for the endocannabinoid system in ethanol-motivated behavior (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679600/
Chronic ethanol exposure increases voluntary home cage intake in adult male, but not
female, Long-Evans rats (full–2015)  http://www.sciencedirect.com/science/article/pii/S0091305715300885
Maternal separation and early stress cause long-lasting effects on dopaminergic and
endocannabinergic systems and alters dendritic morphology in the nucleus accumbens
and frontal cortex in rats (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/dneu.22361/full
In the weeds: a baseline view of cannabis use among legalizing states and their
neighbours (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216038/
Behavioral, Metabolic and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model (abst–2015) http://link.springer.com/article/10.1007/s11481-015-9599-8
Early onset of cannabis use: Does personality modify the relation with changes in
perceived parental involvement? (click “academia” for download–2015)  https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Early+onset+of+cannabis+use%3A+Does+personality+modify+the+relation+with+changes+in+perceived+parental+involvement%3F+++++++++++++++&btnG
Canadian Tobacco Alcohol and Drugs (CTADS): 2013 summary (summary–2015)  https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2013-summary.html
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26253623

European rating of drug harms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25922421

Predicting Alcohol, Cigarette, and Marijuana Use From Preferential Music Consumption
(abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26400900

The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age (abst–2015) http://www.sciencedirect.com/science/article/pii/S0167629611001718

Profiles of medicinal cannabis patients attending compassion centers in rhode island (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at
Glutamatergic Synapses in the Rat Basolateral Amygdala (abst–2015)  http://www.sciencedirect.com/science/article/pii/S002839081530201X
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25827923
Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25940135
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26343919
Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and
cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26427296
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26364922
Effect of Cannabis sativa extract on gastric acid secretion, oxidative stress and gastric mucosal integrity in rats (abst–2015) http://link.springer.com/article/10.1007/s00580-015-2090-3
Sexual identity and prevalence of alcohol and other drug use among Australians in the
general population (abst–2015)
http://www.ijdp.org/article/S0955-3959(15)00347-3/abstract
A longitudinal study of cannabis use initiation among high school students: Effects of
social anxiety, expectancies, peers and alcohol (abst–2015)
https://www.ncbi.nlm.nih.gov/pubmed/25800726
top
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug? (full–2016) http://link.springer.com/article/10.1007/s12640-015-9555-7/fulltext.html
Impacts of Changing Marijuana Policies on Alcohol Use in the United States (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acer.12942/full
Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey (full–2016) http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0746-4
Impaired Ethanol- Induced Sensitization and Decreased Cannabinoid Receptor-1 in a
Model of Posttraumatic Stress Disorder (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871361/
Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2
Receptors in Alcohol Reward-Related Behaviors (full–2016)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886733/
Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol
and sucrose consumption in male C57BL/6J mice (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905821/
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage
Autophagy-Dependent Pathway (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921859/
The Orphan Nuclear Receptor ERRγ Regulates Hepatic CB1 Receptor-Mediated
Fibroblast Growth Factor 21 Gene Expression (full–2016)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0159425
Involvement of Endocannabinoids in Alcohol “Binge” Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962692/
Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol SelfAdministration by Wistar Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152943/
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035052/
Independent Versus Co-occurring Substance Use in Relation to Gambling Outcomes in
Older Adolescents and Young Adults (full–2016)
http://www.jahonline.org/article/S1054-139X(16)30417-7/fulltext
Subjective aggression during alcohol and cannabis intoxication before and after
aggression exposure (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988999/
Is attention deficit/hyperactivity disorder among men associated with initiation or
escalation of substance use at 15-month follow up? A longitudinal study involving young
Swiss men (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215781/
Longitudinal predictors of cannabis use and dependence in offspring from families at
ultra high risk for alcohol dependence and in control families (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444658/
Alcohol and cannabis use among college students: Substitutes or complements? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808449 /
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive

Behavior during Forced Abstinence from Alcohol Drinking (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908652/
Effect of Blood Collection Time on Measured Δ9-Tetrahydrocannabinol Concentrations:
Implications for Driving Interpretation and Drug Policy (full–2016)
http://clinchem.aaccjnls.org/content/62/2/367.long
Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in
HIV/Hepatitis C Virus-coinfected Women (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967608/
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes  (full–2016) http://www.ijdp.org/article/S0955-3959(16)30334-6/fulltext
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a
comprehensive review (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845302/
Age of Alcohol and Cannabis Use Onset Mediates the Association of Transmissible Risk
in Childhood and Development of Alcohol and Cannabis Disorders: Evidence for
Common Liability (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565072/
Brain circuitry associated with the development of substance use in bipolar disorder and
preliminary evidence for sexual dimorphism in adolescents (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123602/
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based
Cohort Study of 45 000 Swedish Men (full–2016)  http://stroke.ahajournals.org/content/48/2/265.long
Restraint use and risky driving behaviors across drug types and drug and alcohol
combinations for drivers involved in a fatal motor vehicle collision on U.S. roadways
(full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819806/
Cannabis use among Navy personnel in Sri Lanka: a cross sectional study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794863/
Drug abuse in slum population (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776588/
Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients (click “full text links” for download–2016) https://www.ncbi.nlm.nih.gov/pubmed/28492376
Connecting the dots, genome-wide association studies in substance use (article–2016)
https://www.researchgate.net/publication/298422234_Connecting_the_dots_genome-wide_association_studies_in_substance_use
Are We Using the Right Model of Cannabis Tolerance? (letter–2016)  http://www.jsad.com/doi/10.15288/jsad.2016.77.992
Treating Depression in Alcoholics (news & abst–2016)
http://neurosciencenews.com/alcoholism-depression-psychology-3541/
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Violence and self-harm in severe mental illness: inpatient study of associations with
ethnicity, cannabis and alcohol (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27679634
Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink With Illicit Drug Use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/josh.12351/full
The Relationships of Cigarette and Alcohol Use With the Initiation, Reinitiation, and Persistence of Cannabis Use (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26751361
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of
adolescent rats (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0304394016302907
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat
basolateral amygdala (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26786379
A common public health-oriented policy framework for cannabis, alcohol and tobacco in
Canada? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26986906
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder
and Substance Use Disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26903256
Cannabis effects on driving longitudinal control with and without alcohol (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26889769
ALCOHOL DEPENDENCE–NEUROBIOLOGY AND TREATMENT (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27008795
Alcohol, Methamphetamine, and Marijuana Exposure Have Distinct Effects on the
Human Placenta (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27038593
Dual Cannabis and Alcohol Use Disorders in Young Adults: Problems Magnified (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27070725
Ethanol downregulates N-acyl phosphatidylethanolamine-phospholipase D expression in
BV2 microglial cells via epigenetic mechanisms (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27266665
Older-adult marijuana users and ex-users: Comparisons of sociodemographic
characteristics and mental and substance use disorders (abst–2016)  http://www.drugandalcoholdependence.com/article/S0376-8716(16)30140-5/fulltext
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatients’ Daily
Lives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27270874
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262964
Traffic accidentability and risky driving behavior in young people in New Caledonia. Results of study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27259836
Substitution and Complementarity of Alcohol and Cannabis: A Review of the Literature (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27249324
Drugs of abuse and alcohol consumption among different groups of population on the Greek Island of Lesvos through sewage-based epidemiology (abst–2016) http://www.sciencedirect.com/science/article/pii/S0048969716308233
Secondary Effects of an Alcohol Prevention Program Targeting Students and/or Parents (abst–2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30152-0/abstract
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27292878
Basolateral amygdala CB1 cannabinoid receptors are involved in cross state-dependent memory retrieval between morphine and ethanol (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716301083
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304304
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27454353
Examining the Relationship Between Traumatic Brain Injury and Substance Use Outcomes in the Canadian Population (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27484302
Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27521979
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27578612
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27659736
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27716956
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
A social network analysis of substance use among immigrant adolescents in six European cities (abst–2016) http://www.sciencedirect.com/science/article/pii/S027795361630538X
Oxytocin for the treatment of drug and alcohol use disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27603752
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population? (abst-2016) http://www.sciencedirect.com/science/article/pii/S089142221630230X
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302465
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28008372
Effect of marijuana on Essential Tremor: A case report (abst–2016)  http://www.mdsabstracts.org/abstract/effect-of-marijuana-on-essential-tremor-a-case-report/
Sexual dysfunction in men diagnosed as substance use disorder (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26940022
Childhood academic ability in relation to cigarette, alcohol and cannabis use from
adolescence into early adulthood: Longitudinal Study of Young People in England
(LSYPE) (full–2017) http://bmjopen.bmj.com/content/7/2/e012989.long
Mice expressing a “hyper-sensitive” form of the CB1 cannabinoid receptor (CB1) show
modestly enhanced alcohol preference and consumption (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398885/
Using Attitudes, Age and Gender to Estimate an Adolescent’s Substance Use Risk
(full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417548/
Patterns of cannabis use during adolescence and their association with harmful substance use behaviour: findings from a UK birth cohort (full–2017)  http://jech.bmj.com/content/71/8/764
Epigenetic Interactions between Alcohol and Cannabinergic Effects: Focus on Histone
Modification and DNA Methylation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515243/
Association Between Use of Cannabis in Adolescence and Weight Change into Midlife (link to download–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0168897
Ethanol Modulates the Spontaneous Complex Spike Waveform of Cerebellar Purkinje
Cells Recorded in vivo in Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328976/
High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who
use illicit drugs in Vancouver, Canada (full–2017) http://www.ijdp.org/article/S0955-3959(17)30057-9/fulltext
Severity and outcomes of acute alcoholic pancreatitis in cannabis users (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539398/
Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for
the Endogenous Cannabinoid System and Neuroinflammation (full–2017)
http://journal.frontiersin.org/article/10.3389/fnbeh.2017.00015/full
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
Binge Alcohol Exposure Transiently Changes the Endocannabinoid System: A Potential
Target to Prevent Alcohol-Induced Neurodegeneration (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742761/
Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol
Consumption in Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777574/
Cannabis, alcohol and fatal road accidents (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678710/
Verbal Learning and Memory in Cannabis and Alcohol Users: An Event-Related
Potential Investigation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727079/
Gender-specific associations between involvement in team sport culture and canadian
adolescents’ substance-use behavior (full–2017)  https://www.sciencedirect.com/science/article/pii/S2352827317301398?via%3Dihub
S100A10 identified in a genome-wide gene × cannabis dependence interaction analysis
of risky sexual behaviours. (link to download–2017) http://jpn.ca/42-4-160189/
Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders (1st page–2017) http://jamanetwork.com/journals/jama/article-abstract/2610319
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107775
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint Association with Sexual Risk Behavior and Outcomes in Young Adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28083726
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28088054
Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse (abst–2017) http://www.sciencedirect.com/science/article/pii/S0277953617300011
Cannabidiol reduces ethanol consumption, motivation and relapse in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28194850
Severity of alcohol dependence is associated with the fatty acid amide hydrolase
Pro129Thr missense variant (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28150397
Medical cannabis access, use, and substitution for prescription opioids and other
substances: A survey of authorized medical cannabis patients (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28189912
Assessment of tobacco, alcohol and cannabinoid metabolites in 645 meconium samples
of newborns compared to maternal self-reports (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28237885
Associations between substance use disorders and suicide or suicide attempts in people
with mental illness: A Danish nationwide, prospective, register-based study of patients
diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality
disorder (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28192643
Cannabis and alcohol use, and the developing brain (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28223098
Marijuana and other substance use among male and female underage drinkers who drive after drinking and ride with those who drive after drinking (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28231494
Demographic Characteristics, Components of Sexuality and Gender, and Minority Stress
and Their Associations to Excessive Alcohol, Cannabis, and Illicit (Noncannabis) Drug
Use Among a Large Sample of Transgender People in the United States (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28405831
Substance Use in Undergraduate Students With Histories of Attention Deficit / Hyperactivity Disorder (ADHD): The Role of Impulsivity (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28406351
Significant reductions in alcohol use after Hepatitis C treatment: Results from the French
ANRS CO13-HEPAVIH cohort (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28430385
Concurrent use of cannabis and alcohol: neuropsychiatric effects and consequences (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28440194
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep
(abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28372506
The rewarding effects of ethanol are modulated by binge eating of a high-fat diet during
adolescence (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301909
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in
rats: involvement of the GABAB and cannabinoid CB1 receptors (abst–2017)
https://link.springer.com/article/10.1007%2Fs00213-017-4644-3
Effects of sleep on substance use in adolescents: a longitudinal perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28547821
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of
alcohol, cigarettes, and cannabis in adolescents (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28544955
Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via
endocannabinoid receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28554529
The endocannabinoid system as a target for addiction treatment: Trials and tribulations
(abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390817302563
Sex- and hormone-dependent alterations in alcohol withdrawal-induced anxiety and
corticolimbic endocannabinoid signaling (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817302484
Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance
and Medication Use, and Health and Disability Characteristics. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28595191
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking
in Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605163
Examination of cumulative effects of early adolescent depression on cannabis and
alcohol use disorder in late adolescence in a community-based cohort (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28600897
Changes in undergraduates’ marijuana, heavy alcohol, and cigarette use following
legalization of recreational marijuana use in Oregon (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28613454
Structural Neuroimaging Correlates of Alcohol and Cannabis Use in Adolescents and
Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28646566
CB1 and ethanol effects on glutamatergic transmission in the central amygdala of male
and female msP and Wistar rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28656627
4-O′-methylhonokiol protects from alcohol/carbon tetrachloride-induced liver injury in
mice (abst–2017) https://link.springer.com/article/10.1007%2Fs00109-017-1556-y
Blockade of alcohol escalation and “relapse” drinking by pharmacological FAAH
inhibition in male and female C57BL/6J mice (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4691-9
Regular cannabis and alcohol use is associated with resting-state time course power
spectra in incarcerated adolescents (abst–2017)
http://www.drugandalcoholdependence.com/article/S0376-8716(17)30324-1/fulltext
Adolescent alcohol and cannabis use in Iceland 1995-2015 (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28752650
Demographic and clinical characteristics of treatment seeking women with full and
subthreshold PTSD and concurrent cannabis and cocaine use disorders (abst–2017) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(17)30009-0/fulltext
Five-year monitoring of 19 illicit and legal substances of abuse at the inlet of a
wastewater treatment plant in Barcelona (NE Spain) and estimation of drug consumption patterns and trends (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0048969717318296
SOGS-RA gambling scores and substance use in adolescents (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28783970
Self-reported Driving Under the Influence of Alcohol and Cannabis Among Ontario
Students: Associations with Graduated Licensing, Risk Taking and Substance Abuse.
(abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28095034
Context-dependent effects of rimonabant on ethanol-induced conditioned place
preference in female mice (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30405-2/fulltext
Substance Use in Young Swiss Men: The Interplay of Perceived Social Support and
Dispositional Characteristics (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28379109
The association between alcohol use trajectories from adolescence to adulthood and
cannabis use disorder in adulthood: a 22-year longitudinal study (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28635349
Pharmacological challenge studies with acute psychosocial stress (abst–2017)
http://www.psyneuen-journal.com/article/S0306-4530(17)30544-9/fulltext
THC inhibits the expression of ethanol-induced locomotor sensitization in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29084627
Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and
alcohol-induced accumbal dopaminergic signaling (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817305075?via%3Dihub
Adolescent ethanol intake alters cannabinoid type-1 receptor localization in astrocytes of
the adult mouse hippocampus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29168269
Investigating the relationships between alcohol consumption, cannabis use and  circulating cytokines: a preliminary analysis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29286537
Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid
expression of innate anxiety and excessive alcohol intake (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29071769
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29178411
Religiosity as a Substance Use Protective Factor Among Female College Students (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110202
The Impact of Combinations of Alcohol, Nicotine, and Cannabis on Dynamic Brain
Connectivity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29134961
Patterns of simultaneous and concurrent alcohol and marijuana use among adolescents
(abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29261344
Is recovery from cannabis use problems different from alcohol and other drugs? Results
from a national probability-based sample of the United States adult population (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29287223
Alcohol, tobacco and cannabis consumption in adolescents from a multicultural
population (Burela, Lugo) (download–2018)  http://www.adicciones.es/index.php/adicciones/article/download/915/906
Effects of alcohol and cigarette use on the initiation, reinitiation, and persistence of
cannabis use from adolescence to emerging adulthood (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460317304744?via%3Dihub
Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders:
variation by race/ethnicity? (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29310741
Investigating causal associations between use of nicotine, alcohol, caffeine, and cannabis: A two-sample bidirectional Mendelian randomization study (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29334416
Cannabis use is associated with reduced prevalence of progressive stages of alcoholic
liver disease (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29341392
Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients
experiencing first episode psychosis: Data from the national RAISE-ETP study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29356438
Cannabis use among middle and high school students in Ontario: a school-based crosssectional study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29367264
Young adults report increased pleasure from smoking cigarettes when drinking alcohol
but not when using marijuana (abst–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779098/


ALLERGIES AND CANNABINOIDS+*
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity (full–2010) http://www.nature.com/aps/journal/v31/n12/full/aps2010155a.html
Protective role of palmitoylethanolamide in contact allergic dermatitis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19909294
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/21056512/abstract/Beneficial_effects_of_cannabinoids__CB__in_a_murine_model_of_allergen_induced_airway_inflammation:_Role_of_CB_1_/CB_2__receptors
The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20150748
top

Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21601500
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up regulation of Serum IgE Levels in Immunized Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419805/
Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis (full–2012) http://www.biomedcentral.com/1746-6148/8/230
Endocannabinoids limit excessive mast cell maturation and activation in human skin (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22226549
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
The cannabinoid receptor-2 is involved in allergic inflammation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22525379
Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic
inflammation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22652530
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation (full–2013) http://www.jimmunol.org/content/190/10/4929.long
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23453134
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23889474
Effect of endocannabinoids on IgE-mediated allergic response in RBL-2H3 cells (abst–2013) http://www.sciencedirect.com/science/article/pii/S1567576913002026
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst–2013)  http://www.jimmunol.org/content/190/1_Supplement/120.12
The expression of cannabinoid receptor 1 is significantly increased in atopic patients (full–2014) http://www.jacionline.org/article/S0091-6749%2813%2902936-9/fulltext
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS (full–2015) http://www.hindawi.com/journals/bmri/2015/980983/
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (asbst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26257969
top
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis (abst–2015) http://www.sciencedirect.com/science/article/pii/S1090023315004712
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen induced pulmonary inflammation in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26850094 
Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed type hypersensitivity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27064137
Acetaminophen Attenuates House Dust Mite Induced Allergic Airway Disease in Mice  (link to PDF–2016) http://jpet.aspetjournals.org/content/early/2016/07/08/jpet.116.233684.long
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell
Permeability through an Arachidonic Acid Metabolite (abst–2016)
http://www.sciencedirect.com/science/article/pii/S1043661816000256
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a
murine model of asthma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27992060
Innate lymphoid cells in asthma: cannabinoids on the balance (full–2017)
http://onlinelibrary.wiley.com/doi/10.1111/all.13145/epdf
Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic
Symptoms in the Mouse (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732963/
The Endocannabinoid System and Its Role in Eczematous Dermatoses (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28098721
Cannabis and crossed allergy with food (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29122396
Marijuana use is associated with hypersensitivity to multiple allergens in US adults (full–2018) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30555-0/fulltext


ALLERGIES TO CANNABIS/CANNABINOIDS
Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic
effects in skin (abst–2010)  http://www.sciencedirect.com/science/article/pii/S0006295210001577
Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21272987

IgE-Mediated Hypersensitivity Reactions to Cannabis in Laboratory Personnel (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21832832
Molecular allergology in practice: an unusual case of LTP allergy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22360137
World Allergy Organization Study on Aerobiology for Creating First Pollen and Mold Calendar With Clinical Significance in Islamabad, Pakistan;: A Project of World Allergy Organization and Pakistan Allergy, Asthma & Clinical Immunology Centre of Islamabad (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23283209
Variations and origin of the atmospheric pollen of Cannabis detected in the province of Tetouan (NW Morocco): 2008-2010 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23208276
Characterization of Cannabis sativa allergens (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726218/
New Food Allergies in a European Non-Mediterranean Region: Is Cannabis sativa to Blame? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23549061
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22697514
Prevalence of Sensitization to Cannabis sativa. Lipid-Transfer and Thaumatin-Like Proteins Are Relevant Allergens (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23921252
Contact urticaria to Cannabis sativa due to a lipid transfer protein (LTP) (full–2014) http://tinyurl.com/pgbxfa4
Allergy to illicit drugs and narcotics (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24588864
Cannabis Sativa: The Unconventional “Weed” Allergen (full–2015) http://www.west-info.eu/it/oltre-al-polline-ce-allergia-da-cannabis/elsevier-cannabis-sativa-theunconventional-weed-allergen-2015-2/
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Marihuana allergy: beyond the joint (link to PDF–2015) http://www.jiaci.org/issues/vol25issue1/vol25issue01-16.htm
Cannabis Allergy: What do We Know Anno 2015 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26178655
Cannabis sativa allergy: looking through the fog (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/all.13043/epdf
Intravenous administration of cannabis and lethal anaphylaxis (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28438101
Identification of IgE- binding pollen protein from Cannabis sativa in pollen hypersensitive patients from north Pakistan (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28603110
Cannabis and crossed allergy with food (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29122396

top


ALS/AMYOTROPHIC LATERAL SCLEROSIS
Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials (full-2010) http://safeaccess.ca/research/pdf/Carter-ALS-2010.pdf
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full–2010)
http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353778
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19452308
The endocannabinoid system in gp120-mediated insults and HIV-associated dementia (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353779
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20498181
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Targeting the endocannabinoid system with cannabinoid receptor agonists:
pharmacological strategies and therapeutic possibilities (full–2012)
http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22594565
Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22998138
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress and cell death during remote neurodegeneration (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22371074
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (link to PDF–2014) http://www.mdpi.com/1420-3049/19/11/18781
top

Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex® -like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24703394
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26260390
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders (full–2015) http://tinyurl.com/oe3oouq
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408162
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy (full-2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801305/
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Pain in amyotrophic lateral sclerosis. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27964824
Up-regulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis (full – 2017) http://dmm.biologists.org/content/early/2017/01/06/dmm.028373.long
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse
model of ALS (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301296?via%3Dihub
Neurological aspects of medical use of cannabidiol (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28412918
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28637354
Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington
mouse model and human ALS spinal cord tissue (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0223523417311285?via%3Dihub
Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29334787


ALZHEIMER’S DISEASE/DEMENTIA*+
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?tool=pubmed
Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992287/
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data (link to PDF–2010) http://www.mdpi.com/1424-8247/3/8/2689
The endocannabinoid system as a target for the treatment of neurodegenerative disease (full-2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931550/
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full–2010)
http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
The development of cannabinoid CBII receptor agonists for the treatment of central
neuropathies. (link to download–2010) http://www.eurekaselect.com/85808/article
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00195.x/full
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20004682
The endocannabinoid system in gp120-mediated insults and HIV-associated dementia (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353779
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
Gadolinium-HU-308-incorporated micelles (full–2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
top
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069704/pdf/awr046.pdf
Palmitoylethanolamide counteracts reactive astrogliosis induced by beta-amyloid peptide (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2011.01267.x/full
The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933972/
Patent WO 2010012506 A1 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA (full-2011) http://www.google.it/patents/WO2010012506A1?cl=en
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo:
relevance to Alzheimers’ disease (link to download – 2011)
http://molpharm.aspetjournals.org/content/early/2011/02/24/mol.111.071290.long
Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21664223
JNK plays a key role in tau hyperphosphorylation in Alzheimer’s disease models (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21628793
The role of phytochemicals in the treatment and prevention of dementia (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21639405/abstract/The_role_of_phytochemicals_in_the_treatment_and_prevention_of_dementia_
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033
Intact cannabinoid CB1 receptors in the Alzheimer’s disease cortex (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21034788
4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20974250
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full-2012) http://www.jneuroinflammation.com/content/9/1/10
Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers beta-amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292807/
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer’s disease (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154439/
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer’s Disease (full–2012) http://download.cell.com/cell-reports/mmcs/journals/2211-1247/PIIS2211124712001258.mmc2.pdf
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/pdf
Monoacylglycerol lipase is a new therapeutic target for Alzheimer’s disease (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513645/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.jneuroinflammation.com/content/9/1/49
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full–2012) http://www.jneuroinflammation.com/content/9/1/79
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419612/
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuro-inflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
[(125)I]SD-7015 reveals fine modalities of CB(1) cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer’s disease (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180663/
CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones (full–2012) http://www.karger.com/Article/Pdf/338494
Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268782/
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-beta and in the cortex of aged rats (full–2012) http://www.jbc.org/content/early/2012/08/13/jbc.M112.350678.long
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical
neurons exposed to amyloid-beta and in the cortex of aged rats (download-2012)
http://www.jbc.org/content/early/2012/08/13/jbc.M112.350678.long
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of
AβPP/PS1 Mice (link to PDF–2012) http://www.ncbi.nlm.nih.gov/pubmed/22451318
Protective effect of cannabinoid CB1 receptor activation against altered intrinsic repetitive firing properties induced by Aβ neurotoxicity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22172925
top
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer’s disease via regulation of β-secretase activity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22330831?dopt=Abstract&holding=f1000,f1000m,isrctn
Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22233683
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22451318
The therapeutic potential of the endocannabinoid system for Alzheimer’s disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22448595
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through  activation of cannabinoid receptors and PPAR-γ pathway (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22634229
In vivo type 1 cannabinoid receptor availability in Alzheimer’s disease (abst–2012) http://jnumedmtg.snmjournals.org/cgi/content/meeting_abstract/53/1_MeetingAbstracts/1961?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Essential fatty acids and lipid mediators. Endocannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22730630
How Weed Can Protect Us From Cancer and Alzheimer’s (book excerpt–2012) http://www.alternet.org/story/156269/how_weed_can_protect_us_from_cancer_and_alzheimer%27s
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer’s disease (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863610/
Δ9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling (full–2013) http://www.cell.com/cell/abstract/S0092-8674%2813%2901360-3?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867413013603%3Fshowall%3Dtrue
top

Effects of magnolol on impairment of learning and memory abilities induced by
scopolamine in mice (full–2013)
https://www.jstage.jst.go.jp/article/bpb/36/5/36_b12-00880/_html
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance
(full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575938/
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in
AβPP/PS1 Mice (link to download–2013) http://diposit.ub.edu/dspace/handle/2445/69200
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid
Pathology in a Mouse Model of Tauopathy (link to PDF–2013)  http://content.iospress.com/articles/journal-of-alzheimers-disease/jad130050
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF–2013) http://www.eurekaselect.com/107977/article
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22795792
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients  (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22763024
Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23369066
Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23501261
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23831388
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23838176
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24030360
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24288245
Neuroactive insecticides: targets, selectivity, resistance, and secondary effects.
(abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23317040
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic (full–2014) http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00037/full
top
The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer’s Disease? (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025825/
Identification of potential herbal inhibitor of acetylcholinesterase associated Alzheimer’s disorders using molecular docking and molecular dynamics simulation (full–2014) http://www.hindawi.com/journals/bri/2014/705451/
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883962/
c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo (full–2014) http://www.nature.com/cddis/journal/v5/n1/full/cddis2013559a.html
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimer’s Disease (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220026/
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014376a.html
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114400/
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Amyrin Attenuates Scopolamine-Induced Cognitive Impairment in Mice (full–2014) https://www.jstage.jst.go.jp/article/bpb/37/7/37_b14-00113/_html
Endocannabinoids in Synaptic Plasticity and Neuroprotection. (full – 2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143501/
Report on Medical Cannabis Research, What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for
Alzheimer’s disease (abst–2014)  http://www.sciencedirect.com/science/article/pii/S022352341300768X
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH
activity: Modulation by cannabinoid agonists (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0531556514002903
Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer’s Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24496074
Endocannabinoid signaling in Alzheimer’s disease: current knowledge and future directions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24813316
top

Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
The Potential Therapeutic Effects of THC on Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/8421pvx80144t354/?p=ff122a13e6cf4bf78324e26d253bd883&pi=8
The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25147120
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/0617070q2404258h/
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23597932
Type-1 Cannabinoid Receptor Activity During Alzheimer’s Disease Progression (abst-2014) http://iospress.metapress.com/content/8622072156706328/
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25171128
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25106636
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25024347
How Smoking Marijuana Might Be The Best Way To Prevent Alzheimer’s Disease
(interview–2014) http://www.leafscience.com/2014/01/30/smoking-marijuana-might-best-way-prevent-alzheimers-disease/
top

Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells (full–2015) http://www.jneuroinflammation.com/content/12/1/81
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture (full-2015) http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0122843&representation=PDF
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation (full-2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567222/
Narrative review of the safety and efficacy of marijuana for the treatment of commonly
state-approved medical and psychiatric disorders (full–2015)  http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-
tetrahydrocannabinol in older persons with dementia (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480847/
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From
Preclinical Models to Clinical Applications (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726 
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521

Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25813826
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818189
Cannabinoids in late-onset Alzheimer’s disease (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25788394
The role of cannabinoids and leptin in neurological diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25880465
Advancements in the treatment of agitation in Alzheimer’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26159445
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26271310
top

Endocannabinoid regulation of amyloid-induced neuroinflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26362942
Endocannabinoids and Neurodegenerative Disorders: Parkinson’s Disease, Huntington’s Chorea, Alzheimer’s Disease, and Others (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408163
Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715300952
Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and their Antioxidant and Acetylcholinesterase Inhibitory Activities (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26585089
top

Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer’s disease mouse model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25443294
Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C (full–2016) http://www.hindawi.com/journals/mi/2016/4854378/
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0484-z
NO2 inhalation promotes Alzheimer’s disease-like progression: cyclooxygenase-2-
derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted
medication (full–2016) http://www.nature.com/articles/srep22429
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
(full–2016) http://www.mdpi.com/1420-3049/21/4/518/htm
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic
potential in Alzheimer’s disease (full–2016)
http://www.sciencedirect.com/science/article/pii/S0028390816300879
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
(full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514994/
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal
Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016)
http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Vascular Dysfunction in a Transgenic Model of Alzheimer’s Disease: Effects of CB1R
and CB2R Cannabinoid Agonists (full–2016)
http://journal.frontiersin.org/article/10.3389/fnins.2016.00422/full
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment
using candidate proteins (full–2016)  http://www.nature.com/tp/journal/v6/n1/full/tp2015205a.html
Cannabidiol Modulates the Expression of Alzheimer’s Disease-Related Genes in
Mesenchymal Stem Cells (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297661/
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
(full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514994/
Endocannabinoids in Cerebrovascular Regulation (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865067/
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26757043
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26758668
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer’s Disease and Mild Cognitive Impairment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825096
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a CannabisBased Medicine (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26890764
Pharmacological management of agitation and aggression in Alzheimer’s Disease: a review of current and novel treatments (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27137221
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27223629
Investigational drugs for treating agitation in persons with dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27232589
Fatty acid amide hydrolase (FAAH), acethylcholinesterase (AChE) and butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti Alzheimer’s Disease agents (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00609
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27389672
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488857
Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVDhemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S1074742716301307
Type-2 cannabinoid receptors in neurodegeneration (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27567873
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis
to a Promising Therapeutic Target (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00030/full
β-Caryophyllene/Hydroxypropyl-β-Cyclodextrin Inclusion Complex Improves Cognitive
Deficits in Rats with Vascular Dementia through the Cannabinoid Receptor Type 2 –
Mediated Pathway (full–2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00002/full
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s
Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00020/full
Simvastatin and Bezafibrate ameliorate Emotional disorder Induced by High fat diet in
C57BL/6 mice (full–2017) https://www.nature.com/articles/s41598-017-02576-5
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
(full – 2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
New drugs in psychiatry: focus on new pharmacological targets (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373420/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric,
Movement and Neurodegenerative Disorders (full–2017)  http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues
for other neuroinflammatory diseases (full–2017)
http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of
Vascular Dementia (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
Prevalence of consumption of addictive substances amongst Moroccan fishermen (full–2017) https://journals.viamedica.pl/international_maritime_health/article/view/IMH.2017.0004/42124
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by
D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
Clinical Evidence for Utilizing Cannabinoids in the Elderly (link to PDF–2017)  https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
MicroRNA-139 modulates Alzheimer’s-associated pathogenesis in SAMP8 mice by
targeting cannabinoid receptor type 2 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28218780
Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer’s disease (abst–2017) http://www.sciencedirect.com/science/article/pii/S0301008216300338
Cannabinoids therapeutic use: what is our current understanding following the
introduction of THC, THC:CBD oromucosal spray and others? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28276775
An update on the advancements in the treatment of agitation in Alzheimer’s disease  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28300462
Neurological aspects of medical use of cannabidiol (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28412918
A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old
mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28481360
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of
endocannabinoid system modulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28497982
N-stearoyl-l-Tyrosine inhibits the cell senescence and apoptosis induced by H2O2 in
HEK293/Tau cells via the CB2 receptor (abst–2017) http://www.sciencedirect.com/science/article/pii/S0009279716307293
Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2
expression in a transgenic mouse model of Alzheimer’s disease (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28551012
GPR3 and GPR6, novel molecular targets for cannabidiol (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0006291X17310744 
Endocannabinoid System in Neurodegenerative Disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28608560
Perspectives of Cannabinoid type 2 receptor (CB2R) ligands in neurodegenerative
disorders: Structure Affinity Relationship (SAfiR) and Structure Activity Relationship
(SAR) Studies. (abst – 2017) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b00155
Synaptic functions of endocannabinoid signaling in health and disease (abst–2017)
http://www.sciencedirect.com/science/article/pii/S0028390817302861
The Use of Cannabinoids in Treating Dementia (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28631194
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28637354
Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer’s Disease-Like Tau
Pathology and Memory Impairment Through AMPK/GSK3β Pathway (abst–2017) https://link.springer.com/article/10.1007%2Fs12035-017-0676-2
Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP
Transgenic Mice Lacking CB2 Receptors (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28733897
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated
microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and
levodopa-induced dyskinesia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28843453
2-arachidonoylglycerol metabolism is differently modulated by oligomeric and fibrillar
conformations of amyloid beta in synaptic terminals (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28844762
Increase in cortical endocannabinoid signaling in a rat model of basal forebrain
cholinergic dysfunction (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28827178
Identification Of Electrophysiological Changes In Alzheimer’s Disease: A Microarray
Based Transcriptomics And Molecular Pathway Analysis Study (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29065845
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A
randomised controlled crossover trial (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27624148
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29256923


AMNESIA
Systemic or intra-amygdala infusion of an endocannabinoid CB1 receptor antagonist AM251 blocked propofol-induced anterograde amnesia (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0304394014008684
Involvement of the serotonergic system of the ventral hippocampus (CA3) on amnesia induced by ACPA in mice (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432815001552

The dual effect of CA1 NMDA receptor modulation on ACPA-induced amnesia in stepdown passive avoidance learning task (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25680309
Synergistic effect between prelimbic 5-HT3 and CB1 receptors on memory consolidation deficit in adult male Sprague-Dawley rats: an isobologram analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26701293
Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced emotional memory consolidation in male Wistar rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26340366
GABAA receptors in the central amygdala are involved in memory retention deficits induced by cannabinoids in rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715300617
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stressinduced amnesia in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27282634
Neuromodulatory effects of the dorsal hippocampal endocannabinoid system in
dextromethorphan/morphine-induced amnesia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916307282
Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28084855
Motor vehicle collisions caused by the ‘super-strength’ synthetic cannabinoids, MAM2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486620/
Precondition of right frontal region with anodal tDCS can restore the fear memory impairment induced by ACPA in male mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318674/
Cross state-dependency of learning between arachidonylcyclopropylamide (ACPA) and muscimol in the mouse dorsal hippocampus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29032058


AMOTIVATIONAL SYNDROME*+
Lifetime prevalence of “amotivational syndrome” (article–undated)  https://www.addictioninfo.org/articles/262/1/Lifetime-Prevalence-of-Amotivational-Syndrome/Page1.html
Rimonabant eliminates responsiveness to workload changes in a time-constrained food reinforced progressive ratio procedure in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387812/
Associations of Alcohol, Nicotine, Cannabis, and Drug Use/Dependence with Educational Attainment: Evidence from Cotwin-Control Analyses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412907/
So called “soft” drugs: cannabis and the amotivational syndrome (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23888577
Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions (abst–2015) http://link.springer.com/article/10.1007/s40279-015-0362-3
top

Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats. (link to PDF – 2016) http://jpn.ca/articles-in-press/41-6-150363/
Moderate and vigorous physical activity patterns among marijuana users: Results from
the 2007-2014 National Health and Nutrition Examination Surveys (abst–2017)
http://www.drugandalcoholdependence.com/article/S0376-8716(17)30275-2/fulltext
Activation of the cannabinoid system in the nucleus accumbens affects effort-based
decision making (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0091305717301387?via%3Dihub
Is Cannabis Use Associated with Various Indices of Motivation Among Adolescents?
(abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29272172
Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors
and TRPV1 channels (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29355640


ANESTHESIA
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in

anaesthetized rats through several mechanisms of action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041249/
Propofol Enhances Memory Formation via an Interaction with the Endocannabinoid System (full–2011) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1933567
Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis (full–2012) http://journals.lww.com/anesthesia-analgesia/Fulltext/2012/06000/Cannabinoid_Receptor_1_Inhibition_Causes_Seizures.12.aspx
Changes of Blood Endocannabinoids during Anaesthesia: a Special Case for Fatty Acid Amide Hydrolase Inhibition by Propofol? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394128/
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS (abst–2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
The effect of propofol on intrathecal morphine-induced pruritus and its mechanism  (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24445631
Systemic or intra-amygdala infusion of an endocannabinoid CB1 receptor antagonist
AM251 blocked propofol-induced anterograde amnesia (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0304394014008684
Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in
anaesthetized rats: role of the paraventricular nucleus (full–2015)
http://www.jpp.krakow.pl/journal/archive/06_15/pdf/343_06_15_article.pdf
Acupuncture Mechanisms: Anesthesia, Analgesia and Protection on Organ Functions
(link to PDF–2015) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.732.8262&rank=2&q=cannabinoid&osm=&ossid
Anaesthetic consideration in a cannabis addict (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25933451
Genetic inactivation and prolonged pharmacologic inhibition of monoacylglycerol lipase
have opposite effects on anesthetic sensitivity to propofol (abst–2015)
http://www.sciencedirect.com/science/article/pii/S0014299915302247
Comparative antinociceptive effect of arachidonylcyclopropylamide, a cannabinoid 1 receptor agonist & lignocaine, a local anaesthetic agent, following direct intrawound administration in rats (full–2016)  http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2016;volume=144;issue=5;spage=730;epage=740;aulast=Kumar
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26942594
Endocannabinoid signaling in hypothalamic circuits regulates arousal from general anesthesia in mice (full–2017) https://www.jci.org/articles/view/91038
Postoperative Shivering Among Cannabis Users at a Public Hospital in Trinidad, West Indies (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29362045


ANGELMAN’S SYNDROME
Investigational new drugs for focal epilepsy (full–2016) http://www.tandfonline.com/doi/full/10.1517/13543784.2016.1110144


ANGIOEDEMA
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (asbt–2015) http://www.ncbi.nlm.nih.gov/pubmed/26257969


ANGIOGENESIS
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation (full–2010) http://www.wjgnet.com/1948-9358/full/v1/i1/12.htm
Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936832/
Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55? (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936831/
Investigational pharmacology for low back pain (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004649/?tool=pmcentrez
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
(full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917429/?tool=pmcentrez
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis (full–2011) http://bloodjournal.hematologylibrary.org/content/117/20/5541.long
Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20950604
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21601562
Cannabidiol inhibits angiogenesis by multiple mechanisms (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504989/
Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/hep.25625/full
Anti-proliferative and Anti-angiogenic Effects of CB2R Agonist (JWH-133) in Non small Lung Cancer Cells (A549) and Human Umbilical Vein Endothelial Cells: an in Vitro Investigation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22578958
Cannabinoids: A new hope for breast cancer therapy? (full-2012)  http://www.academia.edu/23263803/Cannabinoids_A_new_hope_for_breast_cancer_therapy
Autophagy triggered by magnolol derivative negatively regulates angiogenesis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920944/
Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K / AKT / mTOR signaling pathway in mES / EB-derived endothelial-like cells (full–2013) http://www.spandidos-publications.com/ijo/43/2/600
Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line (link to PDF–2013) http://www.dovepress.com/suppression-of-vascular-endothelial-growth-factor-expression-by-cannaba13597
New Insights in Mast Cell Modulation by Palmitoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107979/article
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and
Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect (link to PDF–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076918
Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/akt signaling pathways (abst + 1st page–2013) http://www.tandfonline.com/doi/abs/10.1080/01635581.2013.828082?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
top
Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23722450
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23416116
Systematic review of the literature on clinical and experimental trials on the antitumor
effects of cannabinoids in gliomas (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24142199
Anandamide inhibits breast tumor-induced angiogenesis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140423/
Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244131/
TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265754/
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25090972
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF–2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=2233
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat
chronic granulomatous inflammation. (abst – 2014)
http://www.ncbi.nlm.nih.gov/pubmed/24440533
Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24976505
The use of cannabinoids as anticancer agents (full–2015) http://www.sciencedirect.com/science/article/pii/S0278584615001190
The G-protein coupled receptor 55-agonist L-α-lysophosphatidylinositol mediates ovarian carcinoma cell induced angiogenesis (full–2015) http://www.actaps.com.cn/qikan/manage/wenzhang/2014-3-10.pdf
Human lung-resident macrophages express CB1 and CB2 receptors whose activation
inhibits the release of angiogenic and lymphangiogenic factors (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787289/
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2. (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580018/
New insights into antimetastatic and antiangiogenic effects of cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25619715
Differential role of cannabinoids in the pathogenesis of skin cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25921771
Endocannabinoids and Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408171
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791143/
Integrating cannabis into clinical cancer care (full–2016)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes
metastasis in triple-negative breast cancer (full–2016)  http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=10206&path%5B
%5D=32116
Anticancer mechanisms of cannabinoids (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Cannabinoid pharmacology in cancer research: A new hope for cancer patients? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Antitumorigenic targets of cannabinoids – current status and implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27070944
Anti-inflammatory ω-3 endocannabinoid epoxides (full–2017)
http://www.pnas.org/content/114/30/E6034.long
Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis
and inflammation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28110689
Pharmacological inhibition of MAGL lipase attenuates experimental colon
carcinogenesis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S104366181630932X
Cannabinoids as Anticancer Drugs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826542
RhoA/MLC signaling pathway is involved in Δ⁹-tetrahydrocannabinol-impaired placental
angiogenesis (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0378427417315412?via%3Dihub
top


ANOREXIA/ANOREXIA NERVOSA+>
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full–2010)
http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2 (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20471226
Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931559
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19768813
Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117120/
The intersection between cannabis and cancer in the United States. (full – 2011)
http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
The genetics of eating disorders (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21243475
Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21718968
Functional polymorphism in the GPR55 gene is associated with anorexia nervosa (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20506567
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096804/?tool=pubmed
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22542985
The role of the endocannabinoid system in eating disorders: pharmacological implications (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22785439
The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the
world (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22632862
Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107948/article
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829365
top

Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24006151
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/mgg3.69/full
Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/eat.22173/full
Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24890912
The endocannabinoid system and appetite: relevance for food reward (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24933167
Food intake regulation – 2nd part (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24564775
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa (full–2015) http://ajcn.nutrition.org/content/101/2/262.long
ENP11, a potential CB1R antagonist, induces anorexia in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26072692
Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26248813
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study (full–2016) http://www.nature.com/tp/journal/v6/n7/full/tp2016118a.html
Cannabinoid hyperemesis syndrome masquerading as an eating disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26842268
Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333956
Addison’s Disease and Possible Cannabis Withdrawal Syndrome Presenting as an Eating
Disorder in a Thirty-Year-Old Female (full–2017)
https://www.hindawi.com/journals/crie/2017/4096021/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric,
Movement and Neurodegenerative Disorders (full–2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications (link to PDF – 2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
Role of cannabis in digestive disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in
a rat model of activity-based anorexia (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28561272
2-Arachidonoylglycerol as a possible treatment for anorexia nervosa in animal model in
mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28606779
Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with
advanced cancer? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29286357


ANTI-BACTERIAL PROPERTIES*+
Antibacterial analysis of crude extracts from the leaves of Tagetes erecta and Cannabis sativa (full–2010) http://www.ipublishing.co.in/ijesarticles/twelve/articles/voltwo/EIJES3150.pdf
Microbial metabolism of cannflavin A and B isolated from Cannabis sativa (abst–2010) http://www.sciencedirect.com/science/article/pii/S0031942210000555
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Effect of extraction conditions on total polyphenol contents, antioxidant and antimicrobial activities of Cannabis sativa L (abst–2012) http://www.cabdirect.org/abstracts/20123212113.html;jsessionid=DDBC2FF41C8322957AD4B468D3785A59?gitCommit=4.13.20-5-ga6ad01a

Antimicrobial Activity of Cannabis sativa L. (full–2012) http://file.scirp.org/Html/10-8801078_18123.htm
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV (full–2013) http://www.jleukbio.org/content/93/2/267.long
top

Transcriptional Profiles of the Response of Methicillin-Resistant Staphylococcus aureus
to Pentacyclic Triterpenoids (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577688/
Magnolol Ameliorates Ligature-Induced Periodontitis in Rats and Osteoclastogenesis: In Vivo and In Vitro Study (full–2013) http://www.hindawi.com/journals/ecam/2013/634095/
G-protein coupled receptor 18 (GPR18) in channel catfish: expression analysis and efficacy as immunostimulant against Aeromonas hydrophila infection (abst–2013)  http://www.sciencedirect.com/science/article/pii/S1050464813006554
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
Effect of the synthetic cannabinoid HU-210 on quorum sensing and on the production of quorum sensing-mediated virulence factors by Vibrio harveyi (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531395/
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25425209
Minor oxygenated cannabinoids from high potency Cannabis sativa L. (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883105/
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25173887
Screening of cannabinoids in industrial-grade hemp using two-dimensional liquid chromatography coupled with acidic potassium permanganate chemiluminescence detection (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25845561
Reducing exposure to pathogens in the horse; A preliminary study into the survival of bacteria on a range of equine bedding types (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27659898
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596302
The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration 
(abst–2016) http://link.springer.com/article/10.1007%2Fs00011-016-0969-3
Palmitoylethanolamide induces microglia changes associated with increased migration
and phagocytic activity: involvement of the CB2 receptor (full–2017) http://www.nature.com/articles/s41598-017-00342-1
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells (full–2017) http://journals.sagepub.com/doi/full/10.1177/2050640617698622
Formulation, Characterization and Properties of Hemp Seed Oil and Its Emulsions (full–2017) http://www.mdpi.com/1420-3049/22/5/700/htm
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017) https://www.karger.com/Article/FullText/481824

Metabolome Comparison of Bioactive and Inactive Rhododendron Extracts and
Identification of an Antibacterial Cannabinoid(s) from Rhododendron collettianum (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28612345
Endocannabinoid hydrolases in avian HD11 macrophages identified by chemoproteomics: inactivation by small-molecule inhibitors and pathogen-induced downregulation of their activity (abst–2017)  https://link.springer.com/article/10.1007%2Fs11010-017-3237-0


ANTI-FUNGAL PROPERTIES
Antimicrobial Activity of Cannabis sativa L. (full–2012) http://file.scirp.org/Html/10-8801078_18123.htm
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa (abst–2014) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382491
Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25641229
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596302
Oxidative burst and Dectin-1 triggered phagocytosis affected by Norepinephrine and
Endocannabinoids – Implications for fungal clearance under stress (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29329391


ANTI-MICROBIAL PROPERTIES
Endocannabinoids Inhibit the Growth of Free-Living Amoebae (full–2010)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897284/

Microbial metabolism of cannflavin A and B isolated from Cannabis sativa (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885748/
Trypanocidal Effect of Cannabis sativa on Experimental Camel Trypansomosis (full–2012) http://scialert.net/fulltext/?doi=rjmp.2012.281.285&org=10
Trans-sialidase Stimulates Eat Me Response from Epithelial Cells (full–2013)  http://onlinelibrary.wiley.com/doi/10.1111/tra.12078/full
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)
https://www.karger.com/Article/FullText/481824
Endocannabinoid hydrolases in avian HD11 macrophages identified by
chemoproteomics: inactivation by small-molecule inhibitors and pathogen-induced
downregulation of their activity (abst–2017)
https://link.springer.com/article/10.1007%2Fs11010-017-3237-0


ANTIOXIDANT PROPERTIES
Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010007500015&lng=en&nrm=iso&tlng=en
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869084/?tool=pubmed

Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells (1st page-2010) https://www.karger.com/Article/Abstract/312686
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment
and mortality in rats submitted to sepsis by cecal ligation and puncture (abst-2010)
http://www.ncbi.nlm.nih.gov/pubmed/20561509
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation,
and cell death associated with hepatic ischemia/reperfusion injury (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423243/
Symptom-relieving and neuroprotective effects of the phytocannabinoid D(9) -THCV in
animal models of Parkinson’s disease (link to download–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165958/pdf/bph0163-1495.pdf
Effect of cannabidiol treatment in alimentary induced fatty liver (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1278456
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of
Huntington’s disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21674569
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of
oxidative stress and inflammation (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21279327
Therapeutic Potential of Cannabinoids in the Treatment of Neuroinflammation
Associated with Parkinson’s Disease (abst–2011)  https://www.ncbi.nlm.nih.gov/pubmed/21699489
Antioxidant Activities and Oxidative Stabilities of Some Unconventional Oilseeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311859/?tool=pubmed
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Δ(8)-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB(2) receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423240/
Effect of extraction conditions on total polyphenol contents, antioxidant and
antimicrobial activities of Cannabis sativa L (full–2012)  https://www.researchgate.net/publication/260824507_Effect_of_extraction_conditions_on_total_polyphenol_contents_antioxidant_and_antimicrobial_activities_of_Cannabis_sativa_L
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22178458
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22877651 
top
The isolation and identification of two compounds with predominant radical scavenging activity in hempseed (seed of Cannabis sativa L.) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23107724
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants (link to PDF-2013) http://www.mdpi.com/1420-3049/18/10/12663
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127243/
Resuscitation from experimental traumatic brain injury by magnolol therapy (full–2013) http://www.journalofsurgicalresearch.com/article/S0022-4804(13)00432-0/fulltext
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a
randomised, placebo-controlled trial (full–2013)  http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(13)70159-5/fulltext
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1
Receptor-Mediated Type 2 NADPH Oxidase (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127243/
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24398069
Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/?term=24889782
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25252936
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25166905
A novel hemp seed meal protein hydrolysate reduces oxidative stress factors in
spontaneously hypertensive rats (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276990/
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage
via CB1R-Mediated STAT3 Phosphorylation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Increased oxidative stress enhances endocannabinoid tone (abst–2014) http://www.fasebj.org/content/27/1_Supplement/1097.3.abstract?sid=d2f0f68f-30c5-4027-9334-011c9f8fdd2e
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ9-THC (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25187240

Structural and functional characterization of hemp seed (Cannabis sativa L.) proteinderived antioxidant and antihypertensive peptides (abst–2014)  http://www.sciencedirect.com/science/article/pii/S1756464613002594
N-Palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0009279715300697
Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and their Antioxidant and Acetylcholinesterase Inhibitory Activities (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26585089
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015)  https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
Effect of Cannabis sativa extract on gastric acid secretion, oxidative stress and gastric mucosal integrity in rats (abst–2015) http://link.springer.com/article/10.1007/s00580-015-2090-3
top

Neuroprotective effects of trans-caryophyllene against kainic Acid induced seizure
activity and oxidative stress in mice (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25417010
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands (full–2016) http://www.hindawi.com/journals/np/2016/9815092/
Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids (full–2016) http://www.sciencedirect.com/science/article/pii/S1995764516300712
CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10314&path%5B%5D=32486
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00343/full
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/ Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Effect of Hempseed (Cannabis sativa sp.) Inclusion to the Diet on Performance, Carcass
and Antioxidative Activity in Japanese Quail (Coturnix coturnix japonica) (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597843/
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of
adolescent rats (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0304394016302907
Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure (abst–2016) http://link.springer.com/article/10.1007/s12031-015-0703-6
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S000927971530154X
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X1630076X
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16301150
The role of perivascular adipose tissue in obesity-induced vascular dysfunction (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27761903
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27784678
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596302
Cannabinoid CB2 Receptors are Involved in the Protection of RAW264.7 Macrophages
Against the Oxidative Stress: An in Vitro Study (full – 2017)
http://www.ejh.it/index.php/ejh/article/view/2749/2659
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of
Cannabidiol in Psychiatric Disorders (full–2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP (full–2017) http://www.mdpi.com/1424-8247/10/3/60/htm
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630296/
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663723/
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28092019
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28107775
β-Amyrin, a pentacyclic triterpene, exhibits anti-fibrotic, anti-inflammatory, and antiapoptotic effects on dimethyl nitrosamine–induced hepatic fibrosis in male rats (abst–2017) http://journals.sagepub.com/doi/full/10.1177/0960327116638727
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of endocannabinoid system modulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28497982
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28637354
Neuroprotective activity of cannabinoid receptor-2 against oxidative stress and apoptosis in rat pups having experimentally-induced congenital hypothyroidism (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28799288
Cannabidiol: an alternative therapeutic agent for oral mucositis? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28191662
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771072/
Thallium-Induced Toxicity in Rat Brain Crude Synaptosomal/Mitochondrial Fractions is Sensitive to Anti-excitatory and Antioxidant Agents (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29313218


ANTI-PARASITIC PROPERTIES
High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasis (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/ajhb.22740/full
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)  https://www.karger.com/Article/FullText/481824
top


ANXIETY/AGITATION*+
Cannabis Overdose (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/96/?pagenum=3
Mixed mood disorder (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/228/?pagenum=2
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/437/?pagenum=2
Anxiety Associated with Dying (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/666/
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Anti-anxiety Effects of Fatty Acid Amide Hydrolase Inhibition (full–2010) http://molpharm.aspetjournals.org/content/78/2/260.long
Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? (full–2010) http://www.scielo.br/pdf/rbp/v32s1/en_a04v32s1.pdf
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice (full–2010) http://ijnp.oxfordjournals.org/content/13/7/861.long
The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their
Influence on Tryptophan Metabolism (full–2010)
http://www.mdpi.com/1424-8247/3/8/2647/htm
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders (link to PDF–2010) http://www.mdpi.com/1424-8247/3/8/2517
Therapeutical use of the cannabinoids in psychiatry (full–2010)

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500009&lng=en&nrm=iso&tlng=en
Marijuana craving during a public speaking challenge: Understanding marijuana use
vulnerability among women and those with social anxiety disorder (full–2010)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981668/
Do patients think cannabis causes schizophrenia? – A qualitative study on the causal
beliefs of cannabis using patients with schizophrenia (full-2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954921/?tool=pmcentrez
Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in
mice in the elevated plus-maze (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923489/
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20829306
Endocannabinoids and psychiatric disorders: the road ahead (article–2010)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500003&lng=en&nrm=iso&tlng=en
Cannabinoids and anxiety (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21309120
Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety (abst–2010)
http://www.ncbi.nlm.nih.gov/pubmed/20875432
top

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20457188/abstract/Intra_dorsal_periaqueductal_gray_administration_of_cannabidiol_blocks_panic_like_response_by_activating_5_HT1A_receptors_
Panic Attack after Spice Abuse in a Patient with ADHD (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1243252
Methamphetamine neurotoxicity increases brain expression and alters behavioral
functions of CB₁ cannabinoid receptors (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20378129
Effects of chronic nicotine on food intake and anxiety-like behaviour in CB(1) knockout
mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20189358
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress (full–2011) http://www.sciencedirect.com/science/article/pii/S0091305711002310
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242302/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034086/pdf/nihms262924.pdf
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/
Posttraumatic Stress and Marijuana Use Coping Motives: The Mediating Role of Distress

Tolerance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101637/
Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in
Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress (full–2011) http://cercor.oxfordjournals.org/content/21/9/2056.full
Social Anxiety and Marijuana-Related Problems: The Role of Social Avoidance (full–2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981690/
The role of cannabinoids in modulating emotional and non-emotional memory processes
in the hippocampus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124830/?tool=pubmed
Antagonist-elicited cannabis withdrawal in humans (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717344/
Neuropsychiatric adverse effects of centrally acting antiobesity drugs (1st page–2011)  https://www.deepdyve.com/lp/wiley/neuropsychiatric-adverse-effects-of-centrally-acting-antiobesity-drugs-Sy0a9pYcBp
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist,
arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1
and D2 dopaminergic systems (abst–2011)  https://www.ncbi.nlm.nih.gov/pubmed/20685770
Cannabinoids and emotionality: a neuroanatomical perspective (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21827834
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21867717
Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy (abst–2011) http://www.degruyter.com/abstract/j/jbcpp.2011.22.issue-1-2/jbcpp.2011.005/jbcpp.2011.005.xml?rskey=wRYgJd&result=2&q=cannabinoid
A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21864979
top

Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21497918
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and
impaired anxiolytic action of alprazolam in mice (abst – 2011)
http://journals.sagepub.com/doi/full/10.1177/0269881110379507
The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria
terminalis are mediated by 5-HT1A receptors. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/20945065
Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1
receptor knockout mice (abst–2011)  http://journals.sagepub.com/doi/full/10.1177/0269881109358204
“Spice” girls: synthetic cannabinoid intoxication (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21167669
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full–2012) http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html
Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033260
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug (full–2012) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000500008&lng=en&nrm=iso&tlng=en
The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423235/
Interleukin-1β causes anxiety by interacting with the endocannabinoid system (full–2012) http://www.jneurosci.org/content/32/40/13896.long
Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691841/
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442338/
Cannabidiol in humans-the quest for therapeutic targets (full–2012)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763649/
Social Anxiety and Cannabis Use: An Analysis from Ecological Momentary Assessment
(full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268873/
Comparative Study of Sedation, Pre-Anesthetic and Anti-Anxiety Effects of Hemp Seed Extract and Diazepam in Rats (full–2012) http://docsdrive.com/pdfs/medwelljournals/javaa/2012/2148-2151.pdf
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242309/
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/

Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473327/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
top

Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: Effects of the cannabinoid receptor 1 antagonist AM251 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697052/
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full–2012) http://www.jneurosci.org/content/32/21/7109.long
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565211/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/

Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test (full–2012) http://www.sciencedirect.com/science/article/pii/S0278584612002801
Pharmacological interventions in the treatment of the acute effects of cannabis: a
systematic review of literature (full – 2012)
http://www.harmreductionjournal.com/content/9/1/7
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351574/
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent
memory impairment. (link to PDF– 2012)
https://www.researchgate.net/publication/232066502_Cannabidiol_inhibits_THC-elicited_paranoid_symptoms_and_hippocampaldependent_memory_impairment
The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: a minireview (link to PDF–2012) http://www.ncbi.nlm.nih.gov/pubmed/22540859 
Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22173015
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716146
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22579951
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22534181
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/11982628
top

The cannabinoid receptor CB₁ inverse agonist AM251 potentiates the anxiogenic activity
of urocortin I in the basolateral amygdala (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0028390811002632
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22564034
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22979992
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23000076
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22990678
Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23007604
Cannabis Use Vulnerability Among Socially Anxious Users: Cannabis Craving During a Social Interaction (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23002698
CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23018128
Cannabinoid Modulation of Midbrain Urocortin 1 Neurones During Acute and Chronic Stress (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2012.02355.x/abstract
Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23183218
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional, Features, and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22750843
Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21906661

Marijuana-related problems and social anxiety: the role of marijuana behaviors in social
situations (abst–2012) https://www.ncbi.nlm.nih.gov/pubmed/22004129
The underdiagnosis of cannabis use disorders and other Axis-I disorders among military
veterans within VHA (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22808884
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor
signaling pathway in the brain and associated anxiety-like behavior in mice (abst–2012) http://www.springerlink.com/content/ur5784gm34782505/
Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical
and neurobiological evidence (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22736575
Effect of dietary fat type on anxiety-like and depression-like behavior in mice (full–2013) http://www.springerplus.com/content/2/1/165
Endocannabinoid system and mood disorders: Priming a target for new therapies (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584612002801
top

Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses (full–2013) http://www.biolmoodanxietydisord.com/content/3/1/19
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539121/
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599339/
Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081459
Cannabinoid facilitation of fear extinction memory recall in humans (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445738/
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607008/
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648779/
Does Cannabidiol Protect Against Adverse Psychological Effects of THC? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797438/
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788575/
Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (full–2013) http://ijnp.oxfordjournals.org/content/16/6/1407.long
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full-2013) http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00100/full#B12
Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor (full–2013) http://ijnp.oxfordjournals.org/content/16/8/1781.long
top

The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830591/
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdale (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799070/
Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989442/
CB1 receptor signaling regulates social anxiety and memory (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12045/full
The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attacklike behaviors evoked in the presence of the wild snake Epicrates cenchria crassus
(Reptilia, Boidae) (abst–2013)  http://journals.sagepub.com/doi/full/10.1177/0269881113493363
Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD  symptoms (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23178193
Cannabidiol enhances consolidation of explicit fear extinction in humans (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23307069
Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23578952
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23389966
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst–2013) http://link.springer.com/article/10.1007/s00213-012-2839-1
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behaviorand saccharin palatability (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23103902
Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral peri-aqueductal gray in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23474373
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23584096
top

Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activity in the elevated T-maze (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23711591
Modulation of anxiety-like behaviour by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23714073
Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23844686
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23899460
Continuous central infusion of cannabinoid receptor agonist WIN 55,212-2 decreases maternal care in lactating rats: Consequences for fear conditioning in adulthood males (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24060654
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24321837
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750

Cannabis use motives and personality risk factors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24368004
The endocannabinoid system: An emotional buffer in the modulation of memory function (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24382324
Cannabis use in a Swiss male prison: Qualitative study exploring detainees’ and staffs’ perspectives (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23773686
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors
promoted by murine cerebral malaria (abst – 2013)
http://www.fasebj.org/content/27/1_Supplement/1097.9.abstract?sid=c40dd288-3dae-4c7a-b928-8e0c67991453
Effectiveness of vaginal adelmidrol for treating pelvic visceral discomforts and anxiety: a
prospective observational study (abst – 2013)
http://www.ncbi.nlm.nih.gov/pubmed/24051946
Use of micronutrients attenuates cannabis and nicotine abuse as evidenced from a
reversal design: a case study (abst – 2013)
http://www.ncbi.nlm.nih.gov/pubmed/23909004
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full–2014) http://www.nature.com/tp/journal/v4/n7/full/tp201453a.html

How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia (full–2014) http://schizophreniabulletin.oxfordjournals.org/content/early/2014/07/01/schbul.sbu098.long
top

Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation (full–2014) http://www.cell.com/cell-reports/fulltext/S2211-1247(14)00955-3
Cannabis use and anxiety: is stress the missing piece of the puzzle? (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241884/

Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray (full–2014) http://ijnp.oxfordjournals.org/content/17/8/1193.long
Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023141/
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain (full–2014) http://www.nature.com/npp/journal/v40/n2/full/npp2014198a.html
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies (full–2014) http://journal.frontiersin.org/article/10.3389/fneur.2014.00161/full
Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202541/
Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder (full–2014) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900396-5/fulltext
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat (full-2014) http://ijnp.oxfordjournals.org/content/18/3/pyu104.long
Stress regulates endocannabinoid-CB1 receptor signaling (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247817/
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease (full-2014) http://ww.ncbi.nlm.nih.gov/pmc/articles/PMC4696509/
top

Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning
and recall in humans (full – 2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960373/
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid
Receptors (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059893/
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid
augmentation (full – 2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074568/
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with
depression-related behaviour through corticosterone secretion (full – 2014)  http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html
Modulation of early stress-induced neurobiological changes: a review of behavioural and
pharmacological interventions in animal models (full – 2014)
http://www.nature.com/tp/journal/v4/n5/full/tp201431a.html
Individual differences in response to positive and negative stimuli: endocannabinoid based insight on approach and avoidance behaviors (full–2014)  http://journal.frontiersin.org/Journal/10.3389/fnsys.2014.00238/full
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24930711
Inhibition of FAAH enzyme by pterostilbene: potential mechanism of anxiolytic action (abst–2014) http://www.fasebj.org/content/28/1_Supplement/1144.10.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083569
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25388290

Anxiogenic-like effects induced by hemopressin in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25462856
Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25543004
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS (abst–2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of
Cannabis sativa (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24923339
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25392292
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized
severely demented patients with noncognitive behavioral symptoms (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/23597932
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/hipo.22344/full

Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (full–2015) http://ijnp.oxfordjournals.org/content/18/8/pyv005.long
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs Through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
FAAH genetic variation enhances fronto-amygdala function in mouse and human (full–2015) https://www.nature.com/articles/ncomms7395
top
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxiety like behavior and unaltered seizure susceptibility (full–2015) http://ijnp.oxfordjournals.org/content/ijnp/early/2015/07/29/ijnp.pyv091.full.pdf
Targeting the endocannabinoid system to treat anxiety-related disorders (full–2015)  http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0058/jbcpp-2015-0058.xml

The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669909/
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety (full–2015) http://www.nature.com/articles/srep18218
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Neural correlates of cannabidiol and Δ9-tetrahydrocannabinol interactions in mice: implications for medical cannabis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13333/full
Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0137034
Fluoxetine Facilitates Fear Extinction through Amygdala Endocannabinoids (full–2015) http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2015318a.html
Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder (full–2015) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-015-0104-3
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348185/
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxietylike behavior and sociability (full–2015) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00235/full
top

Developmental regulation of fear learning and anxiety behavior by endocannabinoids (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12253/full
Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25754825
A runner’s high depends on cannabinoid receptors in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26438875
Mechanisms of stress in the brain (abst–2015) http://www.nature.com/neuro/journal/v18/n10/full/nn.4086.html
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586926
Cannabidiol as a Potential Treatment for Anxiety Disorders (abst–2015) http://link.springer.com/article/10.1007/s13311-015-0387-1
Chronic ethanol exposure increases voluntary home cage intake in adult male, but not
female, Long-Evans rats (full–2015)  http://www.sciencedirect.com/science/article/pii/S0091305715300885
Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels (full-2015) http://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00314-5/fulltext
Cannabis use, depression and anxiety: A 3-year prospective population-based study (link to PDF–2015) http://www.jad-journal.com/article/S0165-0327%2815%2931030-2/abstract
Genetic deletion of monoacylglycerol lipase (MAGL) leads to impaired cannabinoid  receptor CB1 R signaling and anxiety-like behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26223500
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats  (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793117/
Cannabis in cancer care (full–2015) http://escholarship.org/uc/item/6367m6vj#page-1
Neurobiological Interactions Between Stress and the Endocannabinoid System (full–2015) http://www.nature.com/npp/journal/v41/n1/full/npp2015166a.html
Behavioral genetics: of mice, men, and internal bliss (full–2015)  http://www.cell.com/current-biology/fulltext/S0960-9822(15)00414-5
Cannabinoid Receptors May Control Aversive Memories (abstract & news – 2015)
http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by
the dorsolateral periaqueductal grey (abst–2015)  http://www.europeanneuropsychopharmacology.com/article/S0924-977X(15)00364-8/abstract
The endocannabinoid system in guarding against fear, anxiety and stress (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26585799
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595265
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at
Glutamatergic Synapses in the Rat Basolateral Amygdala (abst–2015)  http://www.sciencedirect.com/science/article/pii/S002839081530201X
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25641667
Central administration of GPR55 receptor agonist and antagonist modulates anxiety related behaviors in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25620584
Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25707713
The potential of inhibitors of endocannabinoid metabolism as anxiolytic and anti-depressive drugs-A practical view (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25791296
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25701682
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25814137
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
CB1 receptors modulate affective behaviour induced by neuropathic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863168
top

Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26099242
Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper snake (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215005898
The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815300863
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461530004X
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26271310

Effects of CB1 receptor agonism and antagonism on behavioural fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26311003
Endocannabinoid regulation of amyloid-induced neuroinflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26362942
Endocannabinoids and Mental Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408164
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26439367
top

Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26684509
Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815303259
Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development (abst–2015) http://www.sciencedirect.com/science/article/pii/S0161813X15300322
Stress and memory: A selective review on recent developments in the understanding of stress hormone effects on memory and their clinical relevance (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708929
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26747370
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Mediating processes between stress and problematic marijuana use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661989
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25034429
CB1 receptors into the Prelimbic Cortex modulate food intake in rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0278584615000068
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the
modulation of distinct panic-like responses. (abst – 2015)
https://www.ncbi.nlm.nih.gov/pubmed/25601395
Advancements in the treatment of agitation in Alzheimer’s disease. (abst – 2015)
http://www.ncbi.nlm.nih.gov/pubmed/26159445
A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel
Synthetic Cannabinoid ADB-PINACA (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25726258
Runner’s high linked to cannabinoid receptors in mice (news & abstract–2015)  http://medicalxpress.com/news/2015-10-runner-high-linked-cannabinoid-receptors.html
top

Exposure to a Highly Caloric Palatable Diet During Pregestational and Gestational  Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Adiposity and Anxiety -Like Behaviors in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00339/full
Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656987/
Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726806/
Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats  (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153327
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (full–2016) https://elifesciences.org/content/5/e14137
Genetic variation in the endocannabinoid system and response to Cognitive Behavior
Therapy for child anxiety disorders (full–2016)  http://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.32467/full
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory
and Enhances Spatial Working Memory (full–2016)  http://www.hindawi.com/journals/np/2016/9817089/
Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and
Depression-Related Behaviors Caused by Nicotine as a Stressor (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942073/
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models
Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects (full–2016)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158779
Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to
Anxiety after Social Defeat Stress (full–2016) http://www.cell.com/cell-reports/fulltext/S2211-1247(16)30851-8
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in
anxiety-like behavior in experimental autoimmune encephalomyelitis (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0682-8
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in
rats prenatally exposed to valproic acid (full–2016)  http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy
Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and
Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related
Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00454/full
Cannabis craving in response to laboratory-induced social stress among racially diverse
cannabis users: The impact of social anxiety disorder (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147424/
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent
changes in endocannabinoid signaling across species (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in
adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Solitary cannabis use frequency mediates the relationship between social anxiety and
cannabis use and related problems (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147422/
The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado (full–2016) https://peerj.com/articles/2782/
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and
Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993868/
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating
Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and
Parent Descriptive and Injunctive Normative Perceptions (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869705/
Deficient adolescent social behavior following early-life inflammation is ameliorated by
augmentation of anandamide signaling (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461973/
Interactions Between Anandamide and Corticotropin-Releasing Hormone Signaling
Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging
Genetics Strategy for Modeling Molecular Interactions (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935637/
Evidences for the anti-panic actions of Cannabidiol (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412699/
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (full–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid
Release in the Basolateral Amygdala (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978804/
Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe
nucleus by cannabinoids (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868450/
Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review  (abst-2016) https://www.ncbi.nlm.nih.gov/pubmed/27558216
Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the
United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27389672
Pharmacological management of agitation and aggression in Alzheimer’s Disease: a
review of current and novel treatments (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27137221
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26757043

Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26786379
Facilitatory effect of AM281 on recognition memory in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114015003254
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function (abst–2016) http://www.psyneuen-journal.com/article/S0306-4530%2816%2930003-8/abstract
The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809457
top

Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820636
A systematic review of plant-derived natural compounds for anxiety disorders (abst–2016) http://www.eurekaselect.com/139238/article
Concentration, population, and context-dependent effects of AM251 in zebrafish (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26883874
Involvement of M1 and CB1 receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26873081
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1043661816000396
Placebo effect: clinical, biological and therapeutical involvements in depression (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26879253
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26898326
Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26860734
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma (abst–2016) http://www.europeanneuropsychopharmacology.com/article/S0924-977X(16)00077-8/abstract
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27023732
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Pharmacological inhibition of FAAH activity in rodents: a promising pharmacological approach for psychological – cardiac comorbidity? (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416300318
Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependent Interaction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26991409
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/27317835
The association between cannabis use and anxiety disorders: Results from a population based representative sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26775742
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27349158
The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings (abst–2016) http://www.sciencedirect.com/science/article/pii/S104366181630706X
Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27427415
Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27436749
Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27502029
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816303550
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303638
Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27698427
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27716956
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816304580
Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816307999
Targeting the Endocannabinoid System in Psychiatric Illness (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27811555
Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives. (abst – 2016) http://www.jsad.com/doi/10.15288/jsad.2016.77.889
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478
Chapter Eight – The Endocannabinoid System and Anxiety (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28061971
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two
Recent Genetic Endocannabinoid Deficiency Models (abst–2016)  http://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00532-6/fulltext
Investigational drugs for treating agitation in persons with dementia (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27232589
The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27710762
LACTIC ACIDOSIS: A RARE MANIFESTATION OF SYNTHETIC MARIJUANA
INTOXICATION (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27159480
Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between
Cannabinoids and Psychosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26970364
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Treating Depression in Alcoholics (news & abst–2016)  http://neurosciencenews.com/alcoholism-depression-psychology-3541/
Changes in the Brain Endocannabinoid System in Rat Models of Depression
(full – 2017) http://link.springer.com/article/10.1007%2Fs12640-017-9708-y
Endocannabinoids: A Promising Impact for Traumatic Brain Injury. (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/
Precondition of right frontal region with anodal tDCS can restore the fear memory
impairment induced by ACPA in male mice. (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318674/
Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical
Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury
(full–2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00095/full
Addison’s Disease and Possible Cannabis Withdrawal Syndrome Presenting as an Eating
Disorder in a Thirty-Year-Old Female (full–2017)
https://www.hindawi.com/journals/crie/2017/4096021/
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of
Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in dietinduced obese pre-diabetic mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479807/
The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial
orbital cortex of mice with acute stress (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553743/
Cannabis as a substitute for prescription drugs – a cross-sectional study. (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422566/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and
Relevant Animal Studies (full – 2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions
through conditional genetic rescue in forebrain GABAergic neurons. (full – 2017)
https://link.springer.com/article/10.1007%2Fs00429-017-1411-5
Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats.
(full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440922/
Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent
Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581875/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric,
Movement and Neurodegenerative Disorders (full–2017)
http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for
the Endogenous Cannabinoid System and Neuroinflammation (full–2017)
http://journal.frontiersin.org/article/10.3389/fnbeh.2017.00015/full
Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent
Cannabidiol (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655843/
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to
amygdalar cannabinoid-1 (CB1) receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670208/
The Endocannabinoid System Differentially Regulates Escape Behavior in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655002/
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through
amygdala long-term depression in male rodents (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487270/
Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders (1st page–2017) http://jamanetwork.com/journals/jama/article-abstract/2610319
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA (full–2017) http://journals.sagepub.com/doi/abs/10.1177/0269881116684336?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Association of cannabis use with the development of elevated anxiety symptoms in the general population: a meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28053188
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131675
Extinction of avoidance behavior by safety learning depends on endocannabinoid
signaling in the hippocampus (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28222356
Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid
Amide Hydrolase Drive an Anxious Phenotype. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28209423
The effects of synthetic cannabinoids on executive function. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28160034
The Direct Actions of Cannabidiol and 2-Arachidonoyl Glycerol at GABAA Receptors
(abst – 2017) http://www.sciencedirect.com/science/article/pii/S1043661816311392
Cannabidiol regulation of emotion and emotional memory processing: relevance
for treating anxiety-related and substance abuse disorders. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28268256
Repeated Acute Oral Exposure to Cannabis sativa Impaired Neurocognitive Behaviours
and Cortico-hippocampal Architectonics in Wistar Rats. (abst – 2017)
https://www.ncbi.nlm.nih.gov/pubmed/28262852
An update on the advancements in the treatment of agitation in Alzheimer’s disease  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28300462
Anxiety sensitivity and cannabis use-related problems: The impact of race (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28295843
Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model
of social isolation stress (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0361923016303100
Cannabinoids as therapeutic for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S2352250X16302342
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the
Modulation of Anxiety (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0006322317313574
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28319590
Anxious behavior induces elevated hippocampal Cb2 Receptor gene expression (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28392296
Synthetic Cannabinoids: psychopharmacology, clinical aspects, and psychotic onset  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28412921
Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and
cannabidiol on anxiety-like responding in the light-dark emergence test in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28424834
The endocannabinoid system as a target for novel anxiolytic drugs (abst–2017)
http://www.sciencedirect.com/science/article/pii/S0149763416304699
2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate
receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28440729
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28372506
Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced
Suppression of Excitation in the Anterior Cingulate Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28520841
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of
alcohol, cigarettes, and cannabis in adolescents (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28544955
Sex- and hormone-dependent alterations in alcohol withdrawal-induced anxiety and
corticolimbic endocannabinoid signaling (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817302484
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic
stimuli: Possible involvement of the endocannabinoid and endovanilloid systems (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/19591935
User characteristics and effect profile of Butane Hash Oil: An extremely high-potency
cannabis concentrate (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30255-7/fulltext
Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
(abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28636769
CB1 and ethanol effects on glutamatergic transmission in the central amygdala of male
and female msP and Wistar rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28656627
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain
Development (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28685756
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28745306
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28757328
Substance Use in Young Swiss Men: The Interplay of Perceived Social Support and
Dispositional Characteristics (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28379109
Pharmacological challenge studies with acute psychosocial stress (abst–2017)
http://www.psyneuen-journal.com/article/S0306-4530(17)30544-9/fulltext
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse
hippocampus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28888955
Is there a role for cannabidiol in psychiatry? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28112021
Enhanced anandamide signaling reduces flight behavior elicited by an approaching robobeetle (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817304276?via%3Dihub
Acute and long-term effects of Δ9-tetrahydrocannabinol on object recognition and
anxiety-like activity are age- and strain-dependent in mice (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0091305716302672?via%3Dihub
Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats (abst–2017) http://www.sciencedirect.com/science/article/pii/S1734114017303663?via%3Dihub
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids imbalance (abst–2017) http://www.jneurosci.org/content/early/2017/06/20/JNEUROSCI.3516-16.2017
Increased in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28578250
Contribution of CB1Rs in anxiety-related behaviors but not locomotor deficits induced by methamphetamine (abst–2017) https://www.sciencedirect.com/science/article/pii/S0304394017309941?via%3Dihub#!
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29256923

Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid expression of innate anxiety and excessive alcohol intake (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29071769
Marijuana use during pregnancy: A comparison of trends and correlates among married and unmarried pregnant women (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30531-8/fulltext
Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use in older adults with and without HIV infection (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317303878?via%3Dihub
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep (abst–2017) http://journals.sagepub.com/doi/abs/10.1177/0269881117699616

From “Azalla” to Anandamide: Distilling the Therapeutic Potential of Cannabinoids (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752109/
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29083450
The association between adolescent cannabis use and anxiety: A parallel process analysis (abst–2018) https://www.sciencedirect.com/science/article/pii/S0306460317304148?via%3Dihub
Direct and indirect effects of false safety behaviors on cannabis use and related problems (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29280237


APPETITE*+
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900249/?tool=pubmed

The multiple functions of the endocannabinoid system: a focus on the regulation of food intake (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832623/?tool=pubmed
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype (full–2010) http://ajpgi.physiology.org/content/299/1/G63.full?sid=fc6948f0-78cf-405c-981b-afaa05ee417c
CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846762/?tool=pubmed
The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice (full–2010) http://www.jneurosci.org/content/30/21/7369.full
Endocannabinoid control of gastric sensorimotor function in man (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2010.04259.x/full
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis (full-2010) http://www.nature.com/npp/journal/v35/n9/full/npp201058a.html
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990160/
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food reinforced behavior (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522179/
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912197/
Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors (full–2010) http://ijnp.oxfordjournals.org/content/13/9/1247.long
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325767/
Modulation of sweet taste sensitivity by orexigenic and anorexigenic factors (full-2010) https://www.jstage.jst.go.jp/article/endocrj/57/6/57_K10E-095/_pdf
The endocannabinoid system modulates the valence of the emotion associated to food
ingestion (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116974/
The Effects of Rimonabant on Brown Adipose Tissue in Rat: Implications for Energy
Expenditure (full-2010) http://onlinelibrary.wiley.com/doi/10.1038/oby.2008.509/full
Reciprocal modulation of sweet taste by leptin and endocannabinoids (full–2010)
https://link.springer.com/chapter/10.1007%2F978-3-642-14426-4_9
Central and peripheral consequences of the chronic blockade of CB1 cannabinoid
receptor with rimonabant or taranabant (full–2010)  http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.06549.x/full
Dietary intakes in a group of marihuana smoking patients (full in Spanish, abst in English–2010) http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112010000400024&lng=en&nrm=iso&tlng=en
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but  increases food intake and obesity with age (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20936991
Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20349049
top

A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19768813
Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20100574
Bimodal control of stimulated food intake by the endocannabinoid system (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20139974
Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19800340
Analysis of gene expression pattern reveals potential targets of dietary oleoylethanol-amide in reducing body fat gain in C3H mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19954948
AM 251 differentially effects food-maintained responding depending on food palatability (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20331999
A low-Δ9tetrahydrocannabinol cannabis extract induces hyperphagia in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20975531
Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids (abst–2010) https://www.ncbi.nlm.nih.gov/pubmed/20085790
Effects of chronic nicotine on food intake and anxiety-like behaviour in CB(1) knockout
mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20189358
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists (full–2011) http://www.sciencedirect.com/science/article/pii/S0091305711000128
Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity (full–2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117918/
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011)  https://academic.oup.com/annonc/article/22/9/2086/211788/Delta-9-tetrahydrocannabinol-may-palliate-altered
The neutral cannabinoid CB₁ receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023913/
Effect of rimonabant on oesophageal motor function in man (full–2011)  http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2011.04576.x/full

Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117120/
Gut fat sensing in the negative feedback control of energy balance–recent advances (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139739/

The intersection between cannabis and cancer in the United States (full–2011) http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084524/?tool=pubmed
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210336/

Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038245/
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors (abst-2011) http://marijuana.researchtoday.net/archive/8/1/3517.htm
Cannabidiol potentiates Δ(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21667074
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors (abst–2011)  https://www.ncbi.nlm.nih.gov/pubmed/20817042
Cannabinoids in children (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295
Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and  significance (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21062423
The role of central CB2 cannabinoid receptors on food intake in neonatal chicks (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21927979
Ghrelin-mediated appetite regulation in the central nervous system (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21524673
Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21213357
Homology modelling of CB1 receptor and selection of potential inhibitor against Obesity (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/22829723?dopt=Abstract
Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402806/
Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0038609
top

Cannabinoids Facilitate the Swallowing Reflex Elicited by the Superior Laryngeal Nerve Stimulation in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507745/
Hypothalamic CB1 Cannabinoid Receptors Regulate Energy Balance in Mice (full–2012) http://press.endocrine.org/doi/full/10.1210/en.2012-1405
G-Protein-Coupled Receptors in Intestinal Chemosensation (full–2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198
Rimonabant eliminates responsiveness to workload changes in a time-constrained food reinforced progressive ratio procedure in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387812/
2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism  (full–2012) http://www.sciencedirect.com/science/article/pii/S1550413112000526
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/bph.12014/full
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake (full–2012) http://www.karger.com/Article/FullText/343563
The thrifty lipids: endocannabinoids and the neural control of energy conservation (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/22622030
Structural analogs of pyrazole and sulfonamide cannabinoids: Effects on acute food intake in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586205/
GPR119 as a fat sensor (full–2012) http://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147%2812%2900054-5
Photoperiodic Changes in Endocannabinoid Levels and Energetic Responses to Altered
Signalling at CB1 Receptors in Siberian Hamsters (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060156/
Neural Substrates Underlying Interactions between Appetite Stress and Reward (full–2012) https://www.karger.com/Article/FullText/338237
Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide
and the anorexigenic peptide YY in obesity (full – 2012)  http://www.nature.com/ijo/journal/v36/n6/full/ijo2011165a.html
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of
activity-based anorexia (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096804/?tool=pubmed
Hedonic eating is associated with increased peripheral levels of ghrelin and the
endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study (full–2012) http://press.endocrine.org/doi/full/10.1210/jc.2011-3018
Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behavior (abst–2012)  http://www.unboundmedicine.com/medline/ebm/record/22772336/abstract/Contrasting_effects_of_different_cannabinoid_receptor_ligands_on_mouse_ingestive_behaviour_
Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22133635
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22543671
The potential use of cannabidiol in the therapy of metabolic syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22430005
top

Stimulation of acumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22728691
The role of the endocannabinoid system in eating disorders: pharmacological  implications (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22785439
Modulation of sweet responses of taste receptor cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22947916
Non-Δ⁹tetrahydrocannabinol phytocannabinoids stimulate feeding in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22157176
Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study (abst–2012)
https://www.ncbi.nlm.nih.gov/pubmed/22095142
A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men (abst–2012)  http://www.unboundmedicine.com/medline/ebm/record/22133305/abstract/A_pilot_study_of_the_effects_of_cannabis_on_appetite_hormones_in_HIV_infected_adult_men_
Adult mortality and blood feeding behavioral effects of α-amyrin acetate, a novel
bioactive compound on in vivo exposed females of Anopheles stephensi Liston (Diptera:
Culicidae) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22167372
The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21981246
Anti-obesity effects of the combined administration of CB1 receptor antagonist
rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced
obese mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22473329
Rimonabant reduces the essential value of food in the genetically obese Zucker rat: An
exponential demand analysis (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22019829
Ghrelin-Induced Orexigenic Effect in Rats Depends on the Metabolic Status and Is Counteracted by Peripheral CB1 Receptor Antagonism (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060918
Food for thought: hormonal, experiential, and neural influences on feeding and obesity (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818543/
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058760/
Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659363/
Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons (full–2013) http://www.pnas.org/content/110/24/E2229.full
Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677644/
Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes (full–2013) http://www.eymj.org/DOIx.php?id=10.3349/ymj.2013.54.5.1127
top

The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080339
Fasting induces CART down-regulation in the zebrafish nervous system in a cannabinoid receptor 1-dependent manner (full–2013) http://press.endocrine.org/doi/full/10.1210/me.2011-1180
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607008/
Long-term CB1 receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691020/
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Orexin neurons use endocannabinoids to break obesity-induced inhibition (full–2013) http://www.pnas.org/content/110/24/9625.full
Developmental Role for Endocannabinoid Signaling in Regulating Glucose Metabolism and Growth (full–2013) http://diabetes.diabetesjournals.org/content/62/7/2359.full?sid=2f5bda2b-a9c7-432a-9588-80c99189164d
Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2 (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638658/
Insulin induces long-term depression of VTA dopamine neurons via endocannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072656/
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdale (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799070/
The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable
food (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720761/
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-
arachidonoylglycerol with potential anti-obesity effects (full–2013)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687659/
Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107948/article
Effect of Diet on Tissue Levels of Palmitoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107972/article
Therapeutic potential of cannabinoid medicines (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/24006213
Cannabis and Δ(9)-tetrahydrocannabinol (THC) for weight loss? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23410498
Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23398921
Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23434135
Fat to treat fat: Emerging relationship between dietary PUFA, endocannabinoids, and obesity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23466458
top

Central functional response to the novel peptide cannabinoid, hemopressin (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23542442
Cannabinoid receptors and cholecystokinin in feeding inhibition (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23601425
The endocannabinoid system in obesity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23596738
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829365
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23959001
Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24281745
The regulation of food intake by the gut-brain axis: implications for obesity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22710925
Concurrent pharmacological modification of cannabinoid-1 and glucagon-like peptide-1
receptor activity affects feeding behavior and body weight in rats fed a free-choice, high carbohydrate diet (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24370558
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23142959

Is the taste of fat regulated? (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0300908413002526
Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996326/
Effect of intermittent cold exposure on brown fat activation, obesity, and energy homeostasis in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895006/
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic NAcylethanolamines (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100365
Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/eat.22173/full
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/prp2.69/full
Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882055/
The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet (full–2014) http://www.jpp.krakow.pl/journal/archive/08_14/pdf/487_08_14_article.pdf
top

Nabilone for Non-chemotherapy Associated Nausea and Weight Loss due to Medical Conditions: A Review of the Clinical Effectiveness and Guidelines [Internet] (full-2014) http://www.ncbi.nlm.nih.gov/books/NBK253668/toc/?report=reader
Marijuana and Body Weight (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204468/
Involvement of the cannabinoid CB1 receptor in modulation of dopamine output in the prefrontal cortex associated with food restriction in rats (full–2014) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0092224
Rimonabant’s reductive effects on high densities of food reinforcement, but not palatability, in lean and obese Zucker rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036064/
Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/’Spice’ constituent JWH-018 in mice (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157458/
Is fat taste ready for primetime? (full–2014) http://www.sciencedirect.com/science/article/pii/S003193841400136X
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209357/
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin (THCv) on Food Reward and Aversion in Healthy Volunteers (full–2014) http://ijnp.oxfordjournals.org/content/18/6/pyu094.long
Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans (full–2014) http://www.jlr.org/content/55/12/2655.long
Oleoylethanolamide and Human Neural Responses to Food Stimuli in Obesity (full–2014) http://archpsyc.jamanetwork.com/article.aspx?articleid=1904805
Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide (full–2014) http://ajpregu.physiology.org/content/307/2/R167
Baseline Anandamide Levels and Body Weight Impact the Weight Loss Effect of CB1 Receptor Antagonism in Male Rats (full–2014) http://press.endocrine.org/doi/10.1210/en.2014-1730#sthash.Fbslw7v2.dpuf
top

Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standardchow diets (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772744/
Cannabinoid type-1 Receptors in The Paraventricular Nucleus of The Hypothalamus Inhibit Stimulated Food Intake (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24434770
Role of oleoylethanolamide as a feeding regulator in goldfish (full–2014) http://jeb.biologists.org/content/217/15/2761
The endocannabinoid system and appetite: relevance for food reward (full–2014) https://www.cambridge.org/core/journals/nutrition-research-reviews/article/endocannabinoid-system-and-appetite-relevance-for-foodreward/30C65E719848770761B6BEA7D0C1E9CB/core-reader
Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats (abst–2014) http://www.nutritionjrnl.com/article/S0899-9007%2814%2900297-4/fulltext
Cannabinoids, eating behaviour, and energy homeostasis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24375977
Cannabinoid type-1 Receptors in The Paraventricular Nucleus of The Hypothalamus Inhibit Stimulated Food Intake (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24434770
The endocannabinoid system controls food intake via olfactory processes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24509429
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25504799
Food intake regulation – 2nd part (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24564775
Classical endocannabinoid-like compounds and their regulation by nutrients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24677570
Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24681513
Endocannabinoids and energy homeostasis: An update (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24752980
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24930711
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part II: Comparison of Behavioural Effects of Pulmonary Versus Parenteral Cannabinoid Exposure in Rodents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24956154
GPR55: From orphan to metabolic regulator? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24972076
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24996194
New insights on food intake control by olfactory processes: the emerging role of the endocannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25261796
Oleic acid content of a meal promotes oleoylethanolamide response and reduces subsequent energy intake in humans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25347552
Truffles contain endocannabinoid metabolic enzymes and anandamide (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25433633
top

The role of gut hormones in appetite regulation (review) (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25532952
The endocannabinoid system: directing eating behavior and macronutrient metabolism (full–2015) http://journal.frontiersin.org/Journal/10.3389/fpsyg.2014.01506/full
Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Δ9-tetrahydrocannabinol (THC) (full–2015) http://www.sciencedirect.com/science/article/pii/S037663571500042X
Lack of hypophagia in CB1 null mice is associated to decreased hypothalamic POMC and CART expression (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/03/09/ijnp.pyv011.long
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility (full–2015) http://www.casereports.com/article/S2210-2612%2815%2900219-9/pdf
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa (full–2015) http://ajcn.nutrition.org/content/101/2/262.long
Leptin Levels Are Negatively Correlated with 2-Arachidonoylglycerol in the Cerebrospinal Fluid of Patients with Osteoarthritis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383333/
Interaction between orexin A and cannabinoid system in the lateral hypothalamus of rats and effects of subchronic intraperitoneal administration of cannabinoid receptor inverse agonist on food intake and the nutritive utilization of protein (full-2015) http://www.jpp.krakow.pl/journal/archive/04_15/pdf/181_04_15_article.pdf
Effects of high-fructose diets on central appetite signaling and cognitive function (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/
top

Diacylglycerol lipase α knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice (full–2015) http://journal.frontiersin.org/article/10.3389/fendo.2015.00086/full
Cannabis and Cannabinoids–for health professionals (PDQ®) (full–2015) http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all
Anticipatory and consummatory effects of (hedonic) chocolate intake are associated with increased circulating levels of the orexigenic peptide ghrelin and endocannabinoids in obese adults (full–2015) http://www.foodandnutritionresearch.net/index.php/fnr/article/view/29678
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144270
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140592
Intestinal lipid-derived signals that sense dietary fat (full–2015) http://www.jci.org/articles/view/76302/pdf
The role of AMP-activated protein kinase (AMPK) in the androgenic potentiation of cannabinoid-induced changes in energy homeostasis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25550281
top

Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-like  Behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25944409
A pivotal role for enhanced brainstem orexin receptor 1 signaling in the central cannabinoid receptor 1-mediated pressor response in conscious rats (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26096126
Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26100333
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26180248
Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26290104
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid
2-arachidonoylglycerol. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763355/
Cannabis in cancer care. (full – 2015)
http://escholarship.org/uc/item/6367m6vj#page-1
Endocannabinoid and nitric oxide interaction mediates food intake in neonatal chicken (full–2015) http://www.tandfonline.com/doi/full/10.1080/00071668.2015.1059407
Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food Restricted Rats: Involvement of CB1 Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26354043
Intestinal lipid-derived signals that sense dietary fat (link to download–2015) http://www.jci.org/articles/view/76302/pdf
Negative Regulation of Leptin-induced ROS Formation by CB1 Receptor Activation in Hypothalamic Neurons (link to PDF–2015) http://www.jbc.org/content/early/2015/04/13/jbc.M115.646885.full.pdf+html
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females (abst–2015) http://onlinelibrary.wiley.com/doi/10.1111/jhn.12298/full
Dissecting the cannabinergic control of behavior: The where matters (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26260530
Role of cannabinoidergic system on food intake in neonatal layer-type chicken (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25902906
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
ENP11, a potential CB1R antagonist, induces anorexia in rats (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0091305715300174
Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial (abst–2015)
http://www.growthhormoneigfresearch.com/article/S1096-6374(15)30017-4/abstract
New insights on the role of the endocannabinoid system in the regulation of energy balance (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26374449
Endocannabinoids and Metabolic Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408168
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metaboliic Disease (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26412154
Khat (Catha edulis F.) and cannabinoids: Parallel and contrasting behavioral effects in preclinical and clinical studies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26469212
Endocannabinoid Regulation of Neuroendocrine Systems (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638767
top

Interaction Between Endocannabinoid and Opioidergic Systems Regulates Food Intake in Neonatal Chicken (abst–2015) http://link.springer.com/article/10.1007/s10989-015-9457-9
Cannabis: a self-medication drug for weight management? The never ending story (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26456495
Intermittent access to liquid sucrose differentially modulates energy intake and related central pathways in control or high-fat fed mice (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/25484353
Providing a food reward reduces inhibitory avoidance learning in zebrafish (abst-2015) http://www.sciencedirect.com/science/article/pii/S0376635715300309
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acel.12438/full
Exposure to a Highly Caloric Palatable Diet During Pregestational and Gestational Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Adiposity and Anxiety-Like Behaviors in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00339/full
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (full–2016) https://elifesciences.org/content/5/e14137
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes (abst–2016) http://link.springer.com/article/10.1007/s12192-015-0653-5
Endocannabinoids in Feeding Behavior and Energy Homeostasis (full–2016) http://themedicalbiochemistrypage.org/endocannabinoids.php
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study  (full–2016) http://www.nature.com/tp/journal/v6/n7/full/tp2016118a.html
Endocannabinoids in the Gut (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940133/
Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats (full–2016) http://link.springer.com/article/10.1007%2Fs00213-016-4397-4
A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula (full–2016) http://www.nature.com/articles/srep32529
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040794/
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose
Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432

Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855580/
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (full–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30715-6/fulltext
Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123200/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice (full–2016) http://www.ncbi.nlm.nih.gov/pubmed/26873082
Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333956

Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302052/
The inhibitory effect of combination treatment with leptin and cannabinoid CB1 receptor agonist on food intake and body weight gain is mediated by serotonin 1B and 2C receptors (click “Free Full Text” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27512006
Behavioral Characterization of Kappa Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats (link to download–2016) http://jpet.aspetjournals.org/content/early/2016/11/30/jpet.116.235630.long
Why I chose to use cannabis (article–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791147/
Cannabinoid-glutamate interactions in the regulation of food intake in neonatal layertype chicks: role of glutamate NMDA and AMPA receptors (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27000110
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity (abst–2016) http://link.springer.com/article/10.1007/s00394-016-1153-9
Opioid and Cannabinoid System in Food Intake (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26806346
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic
review (abst in German & English-2016)  https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26880264
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome (abst–2016) http://link.springer.com/article/10.1007%2Fs40262-015-0363-2
Regulation of Growth Hormone by the Splanchnic Area (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26940386
Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415301494
Identification of the oleic acid ethanolamide (OEA) isomer cis-vaccenic acid ethanolamide (VEA) as a highly abundant 18:1 fatty acid ethanolamide in blood plasma from rats and humans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334716
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27005465
mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305997
top
Disturbances of sleep and circadian rhythms: novel risk factors for obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27584008
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738
Bisphenol A induces hypothalamic down-regulation of CB1 and anorexigenic effects in male mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27641926
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools (abst–2016) http://www.eurekaselect.com/146167/article
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Got Munchies? Estimating the Relationship between Marijuana Use and Body Mass Index (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27572145
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27935269
Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b01482
Addison’s Disease and Possible Cannabis Withdrawal Syndrome Presenting as an Eating
Disorder in a Thirty-Year-Old Female (full–2017) https://www.hindawi.com/journals/crie/2017/4096021/
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017) https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017) https://www.ncbi.nlm.nih.gov/books/NBK65755/
Inhibiting parabrachial fatty acid amide hydrolase activity selectively increases the intake of palatable food via cannabinoid CB1 receptors (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584854/
Oral Administration of the Endocannabinoid Anandamide during Lactation: Effects on Hypothalamic Cannabinoid Type 1 Receptor and Food Intake in Adult Mice (full–2017) https://www.hindawi.com/journals/jnme/2017/2945010/
Mice expressing a “hyper-sensitive” form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398885/

Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of Inhaled Δ9-Tetrahydrocannabinol and Cannabidiol Reveals No Effect on Sweet Taste Intensity Perception and Liking in Humans (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569584/
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/
Cannabinoid type 1 receptor-containing axons innervate NPY/AgRP neurons in the mouse arcuate nucleus (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369208/
Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A MiniReview (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442223/
Hedonic eating in Prader-Willi syndrome is associated with blunted PYY secretion (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475322/
Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643265/
Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688117/
A cannabinoid receptor antagonist attenuates ghrelin-induced activation of the mesolimbic dopamine system in mice (full–2017) https://www.sciencedirect.com/science/article/pii/S0031938417304274?via%3Dihub
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28065722
Central and peripheral control of food intake (link to download–2017) https://www.degruyter.com/view/j/enr.2017.51.issue-1/enr-2017-0006/enr-2017-0006.xml
Clinical Evidence for Utilizing Cannabinoids in the Elderly (link to PDF–2017) https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Is cannabis an effective treatment for joint pain? (link to PDF- 2017)

http://www.clinexprheumatol.org/abstract.asp?a=12225
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity (abst–2017) http://www.sciencedirect.com/science/article/pii/S0031938416309817
Design, Synthesis and Biological Evaluation of Novel, Non-Brain Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis (abst–2017) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b01504
N-Oleoylglycine-induced hyperphagia was associated with the activation of AgRP neuron by CB1R (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28102080
A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9- tetrahydrocannabinol, elicits hyperphagia in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28125508
Cannabinoids activate monoaminergic signaling to modulate key C. elegans behaviors  (abst–2017) http://www.jneurosci.org/content/37/11/2859.long
Oleoylethanolamide: A fat ally in the fight against obesity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28254531
The rewarding effects of ethanol are modulated by binge eating of a high-fat diet during adolescence (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301909
Effects of anandamide administration on components of reward processing during free choice (abst–2017) http://www.sciencedirect.com/science/article/pii/S0091305717301235
Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits  (abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390817302587?via%3Dihub
Endocannabinoid-dependent disinhibition of orexinergic neurons: Electrophysiological evidence in leptin-knockout obese mice (abst–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444110/
2-Arachidonoylglycerol as a possible treatment for anorexia nervosa in animal model in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28606779
Consequence of dopamine D2 receptor blockade on the hyperphagic effect induced by cannabinoid CB1 and CB2 receptors in layers (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28728428
A behavioral and pharmacological characterization of palatable diet alternation in mice (abst–2017) http://www.sciencedirect.com/science/article/pii/S0091305717305531?via%3Dihub
Anorexigenic effects induced by RVD-hemopressin(α) administration (abst–2017) http://www.sciencedirect.com/science/article/pii/S1734114017300713?via%3Dihub
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29256923
Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29286357
Short-term high-fat diet primes excitatory synapses for long-term depression in orexin neurons (abst–2017) http://onlinelibrary.wiley.com/doi/10.1113/JP275177/abstract
Role of Endocannabinoids on Sweet Taste Perception, Food Preference, and Obesity related Disorders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29293950
Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid food: implications in fat taste, appetite and food liking (abst–2018)  http://pubs.rsc.org/en/Content/ArticleLanding/2018/FO/C7FO01772C#!divAbstract
Hunger, ghrelin and the gut (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0006899318300386


ARTHRITIS
Tissue Engineering of Cartilage; Can Cannabinoids Help? (full–2010) http://www.tara.tcd.ie/bitstream/2262/40674/1/Tissue%20Engineering%20of%20Cartilage%20-%20Can%20Cannabinoids%20Help.pdf
Cannabinoid-induced apoptosis in immune cells as a pathway to immuno-suppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteo-arthritic knee joint pain (full–2010) http://www.oarsijournal.com/article/S1063-4584%2810%2900315-8/fulltext
Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132591/?tool=pubmed
top
Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of proinflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage (full–2010) https://www.jstage.jst.go.jp/article/jphs/114/1/114_10070FP/_pdf
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full–2010) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/21185649/abstract/Local_application_of_the_endocannabinoid_hydrolysis_inhibitor_URB597_reduces_nociception_in_spontaneous_and_chemically_induced_models_of_osteoarthritis_
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/

Cannabinoids for Treatment of Chronic Non-Cancer Pain; a Systematic Review of Randomized Trials (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/
Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164582/
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21683763
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Expression of cannabinoid receptors by human articular chondrocytes (abst–2011) http://www.thebonejournal.com/article/S8756-3282%2811%2900386-3/abstract
The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level (full-2012) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2012/06000/The_Effects_of_Peptide_and_Lipid_Endocannabinoids.30.aspx
Dynamic changes to the endocannabinoid system in models of chronic pain (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm? (full-2012) http://onlinelibrary.wiley.com/doi/10.1002/art.34522/full
Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449266/
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system (full-2012) http://onlinelibrary.wiley.com/doi/10.1002/art.37684/pdf
Neuromodulators for pain management in rheumatoid arthritis (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008921.pub2/abstract
Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22366523
top

Cannabinoids: novel therapies for arthritis? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22530636
Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23199705
Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22558609
Role of type 2 cannabinoid receptors in osteoarthritis (abst–2012) http://www.thebonejournal.com/article/S8756-3282%2812%2900234-7/abstract
Discovery and optimization of novel purines as potent and selective CB2 agonists.
(abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22765893
Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677619/
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice (full–2013) http://arthritis-research.com/content/15/6/R192
Osteoarthritis pain mechanisms: basic studies in animal models (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771690/
Cannabinoid WIN-55,212-2 Mesylate Inhibits Interleukin-1β Induced Matrix Metalloproteinase and Tissue Inhibitor of Matrix Metalloproteinase Expression in Human Chondrocytes (full–2013) http://www.oarsijournal.com/article/S1063-4584%2813%2900999-0/fulltext
Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes (full-2013) http://onlinelibrary.wiley.com/doi/10.1002/jor.22577/full
Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080440
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electro-acupuncture on experimental arthritis of the rat temporomandibular joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23795771
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints (full–2014) http://www.biomedcentral.com/content/pdf/1471-2474-15-258.pdf
 Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (full–2014) http://www.biomedcentral.com/1471-2474/15/275
High hopes for cannabinoid agonists in the treatment of rheumatic diseases (full–2014) http://www.biomedcentral.com/content/pdf/1471-2474-15-410.pdf
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis (full–2014) http://rheumatology.oxfordjournals.org/content/53/5/802.long
top
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201700/
CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288820/
A Systems Pharmacology Perspective on the Clinical Development of Fatty Acid Amide
Hydrolase Inhibitors for Pain (full – 2014)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910012/
Report on Medical Cannabis Research, What the Science Says (article–2014)
http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Involvement of the endocannabinoid system in osteoarthritis pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494687
Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24814038
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells (full–2015) http://www.hindawi.com/journals/mi/2015/362126/
Leptin Levels Are Negatively Correlated with 2-Arachidonoylglycerol in the Cerebro-spinal Fluid of Patients with Osteoarthritis (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383333/
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis (full–2015) http://www.arthritis-research.com/content/17/1/226
Cannabis – the Israeli perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0091/jbcpp-2015-0091.xml
Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner (full–2015) http://www.arthritis-research.com/content/17/1/321

Endocannabinoids and acute pain after total knee arthroplasty (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299927/
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770330/
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/
Deficiency of G-protein coupled receptor 40, a lipid-activated receptor, heightens in vitro- and in vivo-induced murine osteoarthritis (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935402/
The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice (full–2015) http://www.oarsijournal.com/article/S1063-4584(15)01140-1/fulltext
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A
systematic review of randomized controlled trials (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/acr.22727/full
HU-444, A Novel, Potent Anti-Inflammatory, Non-Psychotropic Cannabinoid (link to download–2015) http://jpet.aspetjournals.org/content/early/2015/08/13/jpet.115.226100.long
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601571
top
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25791728
A multi-target approach for pain treatment – dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25719612
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25974389
The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408159
Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for
Rheumatic Disorders (full–2016)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839539/
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of
inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858820/
The CB2 receptor and its role as a regulator of inflammation (full–2016)  http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26791214
Cannabinoid WIN-55,212-2 mesylate inhibits ADAMTS-4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan-1. (link to PDF- 2016) https://www.spandidos-publications.com/10.3892/mmr.2016.5137
Robust anti-nociceptive effects of MAG lipase inhibition in a model of osteoarthritis pain (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056226/
Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
Robust anti-nociceptive effects of MAG lipase inhibition in a model of osteoarthritis pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27501482
Endocannabinoids inhibit neurogenic inflammation in murine joints by a non-canonical cannabinoid receptor mechanism (abst–2016) http://www.neuropeptidesjournal.com/article/S0143-4179(16)30047-6/abstract
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27832442
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842047
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
top

Early blockade of joint inflammation with a fatty acid amide hydrolase inhibitor
decreases end-stage osteoarthritis pain and peripheral neuropathy in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445456/
Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573042/
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674828/
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685274/
Cannabidiol as a Therapy for ASIA Syndrome? An Editorial on a Novel Study (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4046
Comparative in silico analyses of Cannabis sativa, Prunella vulgaris and Withania somnifera compounds elucidating the medicinal properties against rheumatoid arthritis (abst–2017) http://www.sciencedirect.com/science/article/pii/S1093326317302735
Endocannabinoids in arthritis: current views and perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28736968
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29017758
Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis (full–2018) http://www.mdpi.com/1422-0067/19/2/342/htm


ASIA SYNDROME/AUTOIMMUNE/INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS
Cannabidiol as a Therapy for ASIA Syndrome? An Editorial on a Novel Study (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4046


ASTHMA*+
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197781/
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full – 2010)
http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20150748
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway
inflammation: role of CB1/CB2 receptors (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21056512
The role of CB2 receptor ligands in human eosinophil function (full–2012) http://www.biomedcentral.com/content/pdf/2050-6511-13-S1-A13.pdf
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst–2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/120.12?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
top
The expression of cannabinoid receptor 1 is significantly increased in atopic patients (full–2014) http://www.jacionline.org/article/S0091-6749%2813%2902936-9/fulltext
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24467410
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25356537
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS (full–2015) http://www.hindawi.com/journals/bmri/2015/980983/
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655949
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen induced pulmonary inflammation in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26850094

The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell  Permeability through an Arachidonic Acid Metabolite (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000256
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26896777
The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27216000
Δ9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB2 Receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006295216302878
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27992060
top
Innate lymphoid cells in asthma: cannabinoids on the balance (full–2017)
http://onlinelibrary.wiley.com/doi/10.1111/all.13145/epdf
Cannabis: Exercise performance and sport. A systematic review (full–2017)
http://www.jsams.org/article/S1440-2440(17)30342-0/fulltext
Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic
Symptoms in the Mouse (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732963/
Determinants of peripheral airway function in adults with and without asthma (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28397998
The case for cannabinoid CB1 receptors as a target for bronchodilator therapy for β-
agonist resistant asthma (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28641517


ATAXIA
Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain
(full–2011) http://europepmc.org/articles/PMC3157548
Targeted next-generation sequencing identifies a homozygous nonsense mutation in
ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher
syndrome type 3 (full–2012) https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-7-59
The du2J mouse model of ataxia and absence epilepsy has deficient cannabinoid CB1 receptor-mediated signalling (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764637/
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954486/
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias (full–2014) http://www.karger.com/Article/FullText/358127
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0367-5

Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983615/ Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Buzz Juice: Neurological sequelae of synthetic cannabinoids (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27865819
Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3 (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717809
Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407801/
Unintentional Cannabis Ingestion in Children: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28888560


ATHEROSCLEROSIS*+
US Patent Application 20100158973 – THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS (full–2010) http://www.google.com/patents/US20100158973
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro inflammatory responses in ApoE-knockout mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20868672
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques (full–2011) http://eurheartj.oxfordjournals.org/content/33/7/846.full
Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082575/?tool=pubmed
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
top

Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109635/?tool=pubmed
Endocannabinoid system in cardiovascular disorders – new pharmacotherapeutic opportunities (full–2011) http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha

Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells (full–2011) http://www.jci.org/articles/view/41651?search[abstract_text]=&search[article_text]=cannabinoid&search[authors_text]=&search[fpage]=&search[issue]=&search[title_text]=&search[volume
Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury (link to download–2011) http://www.eurekaselect.com/76055/article
Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21884703
The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21893466
Cannabinoids and atherosclerotic coronary heart disease (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/clc.21962/pdf
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484111/
Targeting cannabinoid receptor CB(2 ) in cardiovascular disorders: promises and controversies (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/full
Cannabinoids and atherosclerotic coronary heart disease (download–2012)  http://onlinelibrary.wiley.com/doi/10.1002/clc.21962/pdf
The potential use of cannabidiol in the therapy of metabolic syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22430005
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23253273
Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption
in focal cerebral ischemia in rats (abst–2012)  https://www.karger.com/Article/Abstract/338755
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full–2013) http://www.jlr.org/content/early/2013/03/11/jlr.M035147.long ;
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice (full–2013) http://atvb.ahajournals.org/content/33/2/215.long
Therapeutic Opportunities through the Modulation of Endocannabinoid Transport (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255948/
top
Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24020800
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23906924
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full–2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/183_04_14_article.pdf
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Role of endocannabinoid 2-arachidonoylglycerol in the physiology and pathophysiology of the cardiovascular system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934539
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
Increased oxidative stress enhances endocannabinoid tone (abst–2014) http://www.fasebj.org/content/28/1_Supplement/671.13.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf

Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25245379
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25469884
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315049/
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126839
top
Oxyradical Stress, Endocannabinoids, and Atherosclerosis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686160/
Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581537/
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Endocannabinoids and the Cardiovascular System in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408169
Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26592248
Abstract 577: Medical Marijuana Use: Effect on Lipid Metabolism and Atherosclerosis (abst–2015) http://atvb.ahajournals.org/content/35/Suppl_1/A577
The CB2 receptor and its role as a regulator of inflammation (full–2016) http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0021915015301933
Optimized extraction of 2-arachidonyl glycerol and anandamide from aortic tissue and plasma for quantification by LC-MS/MS (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27274705
N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNFα-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27281236
Selective activation of CB2 receptor improves efferocytosis in cultured macrophages  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27474129
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27465665
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review) (abst–2016) https://www.spandidos-publications.com/10.3892/ijmm.2016.2779
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27784678
The role of exercise training and the endocannabinoid system in atherosclerotic plaque burden and composition in Apo-E-deficient mice (full–2017) http://www.sciencedirect.com/science/article/pii/S1109966616302949
Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665427/
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evalulation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104528
top

Exercise versus targeting of endocannabinoid system for atheromatic plaque stabilization. Opposing or complementary roles? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1109966617301422
Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachment (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28624443
Cannabinoids in the Cardiovascular System (abst–2017) http://www.sciencedirect.com/science/article/pii/S1054358917300431?via%3Dihub
The endocannabinoid system in cardiovascular function: novel insights and clinical implications (abst–2017)  https://link.springer.com/article/10.1007%2Fs10286-017-0488-5
Prospects for the Use of Cannabinoid Receptor Ligands for the Treatment of Metabolic Syndrome and Atherosclerosis: Analysis of Experimental and Clinical Data (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29308855
Ca2+-dependent potassium channels and cannabinoid signaling in the endothelium of apolipoprotein E knockout mice before plaque formation (abst–2018) http://www.jmmc-online.com/article/S0022-2828(18)30002-6/fulltext


AUTISM+
Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child (full–2010) http://www.cannabis-med.org/data/pdf/en_2010_04_1.pdf
Can autism be triggered by acetaminophen activation of the endocannabinoid system? (link to PDF–2010) http://www.ncbi.nlm.nih.gov/pubmed/20628445
Variation in the human Cannabinoid Receptor (CNR1) gene modulates gaze duration for happy faces (full–2011) http://www.molecularautism.com/content/pdf/2040-2392-2-10.pdf
Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137184/
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693401/
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663050/
Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders (link to full–2013) http://www.sciencedirect.com/science/article/pii/S0896627313003619
Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23585028

Alterations in the endocannabinoid system in the rat valproic acid model of autism (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23643692
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
top
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/
Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140638
Endocannabinoid signaling mediates oxytocin-driven social reward (full–2015) http://www.pnas.org/content/112/45/14084.full
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25650954
Endocannabinoid Signaling in Autism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26216231
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling (full–2015) http://www.cell.com/cell/fulltext/S0092-8674(15)00826-0

Endocannabinoids and Mental Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408164
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586374
Oxytocin Enhances Pleasure of Social Interactions by Stimulating Production of “Bliss Molecule” (news/abstract–2015) http://neurosciencenews.com/oxytocin-anandamide-2926/
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907698/
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044872/
top
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453335
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit. (click “Full Text Links” for PDF–2016) http://www.ncbi.nlm.nih.gov/pubmed/26875559
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816308660
Functions of synapse adhesion molecules neurexin/neurexins and neurodevelopmental disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216301419
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation
Link between Inflammatory State and Neuro-Immune Alterations (full–2017)
http://www.mdpi.com/1422-0067/18/7/1425/htm
Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535348/

The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models (full–2017) http://www.mdpi.com/1422-0067/18/9/1916/htm
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187926
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality? (full–2017) https://www.frontiersin.org/articles/10.3389/fnsyn.2017.00015/full
Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced Suppression of Excitation in the Anterior Cingulate Cortex (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28520841
Synaptic functions of endocannabinoid signaling in health and disease (abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390817302861
The Neurobiological Bases of Autism Spectrum Disorders The R451C-Neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28921757
Treating a novel plasticity defect rescues episodic memory in Fragile X model mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29133950


AUTOIMMUNE DISORDERS
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069975/?tool=pmcentrez
A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001487
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23892791
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261058/
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004721/
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells (full–2016)  http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0603-x
Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387


 

Advertisements